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Abstract 
 Legionella pneumophila is the causative agent of Legionnaires’ disease, 
severe pneumonia acquired from inhalation of contaminated water droplets. In the 
lung, L. pneumophila infects alveolar macrophages and creates a compartment 
named the Legionella containing vacuole (LCV), which avoids degradation and 
recruits components of the secretory pathway. LCV creation depends on the action 
of the Dot/Icm system that translocates over 275 effectors into the host cell. To 
study the function of these effectors, models that approximate human disease are 
required.  
 Here, I characterise the larvae of Galleria mellonella as an infection model for L. 
pneumophila. Infection resulted in larval mortality and bacterial replication in a 
strain- and Dot/Icm-dependent manner. Flagella expression was dispensable for 
bacterial virulence, however secreted phospholipases and the Dot/Icm effector SdhA 
were shown to be important in virulence. Deletion of SdhA resulted in disruption of 
the LCV membrane and destruction of haemocytes. The importance of SdhA 
expression was confirmed in a mammalian model, validating the utility of G. 
mellonella.   
 In the second part of this study, the novel protein LtpD was characterised. LtpD 
was translocated via the Dot/Icm secretion system and localised to the LCV. A series 
of truncation mutants defined a C-terminal 153 amino acid domain as required for 
LCV localisation. This region was shown to bind directly to the lipid 
phosphoinositide 3-phosphate. Further analysis revealed that LtpD also interacted 
with the enzyme inositol monophosphatase 1, however did not change the enzyme’s 
activity in vitro. Deletion of LtpD resulted in a subtle growth defect in mammalian 
macrophages at late time points during infection. This growth defect was also seen 
the G. mellonella and mouse lungs, confirming that LtpD is a virulence factor of L. 
pneumophila. 
In summary, here I present an infection model to investigate L. pneumophila 
virulence and further characterisation of the Dot/Icm effector LtpD.  
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Chapter 1 – Introduction 
1.1 Legionella species and transmission 
 
In 1976 an outbreak of severe pneumonia occurred in Philadelphia among attendees of 
an American Legion convention. Of 182 cases of pneumonia, 147 required 
hospitalisation leading to a 45% mortality rate (Fraser et al., 1977). Less than a year 
after the first outbreak, the causative agent, a Gram-negative bacterium, was identified 
and named Legionella pneumophila. Subsequently, the atypical pneumonia caused by L. 
pneumophila was designated as Legionnaires’ disease (Brenner et al., 1979, McDade et 
al., 1977). Legionnaires’ disease has remained a public health concern with 
approximately 350 cases reported each year in the UK (Harrison et al., 2009).  
 
In the past 35 years, over 50 Legionella species have been identified, approximately half 
of which have been associated with human disease. However, over 90% of cases of 
Legionnaires’ disease are due to L. pneumophila and, of these cases, around 84% are the 
result of infection with L. pneumophila serogroup 1 although 70 serogroups have been 
described (Marston et al., 1997, Muder et al., 2002, Yu et al., 2002). After L. pneumophila, 
L. longbeachae, causative agent of 3.9% of cases all worldwide, and L. bozemanii (2.4%) 
are the next most common organisms isolated from clinical samples (Muder et al., 2002), 
with some other species being classified as pathogenic on the basis of one case study. 
This bias of human infection towards L. pneumophila serogroup 1 does not represent the 
environmental distribution of Legionella species. A large study in France found that, 
while L. pneumophila serogroup 1 accounted for 95% of clinical cases, it was only found 
in 28% of environmental isolates (Doleans et al., 2004). The distribution of 
environmental Legionella spp. varies between countries, however L. pneumophila 
appears no more common in the environment than other species that are considerably 
less associated with human disease (Harrison et al., 2009). For example, species such as 
L. anisa, L. dumoffii, or L. feeleii are frequently found in water distribution systems but 
are very rarely implicated in human disease (Doleans et al., 2004, Muder et al., 2002, Yu 
et al., 2002). This strongly suggests that L. pneumophila serogroup 1 is more virulent in 
humans than other species or serogroups, it has been suggested that this increased 
virulence is mostly due to the structure of the lipopolysaccaride (LPS) of the serogroup 1 
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strains (Cazalet et al., 2008). Interestingly, in Australia, New Zealand and Thailand 
between 30 % and 50 % of cases of Legionnaires’ disease are caused by L. longbeachae 
(Yu et al., 2002, Phares et al., 2007) however the reason for this disparity is not yet 
known. 
 
Legionnaires’ disease is caused by inhalation of contaminated aerosols, resulting in 
colonisation of the alveolar macrophages of the lung by the bacteria, leading to 
pneumonia (Fields et al., 2002). Cases of Legionnaires’ disease may be sporadic or occur 
as part of an epidemic (Diederen, 2008). Outbreaks of Legionnaires’ disease can be 
associated with air conditioning cooling towers, evaporative condensers, spa baths and 
even windscreen wiper fluid (Atlas, 1999, Declerck et al., 2009, Henke et al., 1986, 
Wallensten et al., 2010). The notable exception to this is L. longbeachae when infection is 
usually linked to contaminated soil, e.g. potting compost (O'Connor et al., 2007). 
Although Legionella is found ubiquitously in the environment, infection is almost 
exclusively associated with man-made water systems, probably due to increased 
temperatures that allow the bacteria to replicate to higher titres that usually found in 
nature. Supporting the theory that increased temperatures are important in infection, 
outbreaks have been linked to natural hot springs (Lin et al., 2007, Parthuisot et al., 
2011) but very rarely to cold water sources. Transmission appears to occur exclusively 
via aerosols and no human-to-human transmission has ever been recorded. Fatal 
pneumonia caused by L. pneumophila infection has been documented in cattle (Fabbi et 
al., 1998) and antibodies against Legionella spp. were found in domestic poultry in China 
(Pan et al., 1999) however few other reports of environmental infection of animals have 
been documented, probably due to lack of surveillance.  
1.2 Clinical presentation, diagnosis and treatment 
 
Regardless of the causative species, the clinical course of Legionnaires’ disease remains 
similar (Muder et al., 2002). Incubation period is between 2 and 10 days after exposure 
although a prodromal illness may occur, usually short-lived, with symptoms of 
headache, myalgia, asthenia (weakness), and anorexia. Legionnaires’ disease should be 
suspected in cases of pneumonia with the presence of headache, hyponatraemia and 
elevated creatine kinase levels (Diederen, 2008, Pedro-Botet et al., 2005). Altered 
mental status is somewhat indicative and depression of conciseness level is present in 
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up to 60% of patients (Muder et al., 2002). Non-specific features of Legionnaires’ disease 
include fever, non-productive cough, myalgias, rigors, dyspnoea (shortness of breath) 
and diarrhoea (Tsai et al., 1979). This spectrum of largely unspecific symptoms makes 
clinical diagnosis very difficult, for this reason empiric therapy is usually mandated in 
most patients with community-acquired pneumonia of uncertain aetiology (Diederen, 
2008). The presence of a Legionella-specific antigen in the urine of infected patients has 
been useful in diagnosis. Based on a recent analysis, this has excellent specificity for 
serogroup 1 infections however the sensitivity is low, especially for nosocomial 
infections and it is unable to detect non-pneumophila Legionella species (Shimada et al., 
2009). The gold standard in diagnosis remains appropriate microbiological testing. Risk 
factors for the development of Legionnaires’ disease include increasing age, a history of 
heavy smoking and impaired respiratory and cardiac function. Immunocompromised 
patients are also at increased risk (Den Boer et al., 2006). Mortality rates are highly 
variable, ranging from less than 1 % to as high as 80 %, depending on the underlying 
health of the patient, the promptness of specific therapy, and whether the disease is 
sporadic, hospital acquired, or part of a large outbreak (Diederen, 2008). 
 
Legionnaires’ disease has proved difficult to treat, sensitivity results from in vitro 
models such as broth and agar culture have proved unreliable and many antibiotics with 
good activity in vitro have no effect on clinical cases (Pedro-Botet et al., 2005) and the 
bacteria is naturally resistant to several antibiotics (Suter et al., 1997). As Legionella is 
found within cells, drugs that can better penetrate cell membranes are preferred such as 
macrolides, quinolones, tetracyclines, and rifampicin (Edelstein, 1995). Although few 
clinical trials have been done, data suggests azithromycin and fluoroquinolones, 
especially levofloxacin have the best outcomes (Edelstein, 1995, Pedro-Botet et al., 
2005).  
 
1.3 Biogenesis of the Legionella containing vacuole  (LCV) 
Conventionally, phagocytes such as macrophages internalise and isolate foreign 
particles in a specialised vacuole called a phagosome. This fuses sequentially with 
components of the endosomal network resulting in an acidified phago-lysosome and 
degradation of the pathogen (Garin et al., 2001). This process is characterised by the 
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sequential acquisition of markers of endosomal trafficking on the phagosome 
membrane. Initially, the vacuole fuses with early endosomes and acquires the small 
GTPase Rab5 and early endosomal antigen 1 (EEA1). This leads to the recruitment of 
late endosomes and acquisition of the markers Rab7 and lysosome-associated 
membrane glycoproteins (LAMPs). Accumulation of LAMPs and hydrolases (such as 
cathepsin D) results in the fusion of tubular lysosomes with the phagosome, leading to 
the accumulation of vacuolar H+ATPase (v-H+ATPase) on the membrane. This promotes 
the acidification of the vacuole, activation of hydolases and degradation of the particle 
(for detailed reviews of endosomal trafficking, see (Grant et al., 2009, Murphy et al., 
2009, Sun-Wada et al., 2009).  
L. pneumophila subverts the normal trafficking pathway, simultaneously evading 
endosomal trafficking and selectively recruiting mitochondria and components of the 
secretory pathway to form a specialised vacuole named the Legionella containing 
vacuole (LCV). Within 5 - 10 minutes post-internalisation, L. pneumophila recruits the 
resident ER proteins BiP and calnexin (Derre et al., 2004, Tilney et al., 2001). 
Characteristically, L. pneumophila recruits proteins of the secretory pathway such as 
Rab1 and the soluble N-ethylaleimide-sensitive factor attachment protein receptor 
(SNARE) Sec22b that are recruited to the LCV within the first few hours of infection 
(Derre et al., 2004, Kagan et al., 2002). Alternatively, most markers for the endosomal 
trafficking pathway including Rab5, EEA1, LAMP1 and cathepsin D are either absent 
from the LCV or their acquisition is delayed until 18 - 24 h post infection (Clemens et al., 
2000a, Sturgill-Koszycki et al., 2000, Swanson et al., 1995). Interestingly, Rab7, usually a 
marker of late endosomes, is found on the LCV by 3 h post infection although another 
protein usually found on the same compartment, the mannose-6-phosphate receptor, is 
absent (Clemens et al., 2000b, Urwyler et al., 2009b). By 4 - 6 h post infection the LCV is 
studded with ribosomes and ultrastructurally resembles the rough endoplasmic 
reticulum (ER) (Abu Kwaik, 1996, Swanson et al., 1995). It has previously been reported 
that vacuolar H+ATPase, a key step in vacuole acidification, was not recruited to the LCV 
during infection (Lu et al., 2005). However, recent evidence including two proteomic 
studies and the discovery of a bacterial translocated protein, SidK, which binds 
H+ATPase directly, have confirmed that H+ATPase is found on the LCV (Shevchuk et al., 
2009, Urwyler et al., 2009b, Xu et al., 2010). Replication of L. pneumophila occurs 
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between 4-10 hours post infection. Unlike vacuoles progressing along the normal 
phagocytic pathway, the LCV maintains a neutral pH until approximately 10 - 18 hours 
post infection (Swanson et al., 1995).  
Two separate, proteomic analyses of the host cell components of the LCV have provided 
more detail about the composition of this compartment. 566 host proteins were 
identified from infected Dictyostelium including known constituents such as calnexin 
and Rab1 and novel components such as Rab8 (Shevchuk et al., 2009, Urwyler et al., 
2009b). This fairly comprehensive analysis of host proteins will assist in further 
developing our understanding of LCV biogenesis. One of these studies also discovered 
inositol monophosphatase 1 (IMPA1), a key enzyme in inositol biosynthesis and a rate-
limiting step in the production of phosphoinositides, which are important molecules in 
L. pneumophila infection (Atack et al., 1995). Although IMPA1 has not previously been 
implicated in bacterial infection, inhibition of IMPA1 has pleotropic effects on cellular 
function including modulation of second messenger signalling (King et al., 2009), 
autophagy (Sarkar et al., 2006) and cell death (De Meyer et al., 2011).  
The recruitment of mitochondria to the LCV is characteristic of L. pneumophila infection 
(Horwitz, 1983, Oldham et al., 1985). The bacterial protein HtpB, a surface located 
chaperonin has been implicated in this process, as it can recruit mitochondria when 
ectopically expressed on latex beads (Chong et al., 2009). However, the molecular details 
of how HtpB is able to recruit mitochondria have not been defined and the relevance to 
bacterial replication is currently unknown. 
The host cell factors that are required for bacterial replication have also been 
investigated. Double-stranded RNA interference (RNAi) targeting ER-to-Golgi transport 
in a Drosophila cell line found that several small GTPases such as Rab1, Sec22b and Bet5 
were required for bacterial replication (Dorer et al., 2006, Derre et al., 2004) however, 
few individual hits were found, supporting evidence that L. pneumophila has multiple 
mechanisms to hijack the secretory pathway. One of the single protein hits that was 
found to be required for bacterial replication was Rab5c (Dorer et al., 2006). Rab5c is a 
protein of unknown function that has previously been found on the LCV (Clemens et al., 
2000a). Sar1 and ARF1 were also found to be required for bacterial replication (Dorer et 
al., 2006). Interestingly, knock down of the inositol-5-phosphate phosphatase OCRL1 
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increased L. pneumophila replication, even though it was selectively recruited to the LCV 
during infection (Weber et al., 2006).  
 
1.3.1 The role of autophagy in L. pneumophila infection 
 
The contribution of autophagy to L. pneumophila infection is a subject of some debate. 
Autophagy is a process by which damaged organelles and proteins are engulfed in a 
double-membrane vesicle derived from the ER and trafficked to the lysosome for 
degradation, (see (Xie et al., 2007) for a review). Autophagy is an important component 
of the host defence to intracellular pathogens and many bacteria are either degraded by 
or specifically target this pathway (Shahnazari et al., 2011). A key step in autophagy is 
the lipidation of a protein first discovered in yeast named Atg8 (LC3 in humans) and its 
localisation on the autophagosme membrane (Xie et al., 2007). Initially, the observation 
that Legionella resided in vacuole that resembled the autophagosome suggested that 
autophagy was involved in LCV biogenesis (Sturgill-Koszycki et al., 2000, Swanson et al., 
1995). Further work by Swanson et al suggested that L. pneumophila infection activated 
the autophagy process in macrophages, and the autophagy enzymes Atg7 and Atg8 were 
transiently recruited to the LCV (Amer et al., 2005), however these results have not 
since been replicated.  
 
Mounting evidence suggests that autophagy is responsible for inhibiting bacterial 
replication. Knockdown of another key autophagy component, Atg5, resulted in 
increased bacterial replication (Matsuda et al., 2009). Studies have shown that 
autophagy was not essential for bacterial replication in D. discoideum and that L. 
pneumophila replicated slightly better in cells with no functional autophagy pathway 
(Otto et al., 2004, Tung et al., 2010). In addition, another group has shown infection with 
L. pneumophila blocks autophagy through a translocated effector protein, RavZ, that was 
found to irreversibly deconjugate Atg8 from its lipid anchor, preventing autophagy 
(Choy et al., 2012). Recently, it has emerged that triggering of autophagy in infected 
macrophages by activation of the inflammasome. Up-regulation of autophagy results in 
protection of the cells from the deleterious effects of pyroptosis (Byrne, 2013) This 
evidence suggests that, at least in amoebae, autophagy restricts L. pneumophila 
replication and that the bacteria have at least one strategy to inhibit this pathway. The 
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conflicting results obtained from macrophages suggest that the picture may be more 
complex than first believed, however chemical activation of autophagy was shown to 
inhibit L. pneumophila replication (Matsuda et al., 2009) suggesting that this may be a 
conserved mechanism.  
1.3.2 The host cell response to L. pneumophila infection  
 
In response to intracellular pathogens such as L. pneumophila, mammalian cells can 
initiate innate immune responses, potentially leading to activation of caspase-1 and 
initiation of pyroptosis, a form of inflammatory programmed cell death (Miao et al., 
2011). Death of the host cell prevents replication of the bacteria, leading to eventual 
clearance of the infection. In the case of L. pneumophila infection, the host cell protein 
Naip5 (neuronal apoptosis inhibitory protein 5) recognises and directly binds to 
Legionella flagellin. This interaction promotes association of Naip5 with the Nod-like 
receptor protein 4 (NLRC4) and the formation of the inflammasome, activating caspase-
1 and leading to the up-regulation of cell death (Lightfield et al., 2008, Molofsky et al., 
2006, Zhao et al., 2011). Naip5 and NLRC4 interaction also promotes LCV fusion with the 
lysosome, acidifying the vacuole and preventing Legionella from replicating (Amer et al., 
2006). Underlining the importance of this pathway, knock down of hNaip results in 
enhanced L. pneumophila replication (Vinzing et al., 2008). Interestingly, while knock-
out of NLRC4 resulted in significantly enhanced replication, knock-out of caspase-1 
resulted in an intermediate response (Pereira et al., 2011), suggesting that recognition 
of flagella by Naip5-NLRC4 results in activation of both caspase-1-dependent and -
independent responses.  
 
As well as recognition of the flagella by macrophages, the release of nucleic acids by L. 
pneumophila has been shown to have a role in induction of innate immune response. L. 
pneumophila RNA is recognised by the cytoplasmic receptor RIG-1 which induces a type 
1 interferon response (Monroe et al., 2009, Lippmann et al., 2008), a response which has 
been shown to have a role in bacterial clearance in vivo (Lippmann et al., 2011). L. 
pneumophila DNA has also been reported to activate innate immune responses via 
transcription to RNA in the cytoplasm by the pol III pathway (Chiu et al., 2009), however 
these results could not be duplicated (Monroe et al., 2009) and the relevance of DNA 
release in immune activation is still under debate. Complicating the picture futher, it 
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appears that different responses are activated in response to infection in the epithelial 
A549 cell line and in murine macrophages (Monroe et al., 2009, Opitz et al., 2006). 
Future studies will further dissect the pathways involved.  
 
1.4 Legionella in the environment 
 
Environmentally, Legionella lives in oligotrophic aquatic surroundings and has been 
detected from pH 5.0 to pH 9.2 (Atlas, 1999). In contrast, Legionella is a fastidious 
organism when grown as a pure culture, L. pneumophila requires media in a narrow pH 
range supplemented with iron salts and amino acids and several Legionella species 
appear to be obligate intracellular parasites (La Scola et al., 2004). In order to survive in 
the nutrient-poor environment, Legionella is believed to exist as part of complex, multi-
species biofilms (Declerck, 2009, Rogers et al., 1994). Although pure biofilms of L. 
pneumophila have been observed under laboratory conditions (Piao et al., 2006, Hindre 
et al., 2008, Pecastaings et al., 2010), in the environment Legionella appear to be a 
secondary colonizer of established biofilms (Declerck, 2009, Stewart et al., 2012). 
Biofilms provide bacteria with a nutrient-rich environment and protection from 
environmental hazards; however, they are also the ideal hunting ground for predatory, 
free-living, single celled protozoa. By infecting these erstwhile predators, amoebae 
provide Legionella with plentiful nutrients, a niche for intracellular replication and help 
protect it from biocides, antibiotics and other cleaning and sterilization techniques 
(Barker et al., 1992). It has been hypothesised that Legionella merely persists within 
biofilms with almost all replication occurring within amoebae (Declerck, 2009) however 
the true balance of intracellular to extracellular replication is likely to be complex and is 
not currently well understood.  
 
1.5 Evolution of Legionella as an ‘accidental pathogen’ 
 
Legionella is often described as an ‘accidental human pathogen’; the adaptations make it 
a successful pathogen of amoebae also allow it to infect human macrophages. As no 
person-to-person transmission occurs, humans have exerted no evolutionary pressure 
on Legionella. Rather, the ability of L. pneumophila to colonize macrophages probably 
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reflects conservation of cellular pathways between human macrophages and 
environmental phagocytic hosts. Membrane trafficking events appear similar between 
infection of unrelated protozoan species and mammals (Fields, 1996, O'Connor et al., 
2011) and Legionella has infection strategies important in infection of protozoa that are 
not required for replication in macrophages (Chen et al., 2004, Hervet et al., 2011), 
bolstering the notion that the virulence strategy of Legionella has been shaped by 
selective pressures in aquatic ecosystems. Experimentally, Legionella has been shown to 
be capable of infecting a number of phylogenetically unrelated free-living protists 
including at least 14 species of fresh water amoeba, protozoa and the soil amoebae 
Dictyostelium discoideum (Hsu et al., 2009, Rowbotham, 1980, Solomon et al., 2000, 
Steinert et al., 1997) and is probably capable of infecting more species in the 
environment. Consequently, Legionella spp, are considered to have a broad host range, 
although differences in replication between L. pneumophila strains has been 
documented (Buse et al., 2011) and some species of amoebae are more restrictive than 
others (O'Connor et al., 2011).  
 
Genome sequences of eight L. pneumophila strains have been published, Philidelphia-1, 
Paris, Lens, Alcoy, Corby and 130b (Cazalet et al., 2004, Chien et al., 2004, D'Auria et al., 
2010, Glockner et al., 2008, Schroeder et al., 2011, Gomez-Valero et al., 2011b). 
Comparison between genomes has shown L. pneumophila is a diverse species with 7 – 
11 % of genes unique to each strain (Gomez-Valero et al., 2009). Although an 
intracellular lifestyle is usually associated with significant genome reduction, Legionella 
pneumophila encodes over 3,000 protein-coding genes (Cazalet et al., 2004) compared to 
only around 2,100 for the closely related obligate intracellular pathogen Coxiella burnetii 
(Seshadri et al., 2003). The need to establish a replicative niche in the face of significant 
host variation may be the selective pressure driving genome expansion in Legionella 
spp. (Moliner et al., 2010). Legionella is naturally competent for DNA uptake and 
appears to have acquired genes from a variety of sources including eukaryotes (Cazalet 
et al., 2004, Chien et al., 2004, Franco et al., 2009). In addition, all strains sequenced 
encode DNA conjugation systems (Cazalet et al., 2004, Chien et al., 2004, Schroeder et al., 
2011, Gomez-Valero et al., 2011b) and appear to be able to actively share genes between 
species. Although in many cases gene acquisition is too ancient to clearly identify its 
source, phylogenetic analysis of the L. pneumophila protein LegS2 confirmed that the 
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most likely origin of the gene is from a protozoan host (Degtyar et al., 2009) and many 
other Legionella proteins contain motifs likely to have been acquired from eukaryotic 
hosts (Habyarimana et al., 2008, Nagai et al., 2002, Price et al., 2010).  
 
This ability to acquire genes from a range of hosts and distribute genes throughout the 
species probably contributes to the fitness of the bacterium as a pathogen (Moliner et al., 
2010). One hypothesis of the evolution of Legionella as a eukaryotic pathogen is that the 
Legionella genome was assembled in a modular fashion, building on a core genome that 
was sufficient for extracellular replication and possibly intracellular replication in 
limited hosts (O'Connor et al., 2011). Genes that provided an advantage in some hosts 
were kept, while any that gave a serious disadvantage were lost. The lack of negative 
selection pressures resulted in an expanded genome and a broad host range (O'Connor 
et al., 2011, Moliner et al., 2010). This hypothesis was supported by recent experiments 
using mouse macrophages. Interestingly, when L. pneumophila replication was restricted 
to macrophages for hundreds of generations a number of mutations arose, including in a 
flagella regulator fleN and a several genes in the lysine biosynthetic pathway, resulting 
in lysine auxotrophy (Ensminger et al., 2012). These mutations decreased fitness in 
amoebae infection (Ensminger et al., 2012), supporting the hypothesis that host cycling 
in the environment is crucial in the maintenance of a broad host range and expanded 
genome for Legionella.  
 
However, host cycling in the environmental does not necessarily explain why L. 
pneumophila has strategies to avoid host defence pathways not found in amoebae. L. 
pneumophila proteins have been identified that target apoptosis (Banga et al., 2007) and 
NF-κB phosphorylation and activation (Ge et al., 2009, Losick et al., 2010), pathways that 
are not present in protozoan species (Al-Quadan et al., 2012). The evolutionary origin of 
these strategies is unknown, it is possible that Legionella is targeting pathways in 
amoebae and effect on other pathways in mammalian cells is incidental. In support of 
this, the secreted virulence protein SidF has been shown to directly interfere with 
apoptotic signalling in macrophages (Banga et al., 2007). However, recently it has been 
shown to also act on an evolutionary conserved component of phosphoinositide 
signalling, which is important in infection of amoebae (Hsu et al., 2012). 
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1.6 Secretion systems of Legionella pneumophila  
 
In order to survive and replicate, L. pneumophila requires the export of proteins from 
the cytosol of the bacteria, through the inner and outer bacterial membranes, to the 
extracellular environment or directly into the host cell. These proteins then allow L. 
pneumophila to hijack host cell processes and prevent degradation of the bacteria. The 
bacteria achieve this through the expression of various secretion systems, specialised 
multi-protein complexes for the transport of large molecules. The structural 
characteristics of the major Gram-negative bacterial secretion systems are summarised 
in Figure 1.8.1. L. pneumophila is known to express a type I, type II and type IV secretion 
systems and the major genes involved are summarised in Table 1.8.1. Additionally, all of 
the genes which are required for the Sec pathway with the exception of secG have been 
identified, however the L. pneumophila Sec pathway has not yet been characterised 
(Lammertyn et al., 2004). A twin-arginine transport 
(Tat) pathway has also been identified in L. 
pneumophila and appears to have a role in bacterial 
replication in macrophages, biofilm formation and 
motility (De Buck et al., 2005, De Buck et al., 2004). The 
contribution of the Tat pathway to replication within 
amoebae appears to be more complex, in one L. 
pneumophila strain it was required, however was 
largely dispensable in another (De Buck et al., 2005, 
Rossier et al., 2005). Further determination of 
substrates for this pathway will assist in the 
characterisation of its role during infection.  
 
L. pneumophila encodes all of the components of a type 
1 secretion system (named Lss) including a membrane 
fusion protein (LssD). This may have a role in 
Legionella biology but does not appear to be required 
for host-pathogen interactions (Jacobi et al., 2003) and 
has not been extensively studied. More interesting is 
the type II secretion system (T2SS), named the 
Figure 1.6.1 Structural 
overview of the major 
secretion systems found in 
L. pneumophila.  
Reprinted by permission 
from Macmillan Publishers 
Ltd: Nature Review 
Microbiology (Fronzes et al., 
2009) © 2009.  
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Legionella secretion pathway (Lsp), found in all sequenced strains of L. pneumophila 
(Rossier et al., 2004). Mutants in structural components of the T2SS show severely 
attenuated replication in Hartmannella vermiformis and A. castellanii, some attenuation 
in replication in macrophages and reduced capacity to replicate in the lungs of mice 
compared to wild type L. pneumophila (Rossier et al., 2009, Rossier et al., 2004). As well 
as its role during infection, the T2SS also appears crucial for L. pneumophila survival at 
low temperatures, an important consideration in environmental persistence (Soderberg 
et al., 2008). 
 
At least 27 proteins have been identified as being secreted by this pathway (DebRoy et 
al., 2006) however, individual knockouts of these proteins does not appear to affect 
Legionella’s ability to replicate within host cells. One exception to this is ProA, a zinc 
metalloprotease required for efficient replication in H. vermiformis but not in other host 
cell models (Rossier et al., 2009). The acyltransferase PlaC and the phospholipse PlaA, is 
also secreted by the Lsp pathway. The activities of these secreted phospholipases appear 
to overlap and may be able to complement for each other, as individual deletions did not 
affect virulence in macrophages or amoebae (Banerji et al., 2005, Flieger et al., 2002, 
Aurass et al., 2013).  
 *No functionally has been shown. Table adapted from (De Buck et al., 2007) 
 
Table 1.1 Major structural proteins and secreted substrates of four of the 
secretion systems found in L. pneumophila 
Secretion system  Structural proteins  Confirmed substrates  
Type I Lss system*  LssX, Y, Z, A, B, D  No substrates identified  
Type II Lsp system  Prepilin peptidase PilD, 
pseudopilins LspF, G, H, I, J, 
K, LspD, E, LspC, LspL, LspM  
Zinc metalloprotease 
ProA/Msp, RNase, acid 
phosphatases, lipases LipA 
and LipB, phospholipase C 
PlcA, lysophospholipase A 
PlaA, phospholipase A PlaB, 
acyltransferase PlaC, 
chitinase  
Type IVA Lvh 
system  
LvhB2, 3, 4, 5, 6, 7, 8, 9, 10, 
11, LvhD4  
Plasmid DNA  
 Type IVB Icm/Dot 
system  
IcmV, W, X, DotA, B, C, D, 
IcmT, S, R, Q, P, O, N, M, L, K, 
E, F, C, D, J, B, F, H  
Plasmid DNA, over 300 other 
confirmed protein substrates, 
see text for details 
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1.6.1 The Type IV Secretion Systems  
 
Type four secretion systems (T4SS) are ancestrally related to the conjugation systems 
found in diverse Gram-positive and Gram-negative bacterial species which are used to 
transfer DNA between strains and species, potentially contributing to bacterial fitness 
and virulence (Cascales et al., 2003). The T4SS is able to translocate both DNA (Vogel et 
al., 1998) and proteins into bacterial or eukaryotic cells (Nagai et al., 2002). Based on 
structural and organisational similarities and evolutionary relationships, T4SS have 
been divided into three groups; T4ASS, T4BSS and genomic island associated (GI)-T4SS 
(Alvarez-Martinez et al., 2009, Juhas et al., 2008). T4ASS are defined as being similar to 
the archetypal Agrobacterium tumefaciens Vir system (Alvarez-Martinez et al., 2009) and 
are distinct from the T4BSS, the archetype being the L. pneumophila Dot/Icm secretion 
system, which is related to the type 1 conjugation machinery (Christie et al., 2000, 
Lawley et al., 2003). The structure of the core complex of the T4ASS A. tumefaciens Vir 
system has recently been determined (Fronzes et al., 2009), however structural 
similarities between the T4ASS and T4BSS are currently unknown.   
 
Among the eight published, sequenced L. pneumophila strains, three distinct T4ASSs 
have been described: Lvh, Trb-1 and Trb-2 (Ridenour et al., 2003, Samrakandi et al., 
2002, Segal et al., 1999b, Gomez-Valero et al., 2011a). In the Corby strain, Trb-1 and Trb-
2 are localised on mobile genetic elements (Glockner et al., 2008) however have not 
been extensively characterised and will not be discussed further. The prevalence of the 
secretion systems varies between strains, for example, the 130b strain encodes two Lvh 
secretion systems (Schroeder et al., 2011) while the Corby strain does not encode any 
(Glockner et al., 2008). It is not currently known how the variation between secretion 
systems affects virulence of the bacteria.  
 
The Lvh (Legionella vir homologues) T4ASS is not required for intracellular bacterial 
replication in macrophages and amoeba, but appears to have a role in infection at lower 
temperatures (Ridenour et al., 2003) and inclusion into Acanthamoeba castellanii cysts 
(Bandyopadhyay et al., 2007). Interestingly, in L. pneumophila strains Philadelphia, Paris 
and Lens, the lvh region is encoded in a region that either occurs integrated in the 
chromosome or can be excised as a plasmid-like element in a growth-phase dependent 
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manner (Steinert et al., 2007, Doleans et al., 2006). However, in the 130b strain two lvh 
gene clusters were found integrated into the chromosome and were apparently acquired 
separately (Schroeder et al., 2011). The role of the Lvh secretion system is not well 
understood and further work is required to appreciate the contribution of this system to 
infection.  
 
While the role of the Lvh secretion system during infection remains enigmatic, 
investigation of another type IV B secretion system (T4BSS), the defective in organelle 
trafficking/intracellular multiplication (Dot/Icm) translocation system has proved more 
fruitful. Two groups independently discovered the Dot/Icm secretion system in the early 
1990’s. Repeated passage of L. pneumophila on low salt agar led to the isolation of a 
mutant defective in intracellular replication in macrophages, a phenotype that could be 
complemented by the addition of an operon containing icmWXYZ (Brand et al., 1994, 
Marra et al., 1992). Separately, the group of Ralf Isberg found a gene, named dotA, 
required in preventing phago-lysosome fusion (Berger et al., 1993). Both the 
intracellular multiplication and organelle trafficking defects could be complemented by 
the addition of a single locus (Berger et al., 1993). This locus was later identified as a 
double-membrane spanning T4BSS. The Dot/Icm T4BSS is found only in Legionella and 
the related species Coxiella burnetii (Segal et al., 1999b) however, it is highly conserved 
between Legionella strains and species (Franco et al., 2009), highlighting its 
evolutionary importance. The Dot/Icm secretion system has been shown to be crucial 
for entry of the bacteria into host cells, the creation and maintenance of the LCV and 
bacterial exit from cells (Hilbi et al., 2001, Kirby et al., 1998, Marra et al., 1992). 
 
The Dot/Icm secretion system is made up of 25 proteins encoded in two clusters in 
separate regions of the chromosome (reviewed by (Segal et al., 2005)), approximately 
twice as many genes as the archetypal Vir T4ASS. Of these, only four have homologues in 
the Vir system and few of the Dot/Icm components have been characterized in detail. 
DotA, a large, transmembrane protein of unknown function localised to the bacterial 
inner membrane, is required for proper functioning of the complex through and 
unknown mechanism (Nagai et al., 2001, Roy et al., 1998). The core complex of the 
Dot/Icm secretion system is made up of DotF and DotG that span the bacterial inner and 
outer membranes, this complex then interacts with the lipoproteins DotC and DotD 
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which mediate the localisation of DotH in the outer membrane (Nakano et al., 2010, 
Vincent et al., 2006b). DotB and DotO are homologues of VirB11 and VirB4 respectively 
and both are functional ATPases containing Walker box domains and appear to be 
required to supply the system with energy for translocation (Sexton et al., 2004b, Segal 
et al., 2005). Two other proteins, IcmF and DotU, are required for the stability of the 
complex (Sexton et al., 2004a). Interestingly, homologues of these proteins are also 
required for protein secretion in the type VI secretion system (Filloux et al., 2008) and 
were important in the discovery of this system.  
 
Also important in the translocation of proteins across the T4BSS is the type IV coupling 
protein complex (T4CP). This complex is required for two functions, first it links the 
substrates with the secretion machinery and second it provides energy for the 
translocation. Dot/Icm substrates bind to a complex of IcmS/IcmW in the cytoplasm 
which acts as a chaperone (Cambronne et al., 2007). This complex then interacts directly 
the T4SS-adaptor DotL. DotL interacts with the Dot/Icm apparatus proteins DotM and 
DotN, potentially leading to the translocation of the protein across the membranes 
(Sutherland et al., 2012, Vincent et al., 2006a, Vincent et al., 2012). Interestingly, not all 
Dot/Icm substrates require binding to IcmS/IcmW for translocation (Ninio et al., 2005, 
Sutherland et al., 2012) however, whether these proteins require other, currently 
unidentified, chaperones is unknown.  
 
1.6.2 Substrates of the Dot/Icm secretion system 
 
L. pneumophila encodes an unusually large number of substrates for the Dot/Icm 
secretion system. Substrates of the Dot/Icm secretion system have been identified using 
a number of methods including bioinformatically, (Burstein et al., 2009, Ensminger et al., 
2009, Schroeder et al., 2011, Cazalet et al., 2004), by expression induced by known 
response regulators (Zusman et al., 2007), inter-bacterial transfer (Zhu et al., 2011), 
presence of a recognised motif (Huang et al., 2011) or by screening open reading frames 
for the ability to restore translocation of a recognizable antigen to the LCV (Huang et al., 
2011) as well as by other methods (de Felipe et al., 2008).  
These methods have led to the identification and validation of over 275 effector proteins 
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that are injected into the host cell (Burstein et al., 2009, Ensminger et al., 2009, Zhu et al., 
2011) from one strain alone. Considering the effector plasticity between strains, there is 
expected to be well over 300 effector proteins translocated by L. pneumophila. In 
contrast, around 30 effector proteins have been validated for the type III secretion 
system of Salmonella (McGhie et al., 2009), 39 for the type III secretion system of 
Escherichia coli (Tobe et al., 2006), five for the T4ASS of Agrobacterium tumefaciens 
(Gelvin, 2009) and six for the T4ASS of Brucella abortus (Marchesini et al., 2011), 
demonstrating that L. pneumophila is unusual in the sheer quantity of effector proteins 
encoded. Figure 1.6.2 and Table 1.6.1 give an overview of the function of a number of the 
characterised T4BSS effector proteins, which are described in greater detail in the 
following sections. 
 
Initially, it was found that the translocation signal for the T4ASS was located in the 
carboxyl terminal of proteins involved in conjugative DNA transfer (Vergunst et al., 
2000), this was later confirmed for the Dot/Icm secretion system and it was shown that 
only 20 amino acids could be sufficient for translocation (Nagai et al., 2005). However, 
translocation efficiency of substrates into the host cell is not uniform and other 
sequences in the protein substrate were shown to modulate the translocation (Nagai et 
al., 2005). Although no consensus sequence has been defined, it has been shown that 
many Dot/Icm substrates contain three glutamate residues arranged in triangle on an 
alpha-helix in the carboxy terminus which are required for translocation (Huang et al., 
2011). However, although novel Dot/Icm substrates were discovered using this motif, 
not all substrates have this domain and in some cases, the carboxy terminus is 
dispensable for translocation (Chen et al., 2007, Dolezal et al., 2012), suggesting that the 
picture may be complex.  
 
Interestingly, translocated substrates often include motifs usually associated with 
eukaryotic proteins such as ankyrin repeats (Habyarimana et al., 2008, Habyarimana et 
al., 2011), F-boxes (Lomma et al., 2010, Price et al., 2010), ADP-ribosylation factor 
domains (Nagai et al., 2002) and coiled coil repeats (Chen et al., 2004) among others. In 
addition, effectors were shown to have generally lower G+C contents than the 
surrounding genome (Burstein et al., 2009). Interestingly, the established L. 
pneumophila host Tetrahymena thermophila also has an AT rich genome (Eisen et al., 
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2006), which lends weight to the hypothesis that many of these genes have been 
acquired from Legionella’s eukaryotic hosts. Substrates of the Dot/Icm system show high 
functional redundancy; gene deletion mutants rarely have a replication defect (Bardill et 
al., 2005, Newton et al., 2008) even when an entire family of related proteins is deleted 
(Heidtman et al., 2009). Supporting this, a L. pneumophila mutant lacking around 30 % 
of Dot/Icm substrates was indistinguishable from the wild type in growth in 
macrophages (O'Connor et al., 2011), which makes characterisation of effector proteins 
challenging. Recently, it was shown that by combining RNAi and L. pneumophila mutants 
defective in effector proteins, several families of redundant effectors could be 
determined which acted on similar cellular pathways, providing an important tool for 
investigating redundancy between proteins (O'Connor et al., 2012).  
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Figure 1.6.2 Diagram of the known functions of selected L. pneumophila Dot/Icm 
effector proteins.  
Dotted lines indicate unknown pathways. For more details see text.  
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Table 1.2 Summary of the function of selected effectors 
Effector Function Binding 
Partner  
Ref. 
AnkB E3 ubiquitin ligase, farnesylated by 
host cell 
SCF complex, 
ParvB 
(Price et al., 2009, 
Lomma et al., 2010, 
Price et al., 2010) 
AnkX Transfers phosphocholine moiety to 
Rabs 
Rab1-GTP, 
Rab35-GTP 
(Mukherjee et al., 
2011, Tan et al., 
2011a) 
LegK1 Phosphorylates IκB – results in NF-κB 
activation 
 (Ge et al., 2009) 
LegK2 Recruits ER-derived vesicles to LCV Unknown (Hervet et al., 2011) 
Lem3 Removes phosphocholine from Rab1 Rab1-GTP (Tan et al., 2011a) 
LepA Promotes L. pneumophila release from 
protozoa 
Unknown (Chen et al., 2004) 
LepB Rab1 GAP Rab1 (Ingmundson et al., 
2007) 
LidA Prevents GAPs from binding to Rab1-
GTP 
Rab1-GTP, Rab6, 
Rab8, PtdIns(3)P 
(Neunuebel et al., 
2011, Urwyler et al., 
2009b, Weber et al., 
2006) 
Lgt1-3 Glucosyltransferases eEF1A (Belyi et al., 2008) 
LnaB Activates NF-κB signaling Unknown (Losick et al., 2010) 
LubX Targets SidH and Clk1 for 
proteosomal degradation 
Clk1, SidH (Kubori et al., 2010) 
RalF Arf1 GEF Arf1-GDP (Nagai et al., 2002) 
RavZ Deconjugates PE from LC3, preventing 
autophagy 
LC3 (Choy et al., 2012) 
SdhA Required for LCV-membrane integrity 
in macrophages 
Unknown (Creasey et al., 
2012) 
SetA Glycosyltransferase but target 
unknown 
PtdIns(3)P (Jank et al., 2012) 
SidC Recruits ER-derived vesicles to LCV PtdIns(4)P (Ragaz et al., 2008, 
Weber et al., 2006) 
SidD DeAMPylates Rab1 Rab1-GTP (Tan et al., 2011b) 
SidF Phosphoinositide phosphatase 
produces PtdIns(4)P, inhibits 
apoptosis 
Bcl-rambo, 
BNIP3, 
PtdIns(3,4)P2, 
PtdIns(3,4,5)P3 
(Banga et al., 2007, 
Hsu et al., 2012) 
SidH Unknown LubX (Kubori et al., 2010) 
SidI Inhibits host protein synthesis eEF1A,  eEF1B (Shen et al., 2009) 
SidK Inhibits v-ATPase through preventing 
ATP hydrolysis 
VatA (Xu et al., 2010) 
SidL Inhibits protein synthesis Unknown (Fontana et al., 
2011) 
SidM 
(DrrA) 
Rab1 GEF and AMPylates Rab1 PtdIns(4)P, Rab1 (Machner et al., 
2006, Muller et al., 
2010, Brombacher 
et al., 2009) 
VipA Nucleates actin, interferes with 
endosomal trafficking 
Actin (Franco et al., 2012) 
VipD Interferes with endosomal trafficking  Rab5, Rab22 (Ku et al., 2012) 
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1.6.3 Manipulation of small GTPases by L. pneumophila T4SS substrates 
 
Small GTPases are enzymes that bind and hydrolyse guanosine triphosphate (GTP) to 
guanosine diphosphate (GDP). When bound to GTP, small GTPases are active while GDP-
bound GTPases are inactive, proteins known as GTPase activating proteins (GAPs) 
promotes GTP hydrolysis while GTPase exchange factors (GEFs) replace bound GDP 
with bound GTP (Stenmark, 2009). There are several large families of GTPases including 
the Rab and Arf families that are crucial regulators of vesicular trafficking and other 
important host cell processes (D'Souza-Schorey et al., 2006). This functionality makes 
them key target for several intracellular pathogens, including L. pneumophila.  
 
RalF (for 'required for the recruitment of ARF1 to the Legionella phagosome) was the 
first Dot/Icm substrate to be identified. RalF is an ARF1 guanine exchange factor (GEF) 
and is required for the recruitment of ADP-ribosylation factor 1 (ARF1) to the LCV 
(Nagai et al., 2002). ARF1 is an activator of phospholipase D and has a central role in 
vesicular trafficking in intra-Golgi transport (D'Souza-Schorey et al., 2006). Nonetheless, 
while functional ARF1 is required for Legionella replication (Dorer et al., 2006, Kagan et 
al., 2002), RalF has been shown to be dispensable. L. pneumophila without the gene does 
not recruit ARF1, however the vacuole matures normally and there is no defect in 
replication (Nagai et al., 2002). It has been hypothesised that Legionella evolved an array 
of proteins allowing the exploitation of ARF-dependent host cellular processes, however 
no other effectors that target ARF1 have yet been discovered. It has been suggested that 
RalF was acquired relatively recently by horizontal gene transfer and would have 
benefited L. pneumophila by endowing these bacteria with the intrinsic ability to activate 
ARF, alleviating an absolute dependence on a host-encoded ARF-GEF (Nagai et al., 2002). 
 
Rab1 is a key regulator of ER to Golgi traffic and a target for several L. pneumophila 
Dot/Icm substrates. Rab1 is recruited to the LCV in a T4BSS-dependent manner early in 
infection where it appears to be important in the acquisition of ER-derived vesicles, 
however it is lost by approximately 4 hours post infection (Conover et al., 2003, Derre et 
al., 2004, Neunuebel et al., 2011). This is a highly regulated process requiring a number 
of bacterial proteins. SidM is a multi-functional protein; the C-terminal domain anchors 
it to the membrane (Brombacher et al., 2009) and stimulates Rab1 activation by 
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functioning as a guanine nucleotide exchange factor (GEF) (Machner et al., 2006). The N-
terminal region of SidM adenosine monophosphorylates (AMPylates) Rab1, thus 
restricting access of GTPase activating proteins (GAPs), rendering Rab1 constitutively 
active (Muller et al., 2010). Rab1 activation is further stimulated by LidA which binds 
Rab1, Rab6 and Rab8 directly (Machner et al., 2006, Urwyler et al., 2009b), stabilises the 
Rab1-guanine nucleotide interaction and protects Rab1 from GAPs and nucleotide 
extraction (Neunuebel et al., 2011). However, Legionella also encodes SidD which 
preferentially de-AMPylates Rab1 (Tan et al., 2011b) and LepB which inactivates Rab1 
by stimulating GTP hydrolysis (acting as a GAP), regulating removal of Rab proteins 
from membranes (Ingmundson et al., 2007, Mihai Gazdag et al., 2013). Interestingly, 
LepB can act as a GAP for a number of Rabs including Rab8 and Rab35, suggesting its 
role may be broader than first thought (Mihai Gazdag et al., 2013). Previously it was 
reported that LepB and its homologue LepA were required for bacterial escape from the 
LCV in amoebae however this does not fit well with the observed GAP activity (Chen et 
al., 2004, Chen et al., 2007). During infection, translocated levels of both SidD and LepB 
increase by about 3 hours post infection as levels of SidM decrease (Neunuebel et al., 
2011), demonstrating the temporal regulation of Rab1 recruitment. Another protein, 
AnkX, is catalyses the addition of a phosphocholine moiety to Rab1 which can have 
consequences for the activation of the GTPase (Mukherjee et al., 2011, Oesterlin et al., 
2012). This modification can be reversed by the adjacent gene Lem3 (Tan et al., 2011b) 
however, neither AnkX nor Lem3 are required for efficient intracellular growth and, 
unlike SidM and SidD, are expressed at similar levels throughout infection (Tan et al., 
2011a). Thus L. pneumophila is able to recruit, activate, de-activate and remove Rab1 
from the LCV over the course of 4 - 5 hours. However, although the pathway has been 
established in great detail, its relevance to LCV biogenesis and bacterial replication is 
still debatable, L. pneumophila lacking both SidM and LidA has only a slight growth 
defect late in infection (Machner et al., 2006) and silencing of Rab1 in Drosophila 
phagocytic cells did not result in a growth defect (Dorer et al., 2006).  
 
Recently, another effector with a role manipulating small GTPases was discovered. VipD 
was initially shown to interfere with endoplasmic reticulum-to-Golgi transport and 
multivesicular body formation at the late endosome in yeast (Shohdy et al., 2005) and to 
have phospholipase A2 activity, although the function of this domain is currently 
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unknown (Ku et al., 2012). Recently, VipD was shown to directly interact with Rab5 and 
Rab22, key regulators of endosomal trafficking (Ku et al., 2012). Interestingly, VipD does 
not appear to affect any posttranslational modifications however prevents downstream 
Rab-effector proteins from binding, the first bacterial effector protein found to act in this 
way (Ku et al., 2012).  
 
1.6.4 L. pneumophila T4SS substrates affecting cell death 
 
It was initially believed that Legionella infection induced apoptosis of infected 
macrophages through the activation of caspase-3 (Gao et al., 1999, Neumeister et al., 
2002, Zink et al., 2002). However, it is now recognized that Legionella delays apoptosis 
until very late stages of replication in a Dot/Icm dependent manner (Abu-Zant et al., 
2007) and anti-apoptotic effector proteins have been identified. The T4SS effector SidF 
interacts with and inhibits the cell death-inducing activity of BNIP3 and Bcl-rambo (two 
non-canonical, pro-apoptotic members of Bcl-2 protein family) preventing apoptosis 
(Banga et al., 2007). The inhibition of apoptosis has previously been linked to NF-kB 
activation, so it is to the bacteria’s advantage to promote NF-kB activation during 
infection. During L. pneumophila infection of epithelial cells, activation of NF-kB is 
biphasic. Initially it is activated through flagellin binding toll-like receptor 5 (TLR5) 
however, activation is sustained for several hours in a flagellin-independent, Dot/Icm-
dependent manner (Bartfeld et al., 2009). A number of T4SS substrates appear to be able 
to promotes this sustained activation, LegK1 has the ability to phosphorylate and induce 
degradation of the NF- κB inhibitor IκB, resulting in sustained activation (Ge et al., 
2009). LnaB is required for sustained activation through a currently unknown 
mechanism (Losick et al., 2010) and LubX also appears to modulate the activation 
although its contribution to the phenotype seen during infection is unknown (Bartfeld et 
al., 2009).  
1.6.5 L. pneumophila T4SS substrates affecting protein synthesis 
 
Many bacteria including Pseudomonas aeruginosa, Shigella flexneri and Escherichia coli 
target the host cell protein translocation machinery (Popoff, 1998). Elongation factor 
eEF1A plays a key role in ribosome-dependent protein synthesis as well as having a role 
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in a number of other cellular processes including proteosomal degradation of incorrectly 
folded peptides, lipotoxic cell death, apoptosis and regulation of actin cytoskeleton and 
cell morphology (for a review of the function of eEF1A see (Mateyak et al., 2010). 
Legionella encodes several proteins that target eEF1A including the Legionella 
glucosyltransferases Lgt1, Lgt2 and Lgt3. These proteins covalently attach glycosyl 
moieties, altering the target protein’s function (Belyi et al., 2006) and ectopically 
expressing these proteins resulted in the inhibition of protein synthesis (Belyi et al., 
2006, Belyi et al., 2008). In addition the Dot/Icm effector SidI interacts directly with 
eEF1A and eEF1B, inhibiting host protein translation and promoting the stress response 
(Fontana et al., 2011, Shen et al., 2009) and SidL inhibits protein translocation through 
an unknown mechanism (Fontana et al., 2011). 
 
The utility of these proteins during infection is still unclear, it has been hypothesised 
that Ltg1 may act as a lethal toxin and help the bacteria escape from the cell, or that the 
down-regulation of protein synthesis may slow cellular defences (Belyi et al., 2011). 
Recently it has been shown that the inhibition of protein synthesis by concerted action 
of five Legionella effector proteins, Lgt1-3, SidI and SidL, results in the activation of the 
MAPK pathway in macrophages (Fontana et al., 2012). Although amoebae do have a 
MAPK pathway which is modified by L. pneumophila Dot/Icm effector proteins (Hervet 
et al., 2011), activation of the MAPK pathway in macrophages results in a pro-
inflammatory response that may help restrict bacteria replication. This may suggest that 
L. pneumophila evolved to take advantage of the MAPK pathway in amoebae; however, in 
macrophages inhibition of protein synthesis is detected by immune surveillance systems 
and leads to activation of MAPK pathway and restriction of bacterial growth.  
 
1.6.6 Exploitation of phosphoinositides by L. pneumophila T4SS substrates 
 
Phosphatidylinositols are a large family of negatively charged, short-lived lipids found as 
a minor component of eukaryotic cellular membranes. Structurally, they are made up of 
fatty acid tails attached to a glycerol backbone with a myo-inositol head group capable of 
undergoing phosphorylation at three positions, as shown in Figure 1.5.2. 
Phosphatidylinositol monophosphates (PtdInsP), bisphosphates (PtdInsP2) and 
trisphosphate (PtdInsP3) have all been found in eukaryotes and are known collectively as 
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phosphoinositides (PtdIns). Kinases and phosphatases involved in the modification of 
phosphoinositides are localised to specific subcellular compartments, resulting in very 
precise control of the spatial and temporal distribution 
of PtdIns within the cell (Payrastre et al., 2001, Roth, 
2004). The major subcellular localisation of various 
phosphoinositides in mammalian cells is summarised in 
Table 1.8.1. This specificity makes PtdIns ideal as 
signalling molecules and scaffolds for a number of 
aspects of cellular biology including cellular and lipid 
signalling and membrane trafficking (Saarikangas et al., 
2010, Roth, 2004). For example, accumulation of 
PtdIns(4,5)P2 in the plasma membrane is required for 
activity of phospholipase C, a crucial signalling molecule 
in a number of pathways (Falkenburger et al., 2010) and 
the presence of PtdIns(3)P on early endosomes is 
required for recruitment of early endosome antigen 1 
(EEA1) and Rab5 and further endocytic trafficking 
(Murphy et al., 2009).  
 
Pathogenic bacteria have developed various mechanisms to subvert phosphoinositide 
function and multiple phosphoinositide species have been shown to have critical roles in 
the pathogenesis of a number of intra- and extracellular bacteria (Ireton et al., 1999, 
Niebuhr et al., 2002, Pizarro-Cerda et al., 2004). Usually, phagosomes are rich in 
PtdIns(3)P due to its key role in endosomal trafficking (Deretic et al., 2007) however, L. 
pneumophila acts to specifically up-regulate the concentration of PtdIns(4)P in the LCV 
membrane. It achieves this through a number of complementary pathways. RNAi 
demonstrated that PtdIns 4-kinase IIIβ was a major source of PtdIns(4)P on the LCV 
(Brombacher et al., 2009). However, the localisation of PtdIns 4-kinase IIIΒ during 
infection has not been determined and there is currently no suggestion as to how 
Legionella alters the activity of this kinase (Brombacher et al., 2009, Weber et al., 2006). 
In addition, shortly after internalisation, L. pneumophila recruits oculocerebrorenal 
syndrome of Lowe protein (OCRL1), an inositol  
 
Figure 1.6.3 The major 
structural features of 
PtdIns.   
Numbers represent the 
sites      available     for 
phosphorylation. 
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  Adapted from (Falkenburger et al., 2010)  
 
polyphosphate 5-phosphatase, to the LCV where it dephosphorylates PtdIns(4,5)P2 to 
PtdIns(4)P, further increasing the concentration of PtdIns(4)P in the LCV (Weber et al., 
2009b). Depletion of OCRL1 resulted in reduced phagocytosis of L. pneumophila, 
however promoted intracellular bacterial replication, suggesting that OCRL1 may be 
involved in restricting bacterial growth (Weber et al., 2009b). The L. pneumophila 
secreted protein LpnE directly interacts with OCRL1 however is not required for OCRL1 
recruitment to the LCV (Weber et al., 2009b). LpnE has also been shown to be involved 
in entry of L. pneumophila to macrophages and amoebae however it is not known if this 
is via its interaction with OCRL1 (Newton et al., 2007, Newton et al., 2006). OCRL1 is 
implicated in Golgi to ER transport and has a role in actin accumulation during 
phagocytosis and is targeted by a number of bacterial pathogens (Lowe, 2005). 
Manipulation of OCRL1 has also been seen during infection with other pathogens, 
Listeria monocytogenes, recruits OCRL1 to promote actin polymerisation at the site of 
bacterial attachment (Kuhbacher et al., 2012), and both OCRL1 and PtdIns(4)P have 
been found on the membrane of the Chlamydia inclusion body in Chlamydia pneumoniae 
and trachomatis infection (Moorhead et al., 2012) suggesting that targeting of OCRL1 is a 
common mechanism within intracellular bacteria.  
 
However, L. pneumophila does not only exploit host cell proteins to accumulate 
PtdIns(4)P on the LCV. The T4SS substrate SidF, previously shown to have a role in anti-
apoptotic signalling, is a phosphatidylinositol polyphosphate 3-phosphatase, removing 
the D3 phosphate from PtdIns(3,4)P2 and PtdIns(3,4,5)P3 and promoting the 
Table 1.3 Summary of the major subcellular localisations of 
phosphoinositides in eukaryotic cells.  
Phosphoinositide Major subcellular localisation 
PtdIns(3)P  Early endosomes 
PtdIns(4)P  Golgi 
PtdIns(5)P  ? 
PtdIns(3,4)P2  Early endosomes 
PtdIns(4,5)P2  Plasma membrane 
PtdIns(3,5)P2  Multi vesicular endosome/late endosome 
PtdIns(3,4,5)P3  Plasma membrane 
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accumulation of PtdIns(4)P on the surface of the LCV (Hsu et al., 2012, Banga et al., 
2007). The alteration in lipid composition of the membrane results in the LCV 
resembling the cis-Golgi, assisting in the recruitment of secretory vesicles to the vacuole. 
The activity of SidF is also required for the recruitment of other PtdIns(4)P binding 
proteins as described below (Hsu et al., 2012).  
 
After specifically accumulating PtdIns(4)P on the LCV, Legionella uses it to anchor 
Dot/Icm substrates to the membrane. For example, the T4SS-substrate SidC specifically 
binds PtdIns(4)P and recruits ER-derived vesicles to the LCV (Ragaz et al., 2008, Weber 
et al., 2006). SidM also binds PtdIns(4)P and appears to compete with SidC for binding to 
the LCV, the presence of SidC reduces the amount of SidM associated with the vacuole 
(Brombacher et al., 2009). While the function of PtdIns(4)P in the LCV is well 
documented, recently several Dot/Icm substrates have been discovered that interact 
with PtdIns(3)P. In vitro, LidA, the glycohydrolase SetA and the non-T4SS substrate 
LpnE bind PtdIns(3)P (Jank et al., 2012, Weber et al., 2006, Weber et al., 2009b), 
however the abundance of PtdIns(3)P in the LCV is not currently known. PtdIns(3)P is 
usually associated with early endosomes and early endosomal markers such as Rab5 
and early endosomal antigen 1 (EEA1), which directly interacts with PtdIns(3)P, have 
been shown to be specifically excluded from the LCV (Clemens et al., 2000a). However 
the presence of SetA and LidA on the LCV implies either that PtdIns(3)P is present or 
that, in vivo, these proteins bind to a different anchor.  
 
1.6.7 L. pneumophila T4SS substrates involved in ubiquitination 
 
SidH is a confirmed Dot/Icm substrate whose function is currently unknown. 
Interestingly, SidH appears to be temporally regulated by another T4SS-substrate, LubX 
an U-box containing E3 ubiquitin ligase, which targets SidH for degradation by the 
proteosome by 1 h post infection (Kubori et al., 2010). This provided the first evidence 
of a bacterial metaeffector, an effector protein that targets and directly regulates other 
effectors. LubX was previously shown to ubiquinate the host cell protein Clk1 (Cdc2-like 
kinase 1) and appears to have a role in the sustained activation of NF-κB during 
infection (Bartfeld et al., 2009, Kubori et al., 2008). Inhibition of Clk1 results in 
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significantly reduced Legionella replication (Kubori et al., 2008). Deletion of LubX 
resulted in hypervirulence of the strain in a Drosophila model of infection, however 
deletion of SidH did not appear to significantly affect virulence (Kubori et al., 2010) 
suggesting that the role of Clk1 may be more important during infection. 
 
The F-box containing protein AnkB is another ubiqitin ligase and is required for L. 
pneumophila replication in macrophages, protozoa and mice. AnkB interacts with the 
host ubiquitin ligase SCF1 (Skp1-Cullin-F-box protein) complex and is involved in the 
recruitment of ubiquitinated proteins to the LCV by providing a platform for docking of 
the proteins to the membrane (Price et al., 2009). The effector also appears to reduce 
ubiquitination of the host cell protein ParvB (Lomma et al., 2010, Price et al., 2009). 
AnkB is anchored into the LCV membrane by the host farnesylation machinery and this 
localisation is required for the proteins function (Price et al., 2010). Interestingly, the 
polyubiquitinated proteins that AnkB recruits to the LCV are targeted for proteosomal 
degradation and appear to be an important nutrient source for the bacteria as in the 
absence of AnkB, the growth defect can be rescued by the addition of amino acids to the 
media (Price, 2011).  
 
1.6.8 Substrates involved in vacuolar biogenesis  
 
Several other effectors have been shown to contribute to vacuolar biogenesis. SidK 
interacts with VatA, a key component of the proton pump H+ATPase, the binding leads 
to the inhibition of ATP hydrolysis and proton translocation, preventing acidification of 
the LCV (Xu et al., 2010). LegK2 is a kinase whose activity essential for ER recruitment to 
the LCV and for intracellular proliferation in A. castellanii (Hervet et al., 2011). Whether 
the activity of LegK2 is required for intracellular proliferation in mammalian cells is still 
to be determined. Recently it has been suggested that two novel effectors, LecE and 
LpdA, can act either directly or through host enzymes to alter the concentrations of the 
important lipid second messengers diacylglycerol (DAG) and phosphatidic acid (PA) 
(Viner et al., 2012) within the host cell however it is not known what the effects of this 
would be during infection. 
 
SdhA is a highly conserved Dot/Icm substrate found in all currently sequenced L. 
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pneumophila strains, L. longbeachae and L. drancourtii. Infection of macrophages in the 
absence of SdhA resulted in rapid host cell death, characterised by caspase activation 
and mitochondrial disruption (Laguna et al., 2006, Monroe et al., 2009, Ge et al., 2012). 
Interestingly, SdhA is one of the few recognised Dot/Icm substrates that is crucial in the 
replication of L. pneumophila in mouse macrophages (Laguna et al., 2006). Recently, it 
has been shown that SdhA is able to maintain the stability of the LCV, deletion of SdhA 
resulted in the destabilization of the LCV and the expulsion of the bacteria into the 
cytoplasm (Creasey et al., 2012). Cytosolic bacteria are then recognised by cytosolic 
receptors, leading to the degradation of the bacteria and death by pyroptosis via 
caspase-11 activation (Aachoui et al., 2013, Ge et al., 2012). The disruption of the LCV in 
the absence of SdhA was mainly attributed to the activity a secreted phospholipase 
named PlaA; abolishing the phosopholipase activity of PlaA suppressed the cell death 
phenotype of the ΔSdhA strain (Creasey et al., 2012). Deletion of SdhA did not 
significantly affect bacterial replication in amoebae (Laguna et al., 2006) suggesting that 
LCV stability is less important in this cell type, possibly due to less sophisticated 
cytosolic recognition and cell death pathways.  
 
1.7 Entry of Legionella to the host cell 
 
L. pneumophila is a pathogen of professional phagocytes and it appears that the main 
mechanism of entry of the bacteria into host cells is phagocytosis, it has been reported 
that L. pneumophila Knoxville is phagocytosed via a classical zipper-like mechanism 
(Rechnitzer et al., 1989). Phagocytic entry, but not adherence, of the bacteria into both 
macrophages and amoebae appears to require expression of the Dot/Icm secretion 
system (Hilbi et al., 2001) suggesting that effector proteins have a role in promoting 
uptake. An atypical method of phagocytosis of Legionella, termed coiling phagocytosis, 
has been observed both in mammalian cells and amoebae (Bozue et al., 1996, Horwitz, 
1984). Nonetheless, coiling phagocytosis appears uncommon, not reliant on the Dot/Icm 
secretion system, is not seen in all strains of L. pneumophila and has been observed in 
the entry of other pathogens to macrophages, implying that coiling phagocytosis is of 
little direct relevance to Legionella infection (Horwitz, 1984, Rechnitzer et al., 1989, 
Rittig et al., 1992).  
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Macropinocytosis has also been suggested as a mechanism of entry of some strains of L. 
pneumophila into phagocytes (Peracino et al., 2010, Watarai et al., 2001) however the 
relevance of this pathway is not well understood. L. pneumophila is able to invade non-
professional phagocytes, as epithelial cells are also susceptible to infection (Chang et al., 
2005, Garduno et al., 2002, Molofsky et al., 2004). Recently, it was shown that 
filamentous L. pneumophila require binding to E-cadherin and β1 integrin receptors 
expressed on lung epithelial cells (Prashar et al., 2012). This promotes the gradual 
uptake by phagocytosis and breakdown of the bacteria to short rods, which can then 
replicate. Phosphatidylinositol 3-kinase (PI-3K) activity is crucial in conventional 
phagocytosis; however, its involvement in the internalization of Legionella remains 
controversial. L. pneumophila entry was unaffected in macrophages treated with the PI-
3K inhibitor wortmannin and in D. discoideum lacking two PI-3K isoforms (Khelef et al., 
2001, Weber et al., 2006). However, others showed PI-3K inactivation actually increased 
Legionella internalization (Peracino et al., 2010) and it has also been shown that PI-3-
kinase activity is required for non-opsonic phagocytosis of the bacteria in macrophages 
(Tachado et al., 2008). The use of different cells lines in the various studies may account 
for the some of the reported discrepancies however more research is required to fully 
understand the role of PI-3K in L. pneumophila infection. 
 
1.8 The life cycle of Legionella pneumophila 
 
Legionella has a biphasic lifestyle and cycles between two distinct stages, characterised 
by altered physical properties and patterns of gene expression. In Legionella these are 
known as the replicative form (RF) and the transmissive form (TF) (Hammer et al., 
1999). When conditions are favourable, e.g. after establishing an intracellular niche in a 
new host, transmissive traits are repressed and the bacteria replicate. However, as 
nutrients become limiting, the bacteria differentiate, repressing replicative traits and 
expressing traits that assist in the escape from the vacuole and infection of a new host, 
e.g. motility and environmental resistance (Byrne et al., 1998, Molofsky et al., 2003). One 
example of a transmissive trait is the ability to evade or delay lysosomal degradation. 
When macrophages are infected with Legionella, the vacuole initially avoids fusion with 
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the lysosomal pathway until about 10 - 15 hours post infection, then the vacuole begins 
to acquire lysosomal markers and the LCV undergoes acidification. Acidification of the 
LCV does not inhibit bacterial replication at this point. Legionella genetically locked in 
the TF form can survive and form a vacuole within macrophages but cannot replicate 
(Molofsky et al., 2003) while the RF cannot avoid fusion with the lysosome when used to 
infect macrophages and is quickly degraded (Joshi et al., 2001). It appears that the TF is 
required for infection and prevents phagosome maturation to allow the differentiation 
into the RF that is able to survive the harsh conditions and replicate. This bi-phasic life 
style can be approximated in broth culture; transmissive traits are repressed in the 
exponential phase of growth and expressed as the bacteria enter the post-exponential 
phase (Hammer et al., 1999).  
 
It has also been proposed that there is a third stage in the life cycle of L. pneumophila, 
the mature intracellular form (MIF). This was considered after it was noticed that 
passage through amoebae increased the virulence of of L. pneumophila compared to 
broth grown culture (Cirillo et al., 1999, Cirillo et al., 1994, Faulkner et al., 2008) and 
that co-infection of mice with of L. pneumophila and a protozoan host resulted in 
increased bacterial replication (Brieland et al., 1994). MIFs are formed intracellularly in 
amoebae, epithelial cells and, to a lesser extent, macrophages and appear to have many 
of the characteristics of TFs. However, MIFs were more infectious, displayed increased 
resistance to rifampicin and gentamicin, better-resisted detergent-mediated lysis, and 
tolerated higher pH than TFs (Faulkner et al., 2002, Garduno et al., 2002). These changes 
are accompanied by an increase in cytoplasmic inclusions, inner membrane 
invaginations and changes in the membrane structure (Faulkner et al., 2002).  
 
The switch between RF and TF is closely associated with the regulation of motility in L. 
pneumophila. L. pneumophila expresses a single, polar flagella and flagellar-associated 
proteins and type IV pili which is used in twitching motility and in attaching to host cells, 
are upregulated in TF (Hayashi et al., 2010). The flagella of L. pneumophila do not appear 
to be required for intracellular replication in cell culture models, however, does have a 
role in the invasion of both macrophages and amoebae (Dietrich et al., 2001).  
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1.8.1 Regulation of virulence in L. pneumophila  
 
As the switch between RF and TF is so important in the ability of L. pneumophila to infect 
and replicate within host cells, it is under tight regulatory control. After several rounds 
of replication within a vacuole, amino acids are depleted, leading to the induction of the 
bacterial stringent response (Hammer et al., 1999) which leads to the synthesis of 
guanosine pentaphosphate (ppGpp),. An increase in ppGpp concentration activates the 
LetAS two component system, the activity of which can be amplified by expression of the 
regulator, LetE (Bachman et al., 2004). Activation of LetA directly promotes the 
transcription of the small, non-coding RNAs rsmYZ, which bind directly to and represses 
the activity, of the global post-transcriptional regulator CsrA (Sahr et al., 2009, Molofsky 
et al., 2003). The LetAS-rsmYZ-CsrA signalling pathway is involved in the control of a 
number of important virulence traits including motility and environmental persistence 
(Hammer et al., 2002) and expression of the key virulence genes dotA and mip (Shi et al., 
2006). In addition, sigma factor σs encoded by the rpoS gene contributes to this 
regulatory cascade. σs is not required for growth in rich media, however deletion  
Figure 1.8.1 Diagram summarising three two component regulatory systems 
found in L. pneumophila.  
Adapted from (Altman et al., 2008) 
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severely inhibits replication in amoebae and primary macrophages. LetA regulates the 
expression of rsmYZ (Rasis et al., 2009) which affects the expression of many Dot/Icm 
substrates and other virulence factors including genes involved in arginine biosynthesis 
(Hovel-Miner et al., 2009). 
 
Although the LetAS pathway is undoubtedly important in regulating L. pneumophila’s 
virulence, other two component systems also have crucial roles. The PmrA response 
regulator regulates multiple virulence genes including structural components and 
substrates of the Dot/Icm secretion system, substrates of a type II secretion system and 
many others (Zusman et al., 2007, Al-Khodor et al., 2009). PmrA also binds directly to 
CrsA, demonstrating that there is crosstalk between the regulatory pathways (Rasis et 
al., 2009). Legionella also encodes the CpxRA system, which has been shown to directly 
regulate expression of genes involved in the Dot/Icm secretion system and Dot/Icm 
substrates (Gal-Mor et al., 2003, Altman et al., 2008).  
 
1.9 Infection models used to investigate L. pneumophila infection 
 
1.9.1 Environmental protists as models of L. pneumophila infection 
 
Single-celled amoebae such as Acanthamoeba castellanii and Hartmannella vermiformis 
are environmental hosts of L. pneumophila (Valster et al., 2011) and have proved to be 
effective model organisms that have significantly contributed to the understanding of 
the bacteria’s intracellular lifestyle (Abu Kwaik, 1996, Cirillo et al., 1994). However, 
although these are closest to the natural hosts of Legionella, genetic tools have only 
recently become available (Bateman, 2010). This has led to the soil amoebae 
Dictyostelium discoideum becoming the prevalent protozoan model organism as it can 
readily be genetically modified and creation of gene deletion mutants is comparatively 
simple (Solomon et al., 2000). The D. discoideum model has gave insight in the role of 
autophagy in the replication of L. pneumophila (Otto et al., 2004), demonstrated that the 
host cell proteins myosin 1 and OCRL repress Legionella replication (Solomon et al., 
2000, Weber et al., 2009b), has increased our understanding of the role of 
phosphoinositides in infection (Peracino et al., 2010) and has been invaluable in 
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determining the proteome of the LCV (Shevchuk et al., 2009, Urwyler et al., 2009b).  
1.9.2 Mammalian cell lines and in vivo models for L. pneumophila infection 
 
Mammalian cell culture models have also been used extensively in the characterisation 
of L. pneumophila pathogenesis. These have included primary susceptible mouse 
macrophages (Laguna et al., 2006), mouse macrophage cell lines (Schroeder et al., 2011), 
human macrophage-like cell lines (Khelef et al., 2001, Newton et al., 2007) and lung 
epithelial cell lines (Chang et al., 2005, Garduno et al., 2002). The use of these simple 
cellular models has been essential in the investigation of Legionella pathogenesis and 
have several advantages, including increased relevance to human infection by using 
human cell lines, ease of use and genetic tractability. However, there is a limit to the 
usefulness of cell culture in infection, they do not mimic the complexity of the 
environment during in vivo infection and there is limited immune involvement. Despite 
this, cellular models continue to be the first line in investigating L. pneumophila 
infection.  
 
Animal models have been used to increase our knowledge of infectious disease for more 
than a century. In the case of Legionnaires’ disease, both mammalian and non-
mammalian models have been used successfully (Baskerville et al., 1981, Brieland et al., 
1994, Hilbi et al., 2007, Kubori et al., 2010). As with many other infectious diseases, the 
favoured mammalian models of infection are mice and guinea pigs; hamsters (Katz et al., 
1986) and immunodeficient rats (Skerrett et al., 1989) have also been used as models, 
however have not been widely adopted. Disease progression in guinea pigs probably 
most closely resembles Legionellosis in humans. The pathology of infection in guinea 
pigs includes lymphocyte infiltration of the lungs, goblet cell metaplasia, mild fibrosis 
and emphysema with high mortality in the early stages, much like the situation in severe 
human Legionnaires’ disease (Baskerville et al., 1981). Guinea pigs have also been used 
successfully to investigate antimicrobial treatments (Edelstein, 1995) and more 
recently, to investigate the Legionella virulence factor, phospholipase B (Schunder et al., 
2011). However, the increased cost compared to mice and the lack of available mutants 
(Padilla-Carlin et al., 2008) has limited the use of this model. In contrast, the majority of 
mouse strains are naturally resistant to Legionella infection (Wright et al., 2003) with 
the exception of the inbred, albino A/J mouse strain, which develops a mild, self-limiting 
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infection (Brieland et al., 1994). The discovery of a susceptible mouse strain allowed one 
of the key mechanisms of Legionella resistance to be mapped to the lgn1 locus on 
chromosome 13 (Diez et al., 2003). This led to the discovery of polymorphisms in the 
neuronal apoptosis-inhibitory protein 5 (Naip5) gene (also called Birc1) that were 
responsible for the variation in permissiveness of mouse strains (Wright et al., 2003, 
Diez et al., 2003). Despite its limitations, the A/J strain of mice has been used extensively 
and has been crucial in understanding the contribution of Legionella virulence factors to 
infection including the flagella (Lightfield et al., 2008, Molofsky et al., 2006), the 
siderophore Legiobactin (Allard et al., 2009) and the adhesion molecule LaiA/SdeA 
(Chang et al., 2005). 
 
1.9.3 Existing invertebrate models of L. pneumophila infection  
 
The difficulties associated in working with mammalian hosts have led to the evaluation 
of alternative multicellular organisms such as invertebrates. These simple organisms 
have some general weaknesses; invertebrates do not have lungs so facets of disease 
pathology will likely not be comparable. Furthermore, invertebrates do not have an 
adaptive immune system, limiting their use in investigating antibody responses to 
infection. Despite this, use of invertebrate hosts to study infection by bacterial 
pathogens is increasing (Mylonakis et al., 2005). 
 
The nematode Caenorhabditis elegans is a well-established model for several bacterial 
pathogens (Sifri et al., 2005). As C. elegans is a bacterivore, infection of the worms can be 
performed easily and there are extensive genetic resources available. Recently C. elegans 
has been assessed as a model of Legionella infection (Brassinga et al., 2011, Komura et 
al., 2011). C. elegans fed on L pneumophila had a shorter lifespan than uninfected 
controls, however this phenotype was not dependent on the Dot/Icm secretion system. 
In addition the bacteria were found to replicate in the intestinal lumen and do not 
invade intestinal epithelial or phagocytic cells, limiting the usefulness of this model to 
study virulence determinants required for L. pneumophila’s intracellular lifestyle 
(Brassinga et al., 2011).  
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Drosophila melanogaster is another frequently used model organism due to the 
availability of genetic tools available and cell lines of Drosophila primary immune cells. L. 
pneumophila replicates in D. melanogaster and kills the flies in a Dot/Icm T4SS-
dependent manner (Kubori et al., 2010). In addition, elegant studies using RNAi in a D. 
melanogaster phagocyte cell line have been very useful in understanding the host cell 
factors required for bacterial replication (Dorer et al., 2006, O'Connor et al., 2012).  
1.9.4 An alternative infection model, not tested for use with L. pneumophila 
 
In the past 10 years the larva of the greater wax moth Galleria mellonella has been 
increasingly utilised as a model of host-pathogen interactions. G. mellonella larvae have 
several advantages over other models, they can be easily maintained under laboratory 
conditions or purchased cheaply in large quantities. Most importantly, a good 
correlation between the pathogenicity of several microorganisms in G. mellonella and 
other mammalian models of infection has been established (Jander et al., 2000, 
Mukherjee et al., 2010). These benefits have led to the use of G. mellonella as a model for 
infection of a number of bacterial species including Listeria spp. (Joyce et al., 2010, 
Mukherjee et al., 2010), Streptococcus pyogenes (Olsen et al., 2011), Campylobacter jejuni 
(Champion et al., 2010), Yersinia pseudotuberculosis (Champion et al., 2009), 
Burkholderia pseudomallei (Muller et al., 2012) and several pathogenic fungi (Fuchs et 
al., 2010, Mowlds et al., 2008a). The ease of injection means that the larvae are also 
amenable to studies involving small molecule treatment; G. mellonella has been used 
successfully in testing existing and novel antimicrobial compounds (Desbois et al., 2012, 
Hornsey et al., 2011).  
 
Although insects have no system analogous to the mammalian adaptive immune system, 
the human and insect innate immune systems demonstrate surprising similarities 
(Kavanagh et al., 2004, Lemaitre et al., 2007). Most insect species contain specialized 
cells known as haemocytes that phagocytose invaders and form aggregates, named 
nodules, which encapsulate and neutralize foreign microorganisms (Marmaras et al., 
2009). It has been shown that haemocytes from G. mellonella kill phagocytosed 
microorganisms by superoxide production using the same method and highly similar 
proteins as human neutrophils (Bergin et al., 2005). Furthermore, phagocytosis by insect 
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haemocytes can be blocked by pre-treatment with cytochalasin B and haemocyte 
function can be inhibited by gliotoxin (Banville et al., 2012, Renwick et al., 2006), 
demonstrating the evolutionary conservation of these processes and increasing the 
utility of the G. mellonella model. As well as internalising and destroying pathogens, 
haemocytes can trigger a phenoloxidase (PO) cascade that is analogous to the 
myeloperoxidase response in mammals. The action of PO leads to the accumulation of 
melanin and other toxic tyrosine metabolites on the surface of the intruder, leading to 
killing of the organism and physical restriction of its multiplication (Cerenius et al., 
2004, Marmaras et al., 2009). This accumulation of melanin also provides an easy 
method for following the progress of infection without killing the insect, accumulation of 
melanin results in the larvae turning brown and eventually black as the infection 
progresses. Insect haemocytes are also capable of undergoing nodulation, a well-
organised binding of multiple haemocytes to aggregations of bacteria, forming a sheath 
around the invader and physically restricting growth (Lavine et al., 2002, Ratcliffe et al., 
1977). In addition, G. mellonella cells contain caspases and seem to have sophisticated 
apoptosis pathways, unlike single celled amoebae (Khoa et al., 2012a). 
 
Haemocyte-mediated immune responses are complemented by the production and 
secretion of anti-microbial peptides (AMPs) by the insect fat body, an organ similar in 
function to the mammalian liver (Lemaitre et al., 2007, Meister et al., 1997). AMPs are a 
crucial component of the G. mellonella immune system and a number have been 
identified, including peptides similar in structure and function to human defensins 
(Cytrynska et al., 2007). Production of AMPs has shown to be upregulated upon immune 
challenge (Vogel et al., 2011, Mukherjee et al., 2010) and the specific peptides 
upregulated depends on the type of pathogen (Mak et al., 2010). Recently, the AMP 
defensin from G. mellonella was shown to be active against L. dumoffii (Mak et al., 2010), 
further demonstrating the broad range of insect AMPs.  
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1.10 Aims of this study 
 
The aims of this study were to validate of a new tool to investigate L. pneumophila 
pathogenesis and to functionally characterise the translocated protein LtpD. These 
overarching aims are further broken down below: 
 
Validation of the G. mellonella in vivo model 
1. Determine basic infection conditions for L. pneumophila in G. mellonella 
including strain, dose and growth conditions required. 
2. Quantify bacterial replication. 
3. Examine the localisation of L. pneumophila during infection both at a cellular 
and tissue level. 
4. Examine the immune response to bacterial infection. 
5. Determine L. pneumophila genes that have a role in infection in G. mellonella. 
 
Characterisation of LtpD 
1. Confirm the method of translocation of LtpD. 
2. Determine the localisation of LtpD in ectopic expression and infection. 
3. Find and confirm binding partners for LtpD. 
4. Determine the role of LtpD in bacterial replication in: 
a. Cell culture 
b. G. mellonella 
c. A/J mice 
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Chapter 2 – Material and Methods 
2.1 Strains, primers and plasmids 
2.1.1 Bacterial and yeast strains  
Bacterial strains used are listed in Table 2.2.1. All E. coli strains were grown in Luria-
Bertani (LB) broth at 37 °C and 200 rpm, unless otherwise stated, or on LB agar plates 
incubated at 37 oC with appropriate antibiotics. L. pneumophila strains were cultured on 
charcoal-yeast extract (CYE) plates for three or four days at 37 °C then inoculated into 
ACES yeast extract (AYE) at a starting OD600 of 0.1 incubated at 37 °C (unless otherwise 
indicated) at 200 rpm for 21 h until late exponential phase (OD600 > 2.5 - 3). AYE 
medium was 10 g/l ACES, 10 g/l yeast extract (Merk), 1 g/l α-ketoglutarate, pH 6.9, 
CYEA was made from the AYE base with addition of 1.5 g/l activated charcoal powder 
and 1.5 g/l agar (Merk). Media was supplemented with 6 μM Fe(NO3)3 and 30 μM L-
cysteine after autoclaving, for the Lp02 strain, thymidine (100 μg/ml) was added. 
Antibiotics were added to media at the following final concentrations for L. pneumophila 
(or E. coli): kanamycin, 25 μg/ml (100 μg/ml); chloramphenicol, 6 μg/ml (12.5 μg/ml); 
and ampicillin, 100 μg/ml (100 μg/ml); spectinomycin 100 μg/ml; spectromycin 50 
μg/ml. Saccharomyces cerevisiae strain AH109 (Clontech) was cultured in YPD (1% yeast 
extract, 2% peptone, and 2% glucose) or synthetic dropout (SD) medium lacking 
appropriate nutrients at 30 °C. All chemicals were obtained from Sigma unless otherwise 
noted.  
2.1.2 Cell culture  
The alveolar epithelial cell line A549 and the cervical epithelial cell line HeLa were 
maintained in DMEM supplemented with 10% foetal bovine serum (FBS) and Glutamax 
(Invitrogen). The human monocytic cell line THP-1 and the murine macrophage cell line 
RAW246.7 were maintained in RPMI 1640 medium, supplemented with 10% FBS and 
Glutamax (Invitrogen). THP-1 cells were seeded into 24-well tissue culture plates at a 
density of 5 × 105 cells/well and pretreated with 10 ng/ml phorbol 12-myristate 13-
acetate (PMA) for 48 - 72 h to induce differentiation into macrophage-like adherent 
cells. All cells were maintained in a humidified atmosphere of 5 % CO2 at 37 °C.  
Dictyostelium discoideum strain AX2-214 and strain [act15] cnxA:GFP acquired from 
Dictybase (Gaudet et al., 2011) were maintained in axenic HL-5 medium (14 g/l peptone, 
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7g/l yeast extract,  0.5 g/l KH2PO4 and 0.5 g/l  Na2HPO4, 18 g/l maltose, pH 6.6) at 22 °C 
with 20 μg/ml geneticin (Invitrogen) if required.  
2.2 Molecular Biology Techniques 
2.2.1 Polymerase Chain Reaction (PCR) 
DNA products were amplified by PCR with the appropriate forward and reverse primers 
(100 pmol/μl, Thermohybrid) in a mix of 50 ng of DNA template, 1.5 μl of each primer, 3 
μl of 100 mM MgCl2, 5 μl of 25 mM dNTP, 5 μl of 10 x KOD buffer and 1 μl of KOD 
polymerase (All from Merck-Milipore) in a total volume of 50 μl.  
For colony PCR screening, RedTaq Polymerase Mix (Sigma) was used in a mix of 0.3 μl of 
each primer, 14.4 μl of 2x RedTaq mix and 15 μl of dH2O. Bacterial colonies were picked 
and re-streaked onto fresh LB agar plates before use in PCR reaction mixtures.  
For screening of L. pneumophila isolates, PCR was performed with RedTaq using primers 
listed Table 2.3. Genomic DNA of 54 clinical and environmental L. pneumophila isolates 
was obtained from the Respiratory and Systemic Infection Laboratory, Health Protection 
Agency Centre for Infection, London, United Kingdom. These isolates were obtained 
from a range of locations across the United Kingdom and were previously characterized 
by serogroup, monoclonal antibody (MAb) subgroup, allelic profile, and sequence type 
(Harrison et al., 2009). 
Typical PCR conditions were, an initial denaturation step of 92 °C for 5 min followed by 
30 cycles of 92 °C for 30 s, 55 °C for 30 s and 70 °C for 1 min/kb for RedTaq or 15 s/kb 
for KOD before a final elongation step of 70 °C for 10 min. All PCR products were run on 
1 – 2 % agarose gels and gel purified using QIAPrep Gel Extraction kit (Qiagen).  
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Table 2.1 List of strains used in this study 
Strain  Serogroup or characteristics Ref. 
L. pneumophila 
 
    130b (ATCC         
B BAA-74) 
O1; clinical isolate, also known as Wadsworth or AA100 from the 
Wadsworth Veterans Administration Hospital, Los Angeles, CA  
(Newton et al., 
2008) 
    130b ∆dotA dotA gene disrupted with a Kanr cassette (Sansom et al., 
2007) 
    130b ∆ltpD  ltpD gene (lpw_03701) replaced with a Kanr cassette This study 
   130b ∆ltpB lptB gene (lpw_02301) replaced with a Kanr cassette G. Schroeder, 
unpublished 
   130b ∆ltpG ltpG gene (lpw_20091) replaced with a Kanr cassette G. Schroeder 
unpublished 
   130b ∆ltpJ ltpJ gene (lpw_26201) replaced with a Kanr cassette G. Schroeder 
unpublished 
   130b ∆pieE pieE gene replaced with a Kanr cassette A. Mousnier 
unpublished 
   130b ∆flaA flaA gene replaced with a Kanr cassette E. Hartland 
(Harding et al, 
submitted) 
   130b ∆sdhA sdhA gene replaced with a Kanr cassette E. Hartland 
(Harding et al, 
submitted) 
    Paris Worldwide epidemic strain  (Cazalet et al., 
2004)  
    JR32 Salt sensitive streptomycin-resistant derivative of Philadelphia-1 
strain 
(Sadosky et al., 
1993)  
   JR32 ∆icmT icmT gene replaced with a Kanr cassette (Segal et al., 1998b) 
   JR32 Flieger Salt sensitive streptomycin-resistant derivative of Philadelphia-1 
strain obtained from Dr. Antje Flieger 
A. Flieger 
   JR32 ∆dotB dotB gene replaced with a Kanr cassette (Aurass et al., 2013) 
   JR32 ∆plcA plcA gene replaced with a Hygr cassette (Aurass et al., 2013) 
   JR32 ∆plcB plcB gene replaced with a Kanr cassette (Aurass et al., 2013) 
   JR32 ∆plcC plcC gene replaced with a Gmr cassette (Aurass et al., 2013) 
   JR32 ∆plcAB Double mutant constructed as above  (Aurass et al., 2013) 
   JR32 ∆plcBC Double mutant constructed as above  (Aurass et al., 2013) 
   JR32 ∆plcAC Double mutant constructed as above  (Aurass et al., 2013) 
   JR32 ∆plcABC Triple mutant constructed as above  (Aurass et al., 2013) 
    Lp02 Thymine auxotroph streptomycin-resistant derivative of the 
Philadelphia-1 strain  
(Berger et al., 1993) 
E. coli 
 
   BL21(DE3) Star F−ompT hsdSB (rB− mB−) gal dcm  Novagen  
   Top10 F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 nupG recA1 
araD139 Δ(ara-leu)7697 rpsL(StrR) endA1 λ- 
Invitrogen  
S. cerevisiae 
 
     AH109 ATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4∆, gal80∆, 
LYS2::GAL1UAS-GAL1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, 
URA3::MEL1UAS-MEL1TATA-lacZ, MEL1) and Y187 (MATa, ura3-
52, his3-200, ade2-101, trp1-901, leu2-3, 112, gal4∆, gal80∆, met-, 
URA3::GAL1UAS-GAL1TATA-lacZ, MEL1) 
Clontech 
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Table 2.2 List of primers used for screening in this study 
Gene Primer sequence (5′-3′) 
dotA (lpw_29401)  ATTAGCTATTACGGTCCTCCTTTG 
GAGTAGGATTACCCCCACAAG 
lpw_00581 (ltpA)  TCCTTAAAAAATTCTGATGTGCCTC 
CTTGTCTATATTGCTCGGGAGTAA 
lpw_02301 (ltpB)  ATGGCATCGGGGAAACAAGATA 
CCTCCTCCATCGTATCTTCAAAA 
lpw _02381 (ltpC)  ACGGTTCCCTTGGGTGAATTTC 
CAGCATATCTTCATCAGAAGGCTGG 
lpw _03701 (ltpD) TTTTTCTTTCCTTCGCCGCAAG 
CCGTAAAGCCTCATGGCGTTC 
lpw _04551 (ltpE)  TCCATTTAATGGATTACCCAAAGAC 
GCAGCAAAAGCAGAACCTAATTTAA 
lpw _16311 (ltpF)  AAATGAGCTGATTAAGCGGATTAAC 
TTAGAATTTTACCCAGGCCATCA 
lpw _20091 (ltpG)  TGCTTTAGTGTATGGATTTGAACCA 
GGTTGAGGTTATATGCACTCGC 
lpw _20341 (ltpH) CAAATGTTAAGAGCAGCAGCTG 
TCATAAAATAGAGCAGTAGGACCA 
lpw_25791 (ltpI)  CGCACTGAGGTACCCCTTTTCAACTTCCTTTTGAAAAA 
GACGTCGCATCTAGATTACATGAATCTTACAGAATGGCT 
lpw_26201 (ltpJ)  CTGAATTAGCTCAAGCTTTT 
TGAATTACCGATTCTTTGAGC 
  All primers published in (Schroeder et al., 2011) 
 
2.2.2 Site directed mutagenesis 
Site directed mutagenesis was performed using the QuikChange II Site Directed 
Mutagenesis kit (Strategene) as per manufactures instructions. PCR was performed 
using pRK5_LtpD plasmid DNA as a template with specific primers, PCR conditions were 
95 °C for 30 s followed by 18 cycles of 95 °C for 30 s, 55 °C for 1 min then 68 °C for 8 
min. Template DNA was then removed by DpnI (Strategene) digestion at 37 °C for 1 h 
and products transformed into competent E. coli as described below.  
2.2.3 Restriction digest and DNA ligation 
Restriction digests were performed at 37 °C for 2 h in a final volume of 50 μl using 1 μg 
DNA template, 2 units of each restriction enzyme (NEB), the appropriate buffer (NEB) 
and 1 mM BSA if required. Digested products were purified using Qiagen PCR 
purification kit according to manufactures instructions. Ligations were performed 
overnight at 14 °C in a final volume of 15 μl with a vector to insert ratio of 1:3, 1.5 μl T4 
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ligation buffer (NEB) and 30 units of T4 DNA ligase (NEB). 
2.2.4 E. coli transformation 
Bacterial transformation was performed using chemically competent E. coli Top10 
(Invitogen) or BL21(DE3)Star (Novagen). Competent cells were prepared by growing 
bacterial cultures to mid-log phase (OD600 0.4 - 0.5) before harvesting by centrifugation 
(4000 rmp, 10 min, 4 °C). Cells were resuspended in 0.4 x starting culture volume in ice 
cold TFBI buffer (30 mM potassium acetate, 10 mM CaCl2, 50 mM MnCl2, 15% (v/v) 
glycerol, pH 5.8) and incubated for 5 min before being pelleted again. Cells were 
resuspended in TFBII (10 mM MOPS, 75 mM CaCl2, 10 mM RbCl2, 15% (v/v) glycerol, pH 
6.5) and stored at – 80 °C. 50 μl of cells were incubated with the ligation mixture for at 
least 30 min on ice, heat shocked at 42 °C for 45 s then replaced on ice for at least 3 min. 
800 μl of super optimal broth (SOC) media was added (Invitrogen) and bacterial allowed 
to recover for 1 h at 37 °C with shaking. The mix was plated onto LB plates containing 
appropriate antibiotics and incubated at 37 °C overnight.  
2.2.5 Preparation and transformation of electrocompetent L. pneumophila 
L. pneumophila was grown overnight in AYE media then subcultured into 100 ml of AYE 
and grown to exponential phase (OD600 = 0.4 - 0.6). Cells were pelleted and resuspended 
in 35 ml of ice cold sterile buffer (10% (v/v) glycerol in ddH2O) and incubated on ice for 
10 min. Cells were then washed 4 times in ice cold glycerol, resuspended in 750 μl of 
storage buffer, aliquoted in 50 μl and stored at -80 °C. Competent L. pneumophila were 
transformed with appropriate plasmids by electroporation, 450 μl of warm AYE added 
and incubated at 37 °C for 5 - 6 hours. The bacterial suspension was then plated onto 
CYE plates with the appropriate antibiotic and the plates incubated at 37 °C for 3 – 4 
days until colonies seen. 
2.2.6 Natural transformation of L. pneumophila 
For the creation of the LtpD deletion mutant natural transformation was used as 
previously described (Stone et al., 1999, Dietrich et al., 2001). WT L. pneumophila was 
grown to exponential phase in 5 ml AYE media (OD600 = 0.4 - 0.6). 10 μg of pGEMT7 
plasmid prepared as described in section 2.2.9 was added and the mixture incubated at 
30 °C for 3 weeks then plated onto CYE plates containing 12 μg/ml kanamycin, allowed 
to grow for 4 days then restreaked onto CYE plates containing 25 μg/ml kanamycin and 
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grown for three days. Colonies that were recovered were tested for insertion of the gene 
by PCR and sequencing as described in section 2.2.9 
2.2.7 Plasmid Extraction 
Plasmid extraction was carried out from 5 ml overnight cultures of E. coli using Peqlab 
miniprep kits (Peqlab) or from QIAPrep Spin Midiprep kits (Qiagen) according to 
manufactures instructions. Plasmids were eluted in sterile H2O and concentration 
assessed using a NanoDrop NS-1000 reader (Thermo Scientific). 
2.2.8 Agarose gel electrophoresis 
Following PCR, DNA products were analysed by agarose gel electrophoresis. Gels were 
cast using 1.0 – 2.0% agarose (Invitrogen) with 1:10,000 dilution of SYBERSafe DNA 
stain (Invitrogen). DNA samples were mixed with 6 x loading buffer (NEB) and gels run 
in 1 x TAE buffer (40 mM Tris-acetate, 1 mM EDTA) at 100-150 v. Bands were visualised 
using a SafeImage blue light trans-illuminator (Invitrogen) and images acquired using 
BioImaging Syngene software (Syngene). DNA band sizes were assessed using 1 kB 
ladder (NEB). 
2.2.9 Plasmid construction  
Plasmids were constructed using standard molecular biology techniques outlined below 
using the primers and restriction enzymes described in Table 2.3. A ltpD deletion mutant 
of L. pneumophila was constructed via homologous recombination by amplifying the 
genomic regions flanking ltpD by PCR using the oligonucleotide primers, 5’-
GATGTCTCTGATATCCATAAGATTTTC -3’, 5’- GGTACGAATTCCATGAT 
ATTCTCCTGAATAATTCGC -3’ and 5’- GGTACGAATTCGGACGCAAAGTGG 
TAGCGCAATCAAATTC-3’, 5’- GGTGCAAATCATTATGGCTTCGCGACTTATTTATGG -3’. The 
resulting fragments were ligated into pGEM-T (Promega) and the kanamycin resistance 
cassette from pSB315 (Galan et al., 1992) was inserted in the central EcoRI restriction 
site. Deletion mutants were selected for on CYE agar with kanamycin and confirmed by 
PCR using primers outside the flanking regions included in the deletion cassette (5’- 
CGCTAATTATCAAACGTACATTTAACTC -3’ and 5’- CCATTTTATATGTTGCAGTCGCC -3’) 
and sequencing.  For the construction of LtpDΔ472-626 and LtpDΔ472-556 expression 
plasmids, the N-terminal and C-terminal fragments were amplified separately, ligated 
together and amplified using PCR, then inserted into the appropriate plasmid. All 
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constructs were sequenced before use. For inducible protein expression in L. 
pneumophila, plasmids were inserted by electroporation as previously described (Chen 
et al., 2006). The 2xFYVE-GFP plasmid was a kind gift from Dr. Jean Celli (Rocky 
Mountain Labs, NIAID). The Rab5-GFP, Rab7-GFP and Rab1-GFP plasmids were kind 
gifts from Prof. Miguel Seabra (Imperial College London). The VAMP3-GFP plasmid was 
a gift from Prof. Jennifer Stow (Patki et al., 1997) and the CREB3-FLAG (pcLuman) 
plasmid was a gift from Dr Ray Lu (Lu et al., 1997). The Rab4-GFP plasmid was a gift 
from Dr. Hye-Won Shin, (Kyoto University) 
 
 
2.2.8 Ectopic expression of tagged proteins in eukaryotic cells 
A549 or HeLa cells were seeded onto coverslips in 24 well plates 24 h prior to 
transfection to result in approximately 70% confluency. Cells were transfected with 
GeneJuice  (Merk) according to manufactures instructions. Briefly, 0.75 μl of Genejuice 
was mixed with 20 μl of OptiMEM (Invitrogen) and incubated at RT for 5 min. 0.25 μg of 
purified DNA was then added to the mixture and incubated for a further 20 min. The 
total mixture was added to each well and protein expression allowed to proceed for 18 – 
24 h before infection or fixation. If required, cells were treated with PI 3-K inhibitor 100 
nM wortmannin (Enzo). The early endosome Organelle lightsTM baculovirus 
transduction system (Invitorgen) that expressed Rab5-GFP was also used to improve 
transfection efficiency. Cells were prepared as above then incubated for 30 min with 200 
μl of Organelle lightsTM reagent (Invitrogen) diluted in 350 μl D-PBS at room 
temperature in the dark with gentle rocking. The reagent was then removed and 
replaced with DMEM with 1 x the enhancer solution (Invitrogen) and incubated for 2 h 
at 37 °C with 5% CO2. The media was then replaced and the cells incubated overnight 
with standard conditions before infection.  
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Table 2.3 List of plasmids and primers used in this study 
Plasmid Description Ref. 
pRK5 Vector for the expression of proteins with N-terminal Myc-tag in 
mammalian cells 
Clontech 
pRK5-
derived 
Expressed protein Primer sequence (5′-3′) RS Ref. 
pICC1247 Myc-LtpD  CACTGACCCGGGGAACCAAGAAACATTTAAATCCAGAC 
GTCGCAAAGCTTCTAAATCTTTAAACCAGTGTCGC 
HindIII 
BamHI 
This study 
pICC1248 Myc-LtpD1-469  CACTGACCCGGGGAACCAAGAAACATTTAAATCCAGAC 
CAGTCAAGCTTCTACTGAGTTTCAGGTAGGAGGGGC 
HindIII 
BamHI 
This study 
pICC1249 Myc-LtpD472-679  GTATGGAATTCATGGACAGAGACAGAGACAGAGACA 
GTCGCAAAGCTTCTAAATCTTTAAACCAGTGTCGC 
EcoRI 
BamHI 
This study 
pICC1250 Myc-LtpD556-679  CACTAACCCGGGAAGCAACAAATGGGCAAGAAC 
GTCGCAAAGCTTCTAAATCTTTAAACCAGTGTCGC 
XmaI 
BamHI 
This study 
pICC1251 Myc-LtpD626-679  CACTAACCCGGGAATCAAATTCATCAGACGAAACG 
GTCGCAAAGCTTCTAAATCTTTAAACCAGTGTCGC 
XmaI 
BamHI 
This study 
pICC1252 Myc-LtpD472-556  CACTAACCCGGGAAGAGACAGAGACAGAGACAG 
GTCGCAAAGCTTCTAGTTTTCAAACGCTGATTTG 
XmaI 
HindIII 
This study 
pICC1253 Myc-LtpD472-626  CACTAACCCGGGAAGAGACAGAGACAGAGACAG 
GTCGCAAAGCTTGCGCTACCACTTTGCGTCCCTTTTC 
XmaI 
HindIII 
This study 
pICC1254 Myc-LtpDΔ472-626  See section 2.2.9 for details 
 
 This study 
pICC1255 Myc-LtpDΔ472-556  See section 2.2.9 for details 
 
 This study 
 Myc-LtpDFF335AA 
(Mutagenesis) 
GGGTAACTCATTAGCACATGCAGCCTTTCCTTCGCCGCAAGTG 
CACTTGCGGCGAAGGAAAGGCTGCATGTGCTAATGAGTTACCC 
 This study 
 Myc-LtpDS338A 
(Mutagenesis) 
CATTTTTTCTTTCCTGCGCCGCAAGTGTTACG 
CGTAACACTTGCGGCGCAGGAAAGAAAAAATG 
 This study 
 Myc-LtpK GCCTACGAATTCAAAAACAAAATATGAAATAAGTC 
GCTTACAAGCTTTTAACGAAGAATTAATCTATCA 
EcoRI 
HindIII 
This study 
pICC1277 
 
Myc-Lpp0356 GGATACGGATCCATGGACAACGATCAACTGTCAG 
CGTAACCTGCAGCTAATTTTTTAACCTAGTGCCAC 
BamHI 
PstI 
This study 
pICC1285 
 
Myc-LtpH CGCACTGAGGATCCCCTTTTCAACTTCCTTTTGAAAAAAAG 
AGACGTCGCAAAGCTTTTACATGAATCTTACAGAATGGCTTG 
BamHi 
HindIII 
This study 
pICC1290 Myc-LtpI CGCACTGAGGATCCCCTTTTCAACTTCCTTTTGAAAAAAAG 
AGACGTCGCAAAGCTTTTACATGAATCTTACAGAATGGCTTG 
BamHI 
HindIII 
This study 
pGBT9 Vector for the expression of GAL4 DNA-binding domain (DNA-BD) fusion 
proteins in yeast  
Clontech 
pGBT9-
derived 
Expressed protein Primer sequence (5′-3′) RS Ref. 
pICC1268 
 
DNA-BD-LtpD  CACTGAGAATTCACCAAGAAACATTTAAATCCAGACTC 
AGCTGCTGCAGCTAAATCTTTAAACCAGTGTCGC 
EcoRI 
PstI 
This study 
pICC1270 
 
DNA-BD-LtpD1-
469 
CACTGAGAATTCACCAAGAAACATTTAAATCCAGACTC 
CAGTCAAGCTTCTACTGAGTTTCAGGTAGGAGGGGC 
EcoRI 
BamHI 
This study 
pICC1269 
 
DNA-BD-LtpD472-
679  
CACTAACCCGGGAGAGACAGAGACAGAGACAG 
AGCTGCTGCAGCTAAATCTTTAAACCAGTGTCGC 
XmaI 
PstI 
This study 
pGADT7 Vector for the expression of activation domain (AD) fusion proteins in 
yeast 
Clontech 
pGADT7-
derived 
Expressed protein Primer sequence (5′-3′) RS Ref. 
pICC1261 
 
AD-IMPA1  CTAATCCCGGGAATGGCTGATCCTTGGCAGGAATGC 
GCGATCATCGATTTAATCTTCGTCGTCTCGTTGCAAAGG 
XmaI 
ClaI 
This study 
pICC1264 
 
AD-IMPA2 CTAATCATATGATGAAGCCGAGCGGCGAGGACCAGG 
GGACTGGATCCTCACTTCTCATCATCCCGCCC 
NdeI 
BamHI 
This study 
pXDC61 Vector for the expression of proteins with a N-terminal TEM-tag in L. 
pneumophila  
(de Felipe 
et al., 2008) 
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pXDC619-
derived 
Expressed protein Primer sequence (5′-3′) RS Ref. 
 TEM-LegC2   (de Felipe et 
al., 2008) 
 TEM-FAB   (de Felipe et 
al., 2008) 
pICC539 TEM-LtpD CACTGACCCGGGGAACCAAGAAACATTTAAATCCAGAC 
GTCGCAAAGCTTCTAAATCTTTAAACCAGTGTCGC 
Xmal 
HindIII 
(Schroeder 
et al., 2011) 
pICC543 TEM-LtpH CACTGAGGATCCCCCAGTTGCAAAAATAACCCC 
GTCGCAAAGCTTTCATAAAATAGAGCAGTAGGACCA 
BamHI 
XbaI 
(Schroeder 
et al., 2011) 
pICC545 TEM-LtpI CGCACTGAGGTACCCCTTTTCAACTTCCTTTTGAAAAA 
GACGTCGCATCTAGATTACATGAATCTTACAGAATGGCT 
KpnI 
XbaI 
(Schroeder 
et al., 2011) 
 TEM-LtpK CGGTCCGGGTACCAAAACAAAATATGAAATAAGTCAAG 
CGTAACTCTAGACTAATTTTTTAACCTAGTGCCAC 
KpnI 
Xbal 
This study 
pICC1279 TEM-Lpp0356 GATTAGGGTACCGACAACGATCAACTGTCAG 
CGTAACGGATCCCTAATTTTTTAACCTAGTGCCAC 
BamHI 
XbaI 
This study 
pICC562 
 
pMMB207c-4HA; Vector for the expression of proteins with four N-
terminal HA-tags in L. pneumophila  
(Dolezal et 
al., 2012) 
pICC562 
-derived 
Expressed protein Primer sequence (5′-3′) RS Ref. 
pICC1265 
 
4HA-LtpD  CACTGACCCGGGGAACCAAGAAACATTTAAATCCAGAC 
GTCGCAAAGCTTCTAAATCTTTAAACCAGTGTCGC 
Xmal 
HindIII 
This study 
pICC1266 
 
4HA-LtpD1-469  CACTGACCCGGGGAACCAAGAAACATTTAAATCCAGAC 
CAGTCAAGCTTCTACTGAGTTTCAGGTAGGAGGGGC 
XmaI 
HindIII 
This study 
pICC1267 
 
4HA-LtpD472-679  GTATGGTACCATGGGGACAGAGACAGAGACAGAGACA 
GTCGCAAAGCTTCTAAATCTTTAAACCAGTGTCGC 
KpnI 
HinIII 
This study 
pICC1278 4HA-Lpp0356 GATTAGGGTACCGACAACGATCAACTGTCAG 
CGTAACGGATCCCTAATTTTTTAACCTAGTGCCAC 
BamHI 
XbaI 
This study 
pICC1276 4HA-LtpK CGGTCCGGGTACCAAAACAAAATATGAAATAAGTCAAG 
CGTAACTCTAGACTAATTTTTTAACCTAGTGCCAC 
KpnI 
Xbal 
This study 
pGEX-6P-2 Vector for the expression of a GST fusion protein in E. coli GE 
Healthcare 
pGEX-6P2 
-derived 
Expressed protein Primer sequence (5′-3′) RS Ref. 
pICC GST-LtpD GTATGGAATTCAAACCAAGAAACATTTAAATCCAGACTC 
GACGTCGCGGCCGCCTAAATCTTTAAACCAGTGTCGC 
EcoRI 
NotI 
This study 
pICC GST-LtpD472-626 GTATGGAATTCATGAGACAGAGACAGAGACAGAGACA 
GACGTCGCGGCCGCCTAAATCTTTAAACCAGTGTCGC 
EcoRI 
NotI 
This study 
pET28a(+) Vector for the expression of a 6 x His-tag fusion protein in E.coli Novagen 
pET28a(+)-
derived 
Expressed protein Primer sequence (5′-3′) RS Ref. 
pICC1259 
 
His-IMPA1 GGCTAGAGCTCATGGCTGATCCTTGGCAGGAATGC 
GGACTGCGGCCGCTTAATCTTCGTCGTCTCGTTGCAAAGG 
SacI 
NotI 
This study 
pcDNA Vector for the expression FLAG-tag fusion proteins in mammalian cells Invitrogen 
pcDNA-
derived 
Expressed protein Primer sequence (5′-3′) RS Ref. 
pICC1263 
 
FLAG-IMPA1 CTAATCCCGGGAAATGGCTGATCCTTGGCAGGAATGC 
GGACTCTGCAGTTAATCTTCGTCGTCTCGTTGCAAAGG 
XmaI 
PstI 
This study 
Primers for construction of the ΔltpD strain  Ref. 
 Amplification of 
5’ flanking region 
GATGTCTCTGATATCCATAAGATTTTC 
GGTACGAATTCCATGATATTCTCCTGAATAATTCGC  
NA This study 
 Amplification of 
3’ flanking region 
GGTACGAATTCGGACGCAAAGTGGTAGCGCAATCAAATTC  
GGTGCAAATCATTATGGCTTCGCGACTTATTTATGG 
NA This study 
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2.2.9 RT-PCR from L. pneumophila 
L. pneumophila WT 130b were grown in AYE to post exponential phase (OD > 3.5), the 
bacteria pelleted and the cells disrupted by resuspension in buffer RLT from the 
RNAeasy kit (Qiagen). RNA was extracted using a RNAeasy kit (Qiagen) and 
contaminating DNA was digested using Turbo DNA-free kit (Ambion) following the 
manufacturer's instructions. Two-step RT-PCR was performed using Superscript reverse 
transcriptase (Invitrogen) using 2 µg of RNA as a template and random hexamers 
(Invitrogen). Genes were amplified using RedTaq readymix (Sigma) and 0.6 pM of gene 
specific primers as follows, DotA, 5’- ATTAGCTATTACG GTCCTCCTTTG  -3’ and 5’- 
GAGTAGGATTACCCCCACAAG -3’ LtpD, 5’- CACTGACCC 
GGGGAACCAAGAAACATTTAAATCCAGAC  -3’ and 5’- GTCGCAAAGCTTCTAAATCTTT 
AAACCAGTGTCGC -3’    LtpH, 5’- CAAATGTTAAGAGCAGCAGCTG -3’ and 5’- 
TCATAAAATAGAGCAGTAGGACCA -3’   LtpI, 5’- CGCACTGAGGTACCCCTTTTCAACTT 
CCTTTTGAAAAA -3’ and 5’- GACGTCGCATCTAGATTACATGAATCTTACAGAATGGCT-3’. 
DNA was analyzed on a 1% agarose gel with SYBRSafe (Invitrogen) and bands quantified 
using ImageJ software. 
 
2.3 Biochemical Techniques 
2.3.1 SDS-PAGE and coomassie staining 
Resolving gels were cast in the Biorad MiniProtean II cell using 8 - 12% acrylamide in 
Tris-SDS buffer (0.375 M Tris-HCL pH 8.8, 0.1% SDS) while stacking gels were cast using 
4% acrylamide Tris-SDS buffer (125 mM Tris-HCL pH 6.8, 0.1 % SDS), 0.1% (w/v) 
ammonium persulfate and 0.1% (v/v) TEMED were added to induce acrylamide 
polymerisation. Samples were boiled in 5x Laemmli buffer (60 mM Tris-HCl pH 6.8, 2% 
SDS, 10% (v/v) glycerol, 5% (v/v) β-mercaptoethanol, 0.01% (w/v) bromophenol blue) 
for 5 – 10 min. Electrophoresis was performed between 100 – 180 v in 1x Tris-Glycine-
SDS buffer (Bio-Rad). Prestained protein markers (NEB) were used to define protein 
sizes. Following separation, gels were immersed in coomassie stain solution (45% (v/v) 
ethanol, 10% (v/v) acetic acid, 0.24% coomassie R250) overnight with rocking at RT. 
Gels were de-stained by successive washes in de-stain solution (50% (v/v) methanol) 
until protein bands were clearly visible.  
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2.3.2 Western Blot 
Polyvinylidene fluoride (PVDF) membrane was activated by immersing it in 100 % 
ethanol for 30 sec and washed once in dH2O. The membrane and protein gel were placed 
separately in transfer buffer (1 x Tris-Glycine buffer, BioRad) and incubated at RT for 5 
min to equilibrate. A transfer sandwich was then constructed using a foam pad, layer of 
filter paper, membrane, gel, then filter paper and a second foam pad, all soaked in 
transfer buffer. The transfer was carried out using the wet transfer system (BioRad) at 4 
°C at 400 mA for 1 h (or 2 h for LtpD) depending on target protein size. Membrane blots 
were washed with PBS-T (0.1% (v/v) Tween-20) and blocked with PBS-T/2% (w/v) 
skimmed milk (Merck) for at least 1 h. Blots were probed with antibodies at specific 
dilutions (see Table 2.5) in PBS-T/2% milk at 4 °C overnight with rocking. Blots were 
washed three times with PBS-T/2% milk for at least 5 min and incubated with 
horseradish peroxidase-linked anti-mouse IgG or anti-rabbit IgG antibodies at 1:10,000 
dilution for 1 h at RT. Blots were washed another three times and bands visualised using 
ECL or ECL Plus reagents (GE Healthcare). Chemiluminescence was detected and images 
captured using a LAS-3000 Fuji Imager.  
2.3.3 Protein purification  
Production of GST-LtpD and GST-LtpD472-626 fusion proteins in E. coli BL21(DE3) was 
induced at a cell density (OD600) of 0.6 with 0.5 mM IPTG for 5 - 6 h at 37 °C. The cells 
were pelleted and resuspended in PBS with protease inhibitor cocktail (PIC) (Sigma), 
bacterial lysates were prepared using an Emulsiflex (Avestin) and fusion proteins 
purified by incubating the soluble fraction with glutathione-sepharose beads 
(Amersham Biosciences) and eluting the bound fraction using 10 mM reduced 
glutathione in PBS. GST alone was also purified using this method.  
Production of His-IMPA1 was induced as above but using 1 mM IPTG for 5 - 6 h at 37 °C. 
Bacteria were pelleted and resuspended in phosphate buffer (20 mM sodium phosphate, 
30 mM NaCl, 10 mM imidazole, 2 mM β-mercaptoethanol and 10% (v/v) glycerol) with 
PIC and lysate prepared as above. Bacterial lysate was incubated with 5 ml of activated 
His resin (Novagen) (resin washed twice with water, once with charging buffer (50 mM 
NiSO4) and twice with phosphate buffer) for 1 h at 4 °C then washed three times with 
phosphate buffer and eluted using phosphate buffer initially containing 100 mM 
imidazole then 500 mM imidazole. Purity of protein preparations was analyzed by SDS 
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polyacrylamide gel electrophoresis and all proteins were dialysed in 50mM Tris-HCL pH 
8. 
2.3.4 Protein-lipid overlay assay  
Direct binding of GST-LtpD472-626 fusion protein to lipids was performed as described 
previously (Weber et al., 2006) with some minor differences. Experiments were carried 
out with commercially available membrane lipid strips and PIP-arrays (Echelon 
Biosciences), using GST-tagged PH domains of PLC-δ1 (PIP2 Grip, Echelon Biosciences) 
and GST alone as control reagents. After blocking, strips were incubated with purified 
GST-LtpD472-626 or controls overnight in 2 % fatty acid free BSA (Millipore) in TBS with 
0.1% Tween, washed and incubated with the primary anti-GST antibody (Abcam) and 
the secondary anti-mouse HRP (Sigma) then visualized using EZ-ECL (Geneflow) and a 
Las 3000 imager.  
2.3.5 IMPA1 activity assay  
IMPA1 activity in vitro was measured using the Malachite green assay kit (Cambridge 
Biosciences). The assay was performed in a clear, flat bottomed 96 well plate at 37 °C for 
30 min in assay buffer (50 mM Tris-HCL, pH 8.0) with 0.7 mM myo-inositol 
monophosphate, 1 mM ethylene glycol bis(2-aminethyl either)-N,N,N’,N’,-tetraacetic acid 
(EGTA), 2 mM MgCl2 and 0.5 μg/ml purified His-IMPA1 with or without 0.5 μg/ml 
purified GST-LtpD and the IMPA1 inhibitor 1 mM L-690,330 (Tocris Bioscience). To stop 
the reaction, 5 μl of MG acidic solution (Cambridge Biosciences) was then added, 
incubated for 10 min at RT then 25 μl of MG blue solution added to visualize released 
phosphate and incubated for a further 20 min at RT. Quantification was carried out by 
measuring absorbance at 690 nm and comparing to a phosphate standard curve. The 
assay was performed in triplicate and results are mean of three separate experiments ± 
standard deviation. 
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2.4 Galleria mellonella protocols 
2.4.1 Infection of G. mellonella  
L. pneumophila bacteria were diluted in Dulbecco’s phosphate buffered saline (D-PBS) to 
an OD600 of 1, which corresponds to 109 CFU/ml, unless otherwise indicated. Gene 
expression in strains containing the p4HA plasmid was additionally induced during 
infection with 1 mM IPTG. Ten G. mellonella larvae were injected with 10 μl of bacterial 
suspension into the top, right proleg using a Hamilton syringe (Sigma) and larvae 
incubated at 37 °C in the dark in petri dishes lined with filter paper. As a control, ten 
larvae were injected with D-PBS alone. Larvae were individually examined for 
pigmentation, mobility and time of death was recorded. Assays were only allowed to 
proceed for 3 days as pupa formation could occasionally be seen by day 4. At least three 
independent replicates of each experiment were performed. 
2.4.2 In vivo growth assay  
At 0, 5, 18 and 24 h post infection (p.i.), haemolymph was extracted from infected larvae 
by making an incision near the tail and squeezing the haemolymph into a 1.5 ml 
eppendorf tube. Haemolymph from three larvae was pooled and weighed. Cells were 
lysed by incubation of the haemolymph with 1 μl of 5 mg/ml digitonin for 5 min at RT. 
Work proceeded quickly to avoid coagulation of the haemolymph. Extracted 
haemolymph was serially diluted in AYE media and plated onto CYE plates. To prevent 
contamination, the extracted haemolymph was plated on CYE plates supplemented with 
either spectinomycin (50 μg/ml) or streptomycin (100 μg/ml). Plates were incubated at 
37 °C for three days, viable bacteria were enumerated and the number of CFU was 
normalized to the weight of haemolymph extracted.  
2.4.3 Competitive infection in G. mellonella 
 G. mellonella larvae were infected with a total of 107 L. pneumophila in a 1:1 ratio of 
WT:mutant. At 0, 5, 18, and 24 h p.i. haemolymph was extracted as described above and 
serial dilutions were plated onto CYE plates with spectinomycin but with or without 
kanamycin to select for the mutant. Colonies were counted to determine the number of 
viable bacteria and the competitive index (CI) was calculated as follows: CI=(mutant 
output/WT output)/(mutant inoculum/WT inoculum). Students T-test was used to 
determine statistical significance. 
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2.4.4 Indirect immunofluorescence on extracted haemocytes 
Haemolymph from infected G. mellonella were extracted at 5 and 24 hours post 
infection. The extracted haemolymph was dispensed onto poly-L-lysine coated glass 
coverslips and centrifuged at 500 x g for 10 min to allow sedimentation and attachment 
of haemocytes. Coverslips were washed twice with PBS and fixed using 4% 
paraformaldehyde for 20 min followed by quenching with 50 mM ammonium chloride 
and blocking with 2% (w/v) bovine serum albumin (BSA) in PBS. Before 
permeabilisation, cells were stained using mouse anti-Legionella (see Table 2.5 for 
details). Cells were then permeabilised with 0.1% Triton in PBS and total bacteria were 
stained with a rabbit anti-Legionella antibody. To localise 4HA-tagged effector proteins, 
fixed permeabilised cells were stained using rabbit anti-Legionella followed by anti-
rabbit Dylight488 and mouse anti-HA directly conjugated to TRITC (see Table 2.5). 
Samples were analyzed using an Axio M1 Imager microscope and images processed with 
the Axiovision software (Carl Zeiss). 
2.4.5 Staining of formalin fixed sections of G. mellonella  
Infected G. mellonella were fixed in formalin (10% v/v) for one week at RT. Paraffin 
embedding, sectioning and staining with haematoxylin and eosin (H&E) was performed 
by Ms Lorraine Lawrence (Imperial College). Formalin-fixed, paraffin-embedded sections 
were deparaffinised in Histoclear II (VWR) solution, rehydrated in a graded series of 
100%, 95%, 85%, 75% and 50% ethanol and treated with a blocking solution containing 
10% normal donkey serum (Jackson ImmunoResearch) in PBS containing 1% Tween-20 
(PBS-T). Sections were stained using indirect immunofluorescence as described 
previously (Girard et al., 2005). L. pneumophila was stained with rabbit anti-L. 
pneumophila antibody and donkey anti-rabbit Alexa Fluor 488-conjugated antibody. 
Cellular and bacterial DNA was stained with DAPI (Sigma) and the shape of the tissues 
was visualized using Rhodamine Phalloidin (Invitrogen). Samples were mounted using 
Prolong Gold anti-fade medium (Invitrogen) and examined using a Zeiss Axio image 
microscope.  
2.4.6 Transmission electron microscopy  
Haemolymph was extracted from at least ten infected G. mellonella per condition and 
time point. Cells were spun down onto 6 well plates, washed once with PBS and scraped 
and fixed in 2% glutaraldehyde. For Figure 3.4 TEM was performed by Dr Artemis Kosta 
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as described previously (Kosta et al., 2008) and examined using a Tecnai12 (FEI) 
electron microscope. Images were taken with a CCD camera (TVIPS, Gauting, Germany). 
Alternatively, for Figure 3.7, infected haemocytes were transferred to 35 mm dishes and 
centrifuged at 5,000 rpm for 5 minutes. The cells were washed 3 times with PBS and 
cooled on ice before fixation with 0.5% glutaraldehyde (Sigma) in 200 mM sodium 
cacodylate (TAAB) for 5 min on ice, then at RT for a further 25 min. The cells were 
washed with 200 mM sodium cacodylate before post-fixation in 1% osmium tetroxide-
1.5% potassium ferrocyanide for one hour. The cells were washed in water (ddH2O) and 
stained overnight at 4 °C with 0.5% uranyl acetate overnight. The cells were washed 
with ddH2O before serial dehydration in ethanol and embedded flat in Epon resin. 
Ultrathin sections (~70 nm) were cut parallel to the surface of the dish using a Leica 
ultramicrotome. The sections were collected onto formvar-coated 50 mesh EM grids and 
stained for 30 seconds with Reynold’s lead citrate before imaging. Samples were viewed 
by using an FEI Tecnai G2 electron microscope with a Soft Imaging System Megaview III 
CCD camera. Images were collected at 1376 x 1032 x 16 pixels using AnalySIS version 
Docu software (Olympus Soft Imaging Solutions).  
2.4.7 Haemocyte quantification and viability assay  
Infected haemolymph was extracted at 5, 18 and 24 h p.i. Trypan blue (0.02% (v/v) in 
PBS) was added to cells and incubated at room temperature for 10 min. Viable cells per 
mL were enumerated using a haemocytometer and each sample was analysed in 
triplicate.  
2.4.8 Phenoloxidase (PO) activity assay.  
At 5 and 18 h p.i, haemolymph from three infected insects per condition was extracted, 
pooled and diluted in a 3:1 ratio in PBD (pH 6.5) (v/v). Cells and debris were removed 
by centrifugation at 20 000 x g for 10 min at 4 °C. The phenoloxidase activity in the 
plasma was quantified using a microplate enzyme assay as described previously 
(Eleftherianos et al., 2006). The assay was carried out in a black wall/clear flat-bottom 
96-well plate (Becton Dickinson) A reaction mixture containing 115 μl 50 mM PBS (pH 
6.5), 10 μl diluted haemolymph plasma, and 2 μl E. coli LPS (5 mg/ml) (Sigma) was left 
for 1 h at room temperature to allow the activation of the enzyme. 25 μl of 20 mM 4-
methyl catechol (Sigma) was added to initiate the reaction and the final volume of the 
mixture was made up to 200 μl with sterile H2O. The change in absorbance at 490 nm 
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was read for 1 h at room temperature with a reading taken every minute using a 
Fluostar Optima plate reader (BMG labtech, Germany). The experiment was performed 
in triplicate and independently repeated at least three times. Phenoloxidase activity was 
expressed as the mean increase in OD490/minute. 
2.4.9 RNA extraction from G. mellonella  
At 2, 5, 18 and 24 h. p.i. fat bodies from three infected larvae were collected and stored 
in RNAlater (Qiagen) at 4 °C until processing. Tissue was homogenized by a gentleMACS 
homogeniser (Miltenyi Biotech) using M tubes and the 90 s RNA setting and RNA 
extracted and purified as described in section 2.2.11. Primers used to amplify immune 
related genes are listed in Table 2.4. 
 
Table 2.4 List of primers used for RT-PCR used in this 
study 
Gene  Primer sequence (5′-3′) 
Gallerimycin  GAAGATCGCTTTCATAGTCGC 
TACTCCCTGCAGTTAGCAATGC 
Prophenoloxidase  CCGCGAACACCGATCATCATTCCAAG 
GTGCACGCTTCCGTAGAGTTCCCGG 
Gloverin  CGGTAGTCGGGTGTTGAGCCCGTATG 
CGTCTGATACGATCGTAGGTGCC 
PRPB  GGTCATCATCCAGCATACAGTGACG 
CCATCCAGTTGGGCCAGCTTCTTAT 
Transferrin  CCCGAAGATGAACGATCAC 
CGAAAGGCCTAGAACGTTTG 
Galliomycin  CCTCTGATTGCAATGCTGAGTG 
GCTGCCAAGTTAGTCAACAGG 
Actin  
 
GGGACGATATGGAGAAG 
CACGCTCTGTGAGGATCT 
Primer sequences from (Joyce et al., 2010).  
2.4.10 Treatment with cytochalasin D  
Treatment of larvae with cytochalasin has previously been shown to prevent 
phagocytosis by haemocytes (Banville et al., 2012). Ten larvae per condition were 
injected with 100 μM cytochalasin D (Invitrogen) diluted in D-PBS and incubated at 37 
°C in the dark for 4 h. Post-treatment, larvae were injected as previously described 
however the needle was inserted into the second right proleg to avoid unnecessary 
damage to the larvae. Ten treated, uninfected larvae were included in every experiment 
to confirm that the concentration of cytochalasin D was not lethal. Results are the mean 
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of three separate experiments ± standard deviation. 
 
2.5 Bioinformatic techniques 
Alignment of DNA sequences was performed using ApE software (v1.17) and alignment 
of protein sequences was performed using the BLASTp tool 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). Bioinformatic analysis of domains and motifs 
was performed using the Pfam database (Pfam release 24, HMMER3.0 beta 3 (Finn et al., 
2008), and the NCBI Conserved Domain Database (version 2.18 (Marchler-Bauer et al., 
2009)).  Secondary structural predictions was performed using Phyre2 server (Kelley et 
al., 2009). 
 
2.6 Translocation Assay  
The β-lactamase (TEM1) translocation assay for the identification of Icm/Dot T4SS 
substrates was performed as previously described (Schroeder et al., 2011). 7.5 × 104 
RAW264.7 cells/well were seeded in a black wall/clear flat-bottom 96-well plate 
(Becton Dickinson). L. pneumophila WT and ΔDotA strains expressing the TEM-effector 
fusion proteins were prepared as above and RAW264.7 cells infected. After 1 h of 
infection the supernatant was replaced by 100 μl Hanks’ buffered salt solution (Gibco) 
supplemented with 20 mM HEPES and 3 mM probenecid, pH 7.4 (HBSS-HP), and 20 μl 
freshly prepared CFF2-AM β-lactamase substrate (LiveBLAzer FRET-B/G Loading Kit; 
Invitrogen) was added. After 1 h 45 min of incubation at room temperature in the dark, 
cells were washed with HBSS-HP. Fluorescence emission at 450 nm and 520 nm was 
measured from the bottom using a Fluostar Optima plate reader (excitation wavelength, 
410 nm; 10-nm band-pass). Briefly, emission values were first corrected by subtraction 
of the average background signals recorded for empty wells, and then the 450 nm/520 
nm emission ratio for each well was calculated. The translocation rate was expressed as 
the fold increase of the 450-nm/520-nm emission ratio of each infected cell in 
correlation with the emission ratio of uninfected cells.  
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Table 2.5 List of antibodies used in this study  
Antibody Species of 
origin 
Concentration 
(IF) 
Concentration 
(WB)  
Source 
Primary Antibodies 
 
 
Haemagglutin 
(HA) 
Mouse 500 1,000 Covance 
HA-TRITC Mouse 100 NA Sigma 
Myc Mouse 500 1,000 Millipore 
Myc-FITC Mouse 100 NA Sigma 
Legionella LPS  Rabbit 900 NA ViroStat 
Legionella LPS  Mouse 500 NA ViroStat 
Lamina A Mouse 500 NA Abcam 
FLAG Mouse 500 2,500 Sigma 
GST Mouse NA 1,000 Abcam 
EEA1 Mouse 500 NA BD Transduction 
Lab. 
LAMP1 Rat 200 NA Abcam 
LC3A Mouse 500 NA Cell Signalling 
LC3B Rabbit NA 1000 Sigma 
p62 Rabbit 500 NA Caltag 
MedSystems/MBL  
Tubulin Mouse 500 2500 Sigma 
Calnexin Rabbit 100 NA Cambridge 
Biosciences 
Catalase Mouse 500 NA Calbiochem 
GM130 Mouse 500 NA BD Transduction 
Laboratories 
Secondary Antibodies 
 
 
Anti-mouse 
IgG RRX 
Donkey 200 NA Jackson 
ImmunoResearch  
Anti-mouse 
IgG 448 
Donkey 200 NA Jackson 
ImmunoResearch  
Anti-rabbit 
IgG RRX 
Donkey 200 NA Jackson 
ImmunoResearch  
Anti-rabbit 
IgG 448 
Donkey 200 NA Jackson 
ImmunoResearch  
Anti-mouse 
IgG-HRP 
Donkey N/A 10,000 Jackson 
ImmunoResearch  
Anti-rabbit 
IgG-HRP 
Donkey N/A 10,000 Jackson 
ImmunoResearch  
Other  
Rhodamine 
Phalloidin 
NA 200 NA Invitrogen 
DAPI NA 1,000 NA Sigma 
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2.7 Infection of eukaryotic cells 
L. pneumophila strains were on grown CYE plates for three or four days then inoculated 
into AYE in the presence of 6 μg/ml chloramphenicol and 0.5 mM isopropyl β-d-1-
thiogalactopyranoside (IPTG) if required at 37 °C for 21 h until the post-exponential 
phase was reached, as described previously (Schroeder et al 2010). The bacteria were 
then diluted in the appropriate cell culture media to a multiplicity of infection (MOI) of 
40 (for RAW264.7 cells or D. discoideum), 5 (for THP-1 cells) or 100 (for A549 cells) 
(unless otherwise specified), supplemented with chloramphenicol (6ug/ml) and IPTG if 
required. To synchronise infection, plates were centrifuged for 10 min at 500 g. 
2.8 Immunofluorescence microscopy  
Cells on coverslips were washed twice with D-PBS and attached cells fixed using 4 % 
paraformaldehyde for 20 mins, followed by quenching with 50 mM ammonium chloride 
for 10 mins. Coverslips were washed three times with PBS, cells permeabilised with 
0.1% Triton in PBS and then blocked with blocking buffer (2% (w/v) bovine serum 
albumin in PBS). Samples were incubated for one hour with the primary antibody in 
blocking buffer, washed three times in PBS and incubated for a further hour with 
secondary antibodies before mounting using ProLong Gold Antifade (Invitrogen). 
Antibodies used in this study are described in Table 2.5. 5 μg ml−1 of 4′,6-diamidino-2-
phenylindole (DAPI) was used to visualize DNA. Samples were analysed either using an 
Axio M1 Imager or Axio Z1 Imager microscope and images processed using Axiovision 
software (Carl Zeiss) and Photoshop (Adobe). 
2.9 Immunoprecipitation of LtpD for analysis of phosphorylation 
1.5 x 107 A549 cells were infected with WT L. pneumophila 130b expressing 4HA-LtpD 
or 4HA-LtpD1-469 at an MOI of 100 for 5 hours. Infected cells were washed twice with ice 
cold D-PBS then scraped and incubated in 1ml IP buffer (20mM sodium phosphate pH 
7.5, 150mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 50mM NaF, 
1mM Na3VO4, 10mM β-glycerophosphate) with protease inhibitor cocktail (Sigma) on 
ice for 20 min. The lysate was then centrifuged to remove cellular debris and the 
supernatant applied to pre-equilibrated mouse anti-HA agarose (Sigma) beads and 
incubated together on a wheel for 1 h at 4 °C. The beads were then washed 6 times in IP 
buffer and the protein eluted in Laemmeli buffer and the proteins separated and 
 68
transferred as described in sections 2.2.6 and 2.2.7 using blocking buffer (10 mM Tris pH 
7.4, 150 mM NaCl, 0.1% Tween 20, 1 mM EDTA, 3% BSA, 0.5% gelatine) instead of PBS 
at all points.  
2.10 Intracellular Replication Assays  
THP-1 cells were prepared as described above and infected with post-exponential phase 
WT, ΔDotA, ΔLtpD or ΔLtpD + p4HA-LtpD L. pneumophila at an MOI of 5. A549 cells were 
seeded at 5 x 105 cells/well 24 hours before infection and were infected at an MOI of 40. 
The infection was allowed to proceed for 1 hour, media was removed and the cells 
incubated with gentamycin (100 μg/ml) for 1 hour. Cells were then washed twice and 
incubated for the duration of the experiment in RPMI 1640 or DMEM supplemented 
with 6 μg/ml chloramphenicol and 1mM IPTG if required. At 0, 5, 18, 24, 48 and 72 h p.i., 
cells were lysed with digitonin (10 μg/ml), the intra- and extracellular fraction pooled 
and serially diluted and plated onto CYE with 6 μg/ml chloramphenicol to determine the 
total CFU. At 0 and 5 h p.i. the undiluted and -1 dilutions were plated, at 18 and 24 h p.i. -
2 and -3, and at 48 and 72 h p.i. -3 and -4. For the ΔDotA strain, the undiluted and -1 
dilutions were plated at all time points. In order to determine the percentage of 
internalized bacteria after one hour of infection, the ratio of CFU of the inoculum over 
CFU at 0 h p.i. was calculated. Results are the mean ± standard deviation of at least three 
separate experiments.   
2.11 Detachment assay  
THP-1 cells were infected at an MOI of 40 and the infection was allowed to proceed for 8 
hours to visualize early cell killing events. Cells were washed gently twice with D-PBS to 
remove unattached cells and incubated with 100 μl of trypsin at 37 °C for 10 mins until 
all cells had detached. Detached cells were mixed with an equal volume of Trypan blue  
(0.02% (v/v) in PBS) and viable cells counted using a haemocytometer. Results were 
given as a percentage of uninfected wells. The assay was performed in triplicate and 
each well was counted twice. Data are the mean of four separate experiments ± standard 
deviation.   
2.12 Yeast-2-hybrid assay  
All yeast work was preformed according to the Clontech protocol handbook. A Y2H 
screen was performed using LtpD fused to DNA-binding domain as a bait (pICC1268) in 
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the S. cerevisiae Gold strain (Clontech) with the Matchmaker HeLa cDNA library 
(Clontech). Prior to mating, it was confirmed that the expression of LtpD did not induce 
auto activation of the reporter genes or yeast toxicity (results not shown). Colonies 
containing both plasmids were selected by plating onto low stringency SD (DDO), 
lacking leucine and tryptophan, then onto high stringency media (QDOA) lacking leucine, 
tryptophan, histidine and adenine however with the addition of 0.5 μg/ml aureobasidin 
A, to select for interacting proteins. Plasmids were extracted from selected clones and 
sequenced using AD-LD primers from Clontech (5’ 
CTATTCGATGATGAAGATACCCCACCAAACCC 3’ and 5’ AATCGTAGATACTGAAAAA 
CCCCGCAAGTTCACT 3’). Sequences were aligned using Blastx 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) against the Homo sapiens library. In order to 
confirm protein interactions, full length IMPA1 or IMPA2 cDNA (Open Biosystems) was 
then inserted into pGADT7 and directly transformed into the reporter strain AH109 with 
LtpD or the empty pGBT9 vector as a negative control.  
 
2.13 Co-immunoprecipitation of LtpD and IMPA1  
HeLa cells were transfected using Genejuice (Merck) as above and incubated for 48 
hours. Cells were lysed in RIPA buffer (20 mM Tris-HCl (pH 7.5) 150 mM NaCl, 1 mM 
EDTA, 1 mM EGTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS) with protease 
inhibitor cocktail (Sigma) and incubated with 25 μl of agarose beads directly conjugated 
to anti-Myc antibodies on a rotor at 4 °C for 1 h. The beads were then washed 4 times 
with 0.1% Tween/PBS (PBST). Proteins bound to the beads were eluted with 2x SDS-
PAGE sample buffer and boiled for 5 mins. Samples were resolved by SDS-PAGE 
electrophoresis, transferred to PVDF membrane (GE Healthcare) and treated as 
described above in section 2.2.7 using primary antibodies mouse anti-Myc and mouse 
anti-FLAG.  
2.14 Infection of A/J mice  
All animal work took place at the University of Melbourne performed by Ms Clare Oats and 
the University of Melbourne Animals Ethics Committee approved mouse procedures. The 
comparative virulence of L. pneumophila 130b and the mutants and complemented strains 
were examined as described previously (Newton et al., 2008). Briefly, 6 to 8 week old male or 
female A/J mice were anesthetized and inoculated intranasally with approximately 2.5 x 106 
 70
CFU of each L. pneumophila strain under investigation. 72 hours following inoculation, mice 
were killed and their lung tissue isolated. Tissue was homogenized and complete host cell 
lysis was achieved by incubation in 0.1% saponin for 15 min at 37 °C. Serial dilutions of the 
homogenate were plated onto both plain and antibiotic selective CYE agar plates to determine 
the number of viable bacteria and the ratio of wild-type to mutant bacteria colonizing the lung. 
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Chapter 3 – Galleria mellonella as an insect model for 
Legionella pneumophila infection 
 
In order to investigate L. pneumophila pathogenesis, infection models that approximate 
human disease are required. The larvae of G. mellonella have been successfully used to 
model the virulence of a number of important human pathogens, however had not 
previously been investigated in relation to L. pneumophila infection. In this chapter I 
characterise L. pneumophila pathogenesis in G. mellonella and determine several 
bacterial factors required for infection.    
 
3.1 L. pneumophila infection induces Galleria mellonella mortality 
In order to investigate the pathogenicity of L. pneumophila in G. mellonella larvae, three 
serogroup 1 L. pneumophila strains were used: 130b, Paris and JR32, all of which have 
been used extensively in characterizing the molecular pathogenesis of L. pneumophila. 
107 colony forming units (CFU) were injected into the larvae and the larvae’s survival 
monitored over 72 h (Fig. 3.1A). All three L. pneumophila strains caused time-dependent 
death of at least 70% of the G. mellonella, however strain 130b caused significantly (P < 
0.005) higher mortality than the JR32 or Paris strains at 18 h p.i. As the 130b strain 
induced the greatest mortality, it was used in the following experiments. No mortality 
was observed in the control buffer (PBS) injected G. mellonella or in larvae injected with 
heat killed WT bacteria (results not shown). These results demonstrate that G. 
mellonella is susceptible to L. pneumophila infection. Furthermore, over the course of 
performing these experiments, it was noticed that the incubation period of the plates 
made a significant difference to the virulence of the bacteria. WT L. pneumophila 
incubated for three days on plate then grown to post-exponential phase in broth only 
killed around 50% of larvae by 24 h p.i., compared to 100% mortality caused by bacteria 
grown for four days on plate (Fig. 3.1B). Due to this, all experiments were carried out 
using plates incubated for four days.  
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Figure 3.1. L. pneumophila infection of Galleria mellonella induces strain-
dependent lethality.  
10 G. mellonella larvae were injected with L. pneumophila strain 130b, Paris or JR32 (107 
CFU per larvae) and survival monitored over 72 h p.i. (A) All three strains caused time-
dependent death of the infected larvae, with strain 130b inducing significantly higher (P 
< 0.005, unpaired T-test) mortality at 18h p.i. (B) Larval survival depended on the 
incubation period of CYE plates. Plates incubated for three days before inoculation of an 
overnight culture were significantly (P < 0.005 at 24 h p.i., unpaired T-test) less virulent 
than plates incubated for four days. Results represent the mean of at least three 
independent experiments ± standard deviations with 10 larvae per condition. Copyright 
© 2012, American Society for Microbiology. All Rights Reserved doi:10.1128/IAI.00510-
12  
 
3.2 Mortality in L. pneumophila-infected G. mellonella is dose-dependent  
To determine if the mortality caused by L. pneumophila infection was dependent on the 
dose of injected bacteria, G. mellonella were injected with 104, 105 106 or 107 CFU of L. 
pneumophila strain 130b. While infection with 107 CFU resulted in 100 % G. mellonella 
mortality within 24 h of infection, mortality was reduced to less than 40% in larvae 
injected with 106 CFU, and no mortality was observed in G. mellonella injected with 
either of the lower doses (104 and 105 CFU/larvae) (Fig. 3.2A). These results show that L. 
pneumophila induces dose-dependent G. mellonella mortality and that the larvae’s 
immune responses can respond to low doses. 
 
3.3 The growth phase of L. pneumophila influences G. mellonella mortality 
During its lifecycle, L. pneumophila alternates between replicative and transmissive 
forms (Hammer et al., 1999, Hammer et al., 2002). A number of virulence factors that 
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promote infection of new host cells are down-regulated in the replicative phase and up-
regulated in the transmissive phase. These changes can be approximated in broth 
culture, the transmissive traits are repressed in the exponential phase and expressed as 
the bacteria enter the post-exponential phase (Hammer et al., 1999). In order to assess if 
expression of transmissive traits was important in induction of G. mellonella mortality, 
insects were inoculated with 107 CFU L. pneumophila 130b cultured to exponential 
(OD600~0.4), post-exponential (OD600~3) or stationary (OD600>4) phases in broth. Over 
the entire time course, significantly more (P < 0.0005 at 18 h p.i.) larvae injected with 
exponential and stationary phase bacteria survived than the ones inoculated with post-
exponential phase bacteria (Fig. 3.2B). This indicates that the growth phase of L. 
pneumophila significantly influences virulence in the G. mellonella model. Previously, 
post exponential growth phase has been shown to be essential in virulence in primary 
mouse macrophages and ameobae (Byrne et al., 1998, Solomon et al., 2000). This result 
indicates that killing of the larvae by L. pneumophila is dependent on virulence factor 
expression, rather than an unspecific response.   
 
3.4 The L. pneumophila Dot/Icm T4SS is essential for G. mellonella mortality 
The Dot/Icm T4SS of L. pneumophila is essential for intracellular survival and the 
establishment of a replicative vacuole in macrophages and amoebae (Berger et al., 1993, 
Segal et al., 1998b, Segal et al., 1999a). The 130b ΔDotA strain has a kanamycin 
resistance cassette inserted in the dotA gene resulting in a non-functional T4SS 
(Schroeder et al., 2010). Infection of G. mellonella with 107 CFU of the ΔDotA strain did 
not cause any mortality of the larvae over the three days of the experiment, whereas the 
parental wild type strain killed all larvae within 24 h (Fig. 3.2C). This demonstrates that 
L. pneumophila-induced mortality of G. mellonella is dependent on the presence of a 
functional Dot/Icm T4SS, as seen in other infection models.  
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Figure 3.2 Mortality is dose-, growth phase- and Dot/Icm secretion system-
dependent (A) Mortality of the larvae upon infection with L. pneumophila strain 130b 
was dose dependent. (B) Mortality was dependent on the growth phase of L. 
pneumophila. Larvae were inoculated with 130b cultured to exponential (E), post 
exponential (PE) or stationary (S) phase. Bacteria in PE phase demonstrated 
significantly (P < 0.005, unpaired T-test) greater toxicity than bacteria in E or S phase at 
18h p.i. (C) L. pneumophila-induced mortality in G. mellonella was dependent on the 
Dot/Icm T4SS. G. mellonella were injected with 130b WT or T4SS-deficient ΔDotA strain. 
The ΔDotA strain did not induce any mortality in the larvae by 72 h p.i. Results represent 
the mean of at least three independent experiments ± standard deviations with 10 
larvae per condition. Copyright © 2012, American Society for Microbiology. All Rights 
Reserved doi:10.1128/IAI.00510-12  
 
3.5 Uptake of bacteria is required for G. mellonella mortality 
Recently, it was shown that treatment of G. mellonella larvae by injection of cytochalasin 
B lead to inhibition of phagocytosis by haemocytes. This inhibition increased the larva’s 
susceptibly to infection by the yeast Candida albicans (Banville et al., 2012). As L. 
pneumophila is an intracellular pathogen, it was decided to determine if uptake of the 
bacteria is crucial for its pathogenesis in this model. Larvae were pre-treated with 10 μl 
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of either 20 μM or 100 μM cytochalasin D for 4 h at 37 oC, then injected with 107 CFU of 
wild type (WT) L. pneumophila 130b and mortality monitored (Fig 3.3). Control larvae 
were injected with the same volume of DMSO. Previously, Banville et al (2012) used a 
concentration of 20 μM of cytochalasin B, however in this study, no effect on larval 
mortality could be seen at this concentration (results not shown). This may be due to 
differences in the activity or bioavailability of cytochalasin B verses cytochalasin D. 
Treatment with the inhibitor alone or the DMSO vehicle control did not affect larval 
survival over the course of the experiment. However, larvae pre-treated with 100 μM 
cytochalasin D then infected displayed significantly greater survival at 18 h (P = 0.008) 
and 24 h (P = 0.0066) post infection (p.i.) compared to untreated, infected insects (Fig 
3.2). The protective effect of cytochalasin D was abolished by 48 h p.i., possibly due to 
metabolism of the drug. This result demonstrates that cytochalasin D is suitable for 
treatment of larvae and suggests that uptake of L. pneumophila into G. mellonella 
haemocytes is an important aspect of bacterial virulence.  
 
3.6 L. pneumophila is found within haemocytes 
As inhibition of bacterial entry was shown to inhibit L. pneumophila virulence, it was 
decided to determine if bacteria were found inside haemocytes. To analyse if L. 
pneumophila was localised within the phagocytic cells of the haemolymph, haemocytes 
were extracted from infected G. mellonella larvae at 5 and 24 h p.i. and immunostained 
for external and total bacteria (Fig. 3.4A). By 5 h p.i., WT and ΔDotA 130b bacteria were 
found both inside (green bacteria) and outside (yellow bacteria, arrows) haemocytes. By 
24 h p.i. haemocytes extracted from G. mellonella infected with wild type bacteria were 
full of intracellular L. pneumophila, whereas no bacteria could be found in haemocytes of 
G. mellonella infected with the 130b ΔDotA strain (data not shown). This result suggests 
that L. pneumophila invades and may replicate within in G. mellonella haemocytes. 
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Figure 3.3. Mortality is dependent on bacterial internalisation.  
10 G. mellonella larvae were pretreated with 100 μM cytochalasin D (CyD) for 4 h at 37 
°C then infected with 107 WT and mortality monitored. Pretreated larvae demonstrated 
significantly (P = 0.008 at 18 h p.i., unpaired T-test) delayed mortality until 48 h p.i. 
Results represent the mean of at least three independent experiments ± standard 
deviations with 10 larvae per condition.  
 
 
 
3.7 L. pneumophila resides in a LCV in haemocytes  
In order to assess if L. pneumophila forms a LCV in haemocytes, haemocytes from 
infected G. mellonella were analysed by transmission electron microscopy (TEM) (Fig. 
3.4B). TEM samples and images were prepared by Dr. Artemis Kosta (Imperial College 
London). By 5 h p.i. L. pneumophila 130b was observed within distinct vacuoles, as the 
infection progressed, more bacteria could be founds within the LCVs (Fig 3.4B). More 
detailed images revealed that the LCV was associated with mitochondria (arrowheads) 
and ribosomes (arrows) and by 24 h p.i. the majority of haemocytes were filled with 
bacteria in a ribosome-studded vacuole (Fig. 3.4C). L. pneumophila therefore appears to 
reside in LCVs in infected G. mellonella haemocytes, which are similar to those seen in 
human monocytes (Horwitz, 1983).  
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Figure 3.4 L. pneumophila forms a LCV within G. mellonella haemocytes.   
(A) External and total bacteria were immuno-stained. At 5 h p.i. both wild type and 
ΔDotA bacteria were found inside and outside (arrows) cells. By 24 h p.i., wild type 
infected haemocytes had high loads of intracellular bacteria. (B) Haemocytes from G. 
mellonella infected with L. pneumophila 130b were extracted 5, 12 and 24 h p.i. and 
imaged by TEM. At 5 h p.i., bacteria were observed in vacuoles within haemocytes and 
cells appeared filled with bacteria by 24 h p.i. Scale bar represents 2 μm. (C) At 5 h p.i., 
mitochondria (arrowheads), ribosomes (arrows) and ribosome-associated vesicles were 
observed on the surface of the LCV. By 24 h p.i. the LCV was studded with ribosomes 
(arrows). Scale bar represents 500 nm. Copyright © 2012, American Society for 
Microbiology. All Rights Reserved doi:10.1128/IAI.00510-12  
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To further characterise the LCVs formed in haemocytes, the recruitment of SidC was 
evaluated, SidC is a L. pneumophila Dot/Icm effector previously shown to bind the LCV 
membrane through direct interaction with phosphatidylinositol-4 phosphate 
(PtdIns(4)P) (Weber et al., 2006). A 4HA epitope-tagged fragment of SidC (SidC41-918) 
containing the PtdIns(4)P-binding domain was expressed in L. pneumophila and the 
localisation of the protein was analysed by immunofluorescence (Fig. 3.5A). To ensure 
the protein was expressed throughout the infection, larvae were injected with bacterial 
suspension containing 1 μM IPTG. Injection of larvae with IPTG did not cause mortality if 
administered alone or alter the virulence of L. pneumophila WT (Fig. 3.5B). Similarly to 
the reported localisation in macrophages, amoebae (Luo et al., 2004, Weber et al., 2006) 
and human A549 cells (data not shown), staining of 4HA-SidC41-918 was seen 
surrounding intracellular bacteria in haemocytes reminiscent of the LCV. No anti-HA 
staining was observed in the control haemocytes extracted from larvae infected with L. 
pneumophila 130b ΔDotA expressing 4HA-SidC41-918 (Fig. 3.5A) or haemocytes infected 
with 130b WT (results not shown). At 24 h p.i. haemocytes from G. mellonella infected 
with WT 130b expressing 4HA-SidC41-918 were full of bacteria and all bacteria 
surrounded by 4HA-SidC41-918. Similar results were obtained using L. pneumophila JR32, 
a derivative of the Philadelphia-1 strain. Interestingly, the related thymine auxotroph 
strain Lp02 did not show evidence of replication at 24 h p.i. however did display staining  
of 4HA-SidC41-918 on the LCV at both 5 and 24 h p.i (Fig. 3.5A). Together, these results 
indicate that, similar to infection of protozoan or mammalian host cells, L. pneumophila 
is able to translocate T4SS-substrates and to form an LCV in G. mellonella haemocytes. 
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Figure 3.5 SidC is localised to the LCV in haemocytes of infected G. mellonella  
(A) G. mellonella larvae were injected with L. pneumophila strains 130b, JR32 or Lp02 
expressing 4HA-SidC41-918. At 5 and 24 h p.i., haemocytes were extracted, fixed and 
stained with anti-HA (red) antibody. By 5 h p.i. 4HA-SidC41-918 was localised on the LCV 
surface in haemocytes from WT infected G. mellonella but not 130b ΔDotA. By 24 h p.i., 
haemocytes from G. mellonella infected with 130b or JR32 were full of bacteria 
surrounded by 4HA-SidC41-918. In contrast, far fewer bacteria were observed in 
haemocytes from Galleria infected with strain Lp02. Scale bar represents 5 μm. (B) 10 
larvae were injected with PBS or WT L. pneumophila 130b, with or without addition of 
1mM IPTG and survival monitored. IPTG did not affect larval survival in uninfected or 
infected insects. Results are representative of at least two separate experiments. 
Copyright © 2012, American Society for Microbiology. All Rights Reserved 
doi:10.1128/IAI.00510-12  
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3.8 L. pneumophila replicates within G. mellonella in a Dot/Icm T4SS-
dependent manner  
Immunofluorescence and TEM results strongly suggest that L. pneumophila is capable of 
replicating within haemocytes. In order to confirm this, larvae were injected with 107 
CFU of WT or ΔDotA L. pneumophila 130b. At selected time points, haemolymph from 
three live larvae was extracted and pooled, and the number of CFU/100 μl of extracted 
haemolymph was determined (Fig. 3.6A). The 130b ΔDotA mutant was cleared from the 
injected larvae by 24 h p.i. and did not exhibit any replication. In contrast, infection of G. 
mellonella with WT 130b resulted in an initial 10-fold reduction of CFU at 5 h p.i., but the 
bacterial numbers then significantly increased from the inoculum until 24 h p.i. (Fig. 
3.6A), demonstrating that L. pneumophila is able to replicate in G. mellonella and that 
replication depends on a functional Dot/Icm T4SS. 
3.9 Persistence of bacteria has a role in G. mellonella mortality.  
Both larval mortality and bacterial replication depend on the presence of the Dot/Icm 
secretion system however it was not clear how replication and mortality were linked. In 
order to further analyse the impact of L. pneumophila intracellular replication on G. 
mellonella mortality, two closely related strains derived from the L. pneumophila strain 
Philadelphia-1 were tested, JR32 and Lp02, with JR32 ΔIcmT as a T4SS-deficient control. 
While both JR32 and Lp02 encode a functional Dot/Icm T4SS, the latter is a thymine 
auxotroph showing reduced intracellular survival and replication in cultured cells in the 
absence of added thymine or thymidine (Berger et al., 1993). Quantification of the 
number of CFU extracted from the haemolymph over 24 h (Fig. 3.6B) showed that the 
JR32 bacteria persisted in injected G. mellonella throughout the infection, while the JR32 
ΔIcmT strain, which does not have a functional T4SS, was cleared within 18 h. The Lp02 
strain persisted to a higher CFU count than the JR32 ΔIcmT strain at 18 h p.i. before 
ultimately being cleared by 24 h p.i. While JR32 killed all the infected insects, both the 
Lp02 and JR32 ΔIcmT strains were unable to cause death in injected G. mellonella over 3 
days p.i. (Fig. 3.6C). These data indicate that a functional T4SS which enables the Lp02 
strain to translocate effectors during the first hours of infection is required, however not 
sufficient, to induce death of the larvae. The mortality of L. pneumophila-injected G. 
mellonella depends, therefore, on both the T4SS and the ability of the bacteria to persist 
within the larvae for more than 18 h. 
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Figure 3.6 L. pneumophila replication causes mortality in G. mellonella. 
Haemolymph was extracted from three L. pneumophila infected larvae, pooled, and the 
CFU/100 μl was quantified. (A) Wild type L. pneumophila 130b suffered a brief drop at 5 
h p.i. but  while the ΔDotA mutant was nearly cleared from G. mellonella by 5 h p.i. (B 
and C) Larvae were inoculated with L. pneumophila strains JR32 or Lp02. In contrast to 
JR32 strain, the thymine auxotroph strain Lp02 neither persisted in haemolymph 24 h 
p.i. (B), nor induced mortality in G. mellonella 72 h p.i. (C). Results represent the mean of 
at least three independent experiments ± standard deviations with 10 larvae per 
condition. Copyright © 2012, American Society for Microbiology. All Rights Reserved 
doi:10.1128/IAI.00510-12  
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3.10 Low temperature is not sufficient to rescue the virulence of the ΔIcmT 
strain  
The Lvh secretion system has been implicated in the virulence of L. pneumophila at low 
temperatures (Ridenour et al., 2003, Bandyopadhyay et al., 2007). It has previously been 
reported that Dot/Icm-deficient mutants can become more virulent at lower 
temperatures, potentially through the action of the Lvh T4ASS (Bandyopadhyay et al., 
2007). G. mellonella can tolerate a range of incubation temperatures (Mowlds et al., 
2008b) so the effect of low temperatures on bacterial replication of the JR32, Lp02 and 
JR32 ΔIcmT strains was analysed. The Lp02 strain does not encode a Lvh T4ASS 
(Brassinga et al., 2003) and was included to investigate the potential role of this 
secretion system. Larvae were infected with 107 CFU of JR32 WT, JR32 ΔIcmT strains or 
Lp02, grown for 21 h at either 30 oC or 37 oC. The infected larvae were then incubated at 
22 or 37 °C for the duration of the experiment and CFU from the extracted haemolymph 
determined (Fig. 3.7). Generally, reduced temperature decreased the recovered CFU of 
the WT JR32 and Lp02 strains in a similar manner, whereas temperature did not affect 
the speed of the ΔIcmT strain clearance. These data echo previous studies which 
demonstrated that L. pneumophila is less able to grow and so less virulent at lower 
temperatures (Ohno et al., 2008, Buse et al., 2011).  
 
This experiment did not show a change in bacterial replication or toxicity of the ΔIcmT 
strain when grown or incubated at lower temperatures (Fig. 3.7) suggesting that the Lvh 
system seems not to be contributing to virulence in the G. mellonella model. However, 
reducing the incubation temperature can have pleiotropic effects, for example on the 
immune response of the larvae (Mowlds et al., 2008b, Desalermos et al., 2012) and on 
the expression of a number of L. pneumophila virulence traits (Mauchline et al., 1994, 
Ohno et al., 2008, Qin et al., 2012). In order to rule out a contribution of the Lvh system 
to virulence, a detailed analysis of deletion mutants is required which was beyond the 
scope of this study.  
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Figure 3.7 Decreasing the infection temperature decreases bacterial replication in 
G. mellonella.  
Haemolymph was extracted from G. mellonella inoculated with L. pneumophila strains 
Lp02, JR32 WT or JR32 ΔIcmT. Prior to infection, bacteria were grown for 21 hours in 
AYE broth culture at either 30 or 37 oC. Larvae were then infected and incubated for the 
duration of the experiment at 22 or 37 oC. Modification of the temperature made no 
difference to CFU recovered from the ΔIcmT strain. Under most conditions tested the 
WT strain showed no significant variation in recovered CFU, however when the bacteria 
were grown at 30 oC and the larvae incubated at 22 oC a decrease in Legionella CFU was 
observed. Results representative of two separate experiments. 
 
3.11 The role of selected L. pneumophila phospholipases in the G. mellonella 
model 
Many bacterial pathogens require phospholipase activity for in vivo infection, either to 
promote dissemination by destroying host tissue or by directly modulating the hosts 
immune system (Schmiel et al., 1999). L. pneumophila culture supernatants display both 
phospholipase A (PLA) and phospholipase C (PLC) activity. PLA activity has been 
attributed to the protein PlaB which is secreted by the T2SS and was shown have a role 
in infection of mice but not in cell culture (Flieger et al., 2004, Schunder et al., 2011). 
Recently, three enzymes with PLC activity have been identified in L. pneumophila, PlcA, 
PlcB and PlcC (previously known as CegC1). All three enzymes are conserved between 
all of the sequenced L. pneumophila genomes, PlcB is also found in L. longbeachae and 
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PlcC is found in L. longbeachae, one strain of L. drancourtii and one strain of L. dumoffii. 
PlcC is secreted via the Dot/Icm secretion system (Aurass et al., 2013) while PlcA and 
PlcB have signal peptides and are secreted via the Sec-dependent pathway (McCoy-
Simandle et al., 2011). PLC activity was shown to be dispensable in bacterial replication 
in amoebae and in macrophages (Aurass et al., 2013) however, the contribution of PLC 
activity to in vivo infection had not been investigated.  
In order to determine the requirement of the different PLC L. pneumophila enzymes for 
in vivo virulence the G. mellonella model was used. 10 larvae were infected with the JR32 
parental strain from Prof. Antje Flieger’s (Robert Koch-Institut) laboratory (JR32 
Flieger), the single mutant strains ΔPlcA, ΔPlcB and ΔPlcC, the double mutant strains 
ΔPlcAB, ΔPlcBC and ΔPlcAC and the triple mutant ΔPlcABC and survival monitored over 
72 hours. The ΔDotB strain was included as a T4SS-deficient negative control. 
Unexpectedly, the JR32 strain used in these assays was less virulent both than L. 
pneumophila 130b and the JR32 strain routinely used in our laboratory. The CFU of the 
inoculum was confirmed to be as expected (results not shown) and the reason for the 
decreased virulence is unknown, however it may be due to increased passage of the 
JR32 Flieger strain on CYE agar as this has previously been shown to reduce the 
virulence of L. pneumophila strains (Catrenich et al., 1988). 
Although single and double mutants of the three PLC’s did not affect larval survival (Fig. 
3.8A and B), deletion of all three enzymes resulted in a significant (P < 0.005 at 24 and 
48 h p.i., P < 0.05 at 72 h p.i.,) decrease in larval mortality, suggesting that not the 
individual proteins but their combined PLC activity has a role in L. pneumophila infection 
of G. mellonella (Fig. 3.8C).  
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Figure 3.8 Secreted PLC’s have a role in L. pneumophila infection of G. mellonella.  
10 larvae were injected with the WT L. pneumophila JR32 or  (A) single, (B) double or 
(C) the triple mutant in the three PLC genes and larval survival recorded. No difference 
in mortality was observed for G. mellonella injected with the single or double PLC 
mutants. However, deletion of all three enzymes resulted in increased survival (P < 
0.005 at 24 and 48 h p.i., P < 0.05 at 72 h p.i., unpaired T-test). Results are the mean of 
three independent experiments ± standard deviation.  Copyright © 2013, American 
Society for Microbiology. All Rights Reserved doi: 10.1074/jbc.M112.426049  
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3.12 G. mellonella pathology in response to L. pneumophila infection 
In order to examine the effect of L. pneumophila infection on G. mellonella physiology, 
infected larvae were fixed and paraffin embedded sections were stained with 
hematoxylin and eosin (H&E) and evaluated for histological changes by Prof. Stuart 
Reynolds (University of Bath) (Fig. 3.9). Mock-infected controls appeared healthy with 
no bacteria observed in the haemocoel and individually distributed haemocytes 
occasionally forming loose aggregations. However, in both wild type and ΔDotA 130b 
infected insects, vigorous host defences appeared to be mounted. At 16 h p.i. with 130b 
ΔDotA, fewer individual haemocytes were observed compared to the mock infected 
control, with the majority of haemocytes present in tightly packed aggregation nodules 
(N) and some evidence of melanisation (arrows). By 24 h p.i. similar features were 
observed, but the majority of the tissue looked healthy. However, in larvae infected with 
WT L. pneumophila 130b at 16 h p.i. haemocytes were observed in nodules attached to 
organ structures, with clearly visible nodule melanisation. By 24 h p.i. some nodules 
were still observed, however septicemia was found in much of the haemocoel (B) and 
organ structures including the gut appeared severely damaged. 
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Figure 3.9 L. pneumophila infection of G. mellonella initiates a robust innate 
immune response.  
G. mellonella larvae were injected with L. pneumophila 130b, fixed and paraffin 
embedded sections were stained with H&E. Uninfected G. mellonella appeared healthy 
with some occasional loose aggregations of haemocytes. At 16 h p.i. with wild type 
bacteria a number of nodules (N) could be observed with evidence of melanisation 
(arrowheads). At 16 h p.i. with ΔDotA some nodules were visible but by 24 h p.i., the 
larvae appeared similar to the uninfected control. At 24 h p.i. with the wild type bacteria, 
some nodules were still visible but a large number of L. pneumophila were visible in the 
haemcoel (B). Copyright © 2012, American Society for Microbiology. All Rights Reserved 
doi:10.1128/IAI.00510-12  
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In order to confirm that the bacteria observed in formalin fixed sections of the infected 
G. mellonella were L. pneumophila, sections were stained using a specific anti-L. 
pneumophila antibody. DNA was visualised by DAPI staining and the tissue structure 
was counterstained using rhodamine-conjugated phalloidin (Fig. 3.10). Anti-L. 
pneumophila antibodies did not stain any bacteria in the uninfected or ΔDotA infected 
insects at 18 h p.i. In the G. mellonella infected with WT, bacteria stained with the anti-L. 
pneumophila antibody were found throughout the haemolymph (Fig. 3.10) and 
occasionally in cells within the fat bodies (results not shown). Bacteria were exclusively 
associated with cells and were usually found in aggregates of haemocytes.  
Together, these data suggest that L. pneumophila triggers an immune response in G. 
mellonella that successfully clears the ΔDotA mutant from the larvae, whereas wild type 
L. pneumophila are resistant to host defences. 
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Figure 3.10 Indirect immunofluorescence microscopy of formalin fixed sections of 
L. pneumophila infected G. mellonella.  
 
G. mellonella larvae were infected with L. pneumophila 130b for 18 h, fixed and paraffin 
embedded sections were stained using a specific anti-L. pneumophila antibody, DAPI was 
used to visualise bacterial and eukaryotic cell DNA and phalloidin to counter stain the 
tissue. No L. pneumophila staining was observed in the uninfected or ΔDotA controls. G. 
mellonella infected with wild type L. pneumophila demonstrated a systemic infection 
with large numbers of bacteria throughout the haemolymph. Bacteria were usually 
associated with cells (arrowheads), a proportion of which displayed apoptotic nuclei 
(arrows). Scale bar represents 20 μm. Copyright © 2012, American Society for 
Microbiology. All Rights Reserved doi:10.1128/IAI.00510-12  
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3.13 Infection of larvae results in a transient up-regulation of phenoloxidase 
activity  
The pathology of infected insects demonstrated that L. pneumophila infection activated 
larval immune responses, so these were examined in more detail. Progression of L. 
pneumophila infection resulted in an increase in G. mellonella pigmentation (Fig. 3.11A), 
which is usually indicative of activation of the phenoloxidase (PO) cascade (Cerenius et 
al., 2004). Upon recognition of pathogen associated molecular patterns (PAMPs) such as 
LPS, the pro-PO system components are released from haemocytes into the 
haemolymph, leading to activation of PO. The activity of this enzyme subsequently 
induces the formation of quinones and melanin, which are involved in defence reactions 
against pathogens invading the haemocoel, such as nodule formation and encapsulation, 
seen in Fig. 3.9 (Cerenius et al., 2004). In order to quantify this innate immune response, 
the level of PO activity in the haemolymph of G. mellonella infected with WT or ΔDotA L. 
pneumophila 130b at 5 and 18 h p.i. was analysed (Fig. 3.11B). By 5 h p.i. insects infected 
with WT bacteria exhibited dramatically increased PO activity compared to larvae 
injected with PBS alone (P < 0.005). Larvae inoculated with L. pneumophila ΔDotA 
presented an intermediate level of PO activity. By 18 h p.i. the level of PO activity did not 
significantly change in the PBS and 130b ΔDotA injected G. mellonella. However, in G. 
mellonella injected with WT bacteria, levels of PO activity dropped significantly 
compared to 5 h p.i. (P < 0.005), reaching levels similar to the PBS control. These results 
indicate that L. pneumophila infection initiates an immune defence in G. mellonella 
through PO activation, a response that is nonetheless abrogated by 18 h p.i. 
The major producers of pro-PO are haemocytes and infection has previously been 
correlated with haemocyte depletion (Chain, 1982, Bergin et al., 2003). As this may help 
to explain the dramatic decrease in PO activity, haemocyte concentration of infected 
larvae was quantified. Insects were infected with WT or ΔDotA L. pneumophila 130b, or 
injected with PBS and viable haemocytes were counted by light microscopy at 5 and 18 h 
p.i. using a trypan blue exclusion assay (Fig. 3.11C). At 5 h p.i. the concentration of 
haemocytes per mL of extracted haemoplymph was comparable in the different groups 
with no significant differences. However, by 18 h p.i. the number of haemocytes was 
reduced by almost 90% in G. mellonella inoculated with WT bacteria compared to 5 h p.i. 
or the controls, suggesting that L. pneumophila infection induces haemocyte destruction. 
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Several factors could be responsible for this dramatic depletion, L. pneumophila is 
known to lyse host cells at the end of its replication cycle (Alli et al., 2000, Molmeret et 
al., 2002b) potentially reducing the circulating population. Furthermore, bacterial 
infection of G. mellonella is known to result in haemocytes aggregating to form nodules 
(Ratcliffe et al., 1977), which are present in L. pneumophila infection (Fig. 3.9), again 
reducing the number of circulating cells. The reduction in haemocyte number observed 
may well contribute to the decreased PO activity observed 18 h p.i (Fig 3.11B). 
. 
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Figure 3.11 Characterisation of the G. mellonella innate immune response to L. 
pneumophila infection.  
G. mellonella were infected with L. pneumophila 130b. (A) Larvae and extracted 
haemolymph became darker over the course of the infection, indicative of melanin 
production by phenoloxidase (PO). (B) PO activity was quantified in the plasma of 
infected G. mellonella at 5 and 18 h p.i. In larvae infected with wild type L pneumophila, 
PO activity increased dramatically at 5 h p.i. (P < 0.005, unpaired T-test) and was almost 
abolished at 18 h p.i. (C) Haemocyte concentration was recorded at 5 and 18 h p.i. with 
L. pneumophila 130b. Infection with wild type bacteria resulted in an approximately 90 
% reduction in haemocyte concentration after 18 h of infection (P < 0.005, unpaired T-
test). Results represent the mean of three independent experiments ± standard 
deviations with three larvae per condition. Copyright © 2012, American Society for 
Microbiology. All Rights Reserved doi:10.1128/IAI.00510-12  
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3.14 Infection with L. pneumophila up-regulates antimicrobial peptide 
expression 
A major component of the defence response of insects is the production of antimicrobial 
peptides, (AMP), small positively charged molecules that can directly lyse bacteria 
(Meister et al., 1997, Lemaitre et al., 2007). In order to assess if G. mellonella up-
regulated AMP production following L. pneumophila infection, AMP mRNA levels in fat 
bodies, the major center of production, were analysed (Meister et al., 1997, Lemaitre et 
al., 2007). Semi-quantitative RT-PCR was performed on extracted mRNA and normalised 
using actin expression. This showed that infection with WT L. pneumophila resulted in 
an up-regulation of most of the immune-related peptides tested, compared to a PBS-
injected control (Fig. 3.12), with a significantly increased expression of gloverin and pro-
PO (PPO) as soon as 2 h p.i. (P < 0.006). In contrast, gallerimycin, galliomycin and 
transferrin were significantly up-regulated only after 18 h of infection (P < 0.0005 for 
gallerimycin and transferrin and P < 0.005 for galliomycin). The expression of the 
peptidoglycan recognition protein B (PRPB) did not significantly increase upon 
inoculation with wild type L. pneumophila. Injection with ΔDotA bacteria did not cause a 
significant variation in expression from the baseline level with the exception of gloverin, 
where expression approximately doubled after 24 h (P < 0.01) (Fig. 3.12). These results 
demonstrate that infection with L. pneumophila results in stimulation of the immune 
system by both the WT and ΔDotA bacteria, yet infection with the WT resulted in a 
significantly increased response. This may be due to the specific action of Dot/Icm 
effector proteins, however it is also likely that the rapid clearance of the ΔDotA bacteria 
by haemocytes removes the source of immune stimulation, leading to less of an increase 
in immune response. 
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Figure 3.12 L. pneumophila infection of G. mellonella up-regulates the expression 
of antimicrobial peptides.  
Larvae were injected with PBS, wild type L. pneumophila 130b, or ΔDotA. Fat bodies of 
three infected G. mellonella were harvested and pooled at indicated time points. Semi-
quantitative RT-PCR was performed and the results were normalised to actin mRNA 
expression. Larvae infected with wild type bacteria demonstrated increased expression 
of antimicrobial peptides. Results are the mean of three independent experiments ± 
standard deviation. Copyright © 2012, American Society for Microbiology. All Rights 
Reserved doi:10.1128/IAI.00510-12  
 
 
3.15 Motility and flagellin expression are not required for virulence or 
bacterial replication in G. mellonella 
Bacterial motility mediated by flagella is an important virulence factor for many 
pathogens, but it comes at a significant cost. Motile bacteria can have an advantage in 
accessing optimal niches for colonisation, however flagella components are highly 
immunogenic and can lead to recognition by the immune system and clearance of the 
bacteria (Ottemann et al., 1997). In L. pneumophila, in vitro infection experiments 
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showed that flagella were important in bacterial invasion; however flagella expression 
were dispensable for establishment of the LCV or intracellular replication (Dietrich et al., 
2001). To determine the role flagella-mediated motility plays in virulence of L. 
pneumophila in the G. mellonella model, a ΔFlaA mutant with the flagellin gene deleted 
was tested. Deletion of flaA has previously been shown to result in non-motile bacteria 
(Ren et al., 2006) which was confirmed by light microscopy (results not shown). Larvae 
were infected with 107 WT or ΔFlaA L. pneumophila and larval survival monitored over 
72 hours. No difference in virulence between the two strains was observed over the 
course of the experiment (Fig. 3.13A). In order to ascertain if bacterial replication was 
affected by the lack of flagella, the viable bacteria load was determined. Haemolymph 
was extracted from infected larvae and the CFU/100 μl of haemolymph was determined 
at 0, 5, 18 and 24 h p.i. In this model, the ΔFlaA strain replicated as efficiency as the WT 
while the ΔDotA strain was cleared (Fig. 3.13B). This demonstrates that flagellin and 
flagella-mediated motility are not required for L. pneumophila virulence in the G. 
mellonella model. 
 
3.16 Clearance of low-infectious doses of L. pneumophila by G. mellonella 
does not depend on the detection of flagellin 
Previous studies have shown that bacteria lacking the key flagella component flagellin 
were able to replicate in the lungs of a non-permissive a mouse strain while the WT was 
unable to undergo any replication (Molofsky et al., 2006, Ren et al., 2006). As rapid death 
of larvae infected with 107 CFU of WT occurs, any increase in virulence may not be 
observed. Therefore, larvae were infected with 105 or 106 bacteria, which have been 
shown to be less toxic (106) and non-toxic (105) for the insect (Fig. 3.2B). At these doses 
the mortality induced by the L. pneumophila ∆FlaA mutant was indistinguishable from 
the WT bacteria (Fig. 3.13C). This suggests that the induction of an antimicrobial 
response and clearance of low infectious doses of L. pneumophila does not depend on 
detection of flagellin by G. mellonella.  
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Figure 3.13 Deletion of the flagellin gene does not affect virulence or bacterial 
replication  
(A) 10 larvae were infected with the WT, ΔDotA or ΔFlaA strains and mortality 
monitored over 72 h, there was no difference between the WT and ΔFlaA strains. (B) 
Bacterial CFU was quantified from larvae infected as above however there was no 
difference in bacterial replication between the WT and ΔFlaA strains. Results are the 
mean of three independent experiments ± standard deviation. (C) To determine if 
deletion of FlaA increased virulence, larvae were injected with 105 or 106 CFU and 
mortality monitored. The ΔFlaA strain showed the same virulence as the WT at both 
doses. Results representative of two separate experiments.  
 
3.17 The role of selected novel Dot/Icm substrates in G. mellonella infection 
The fact that flagella expression is dispensable for virulence while Dot/Icm activity is 
required suggests that translocation of Dot/Icm effector proteins is the major virulence 
factor in L. pneumophila infection. Therefore, it was decided to test the virulence of 
several Dot/Icm effector protein mutants. Determining the function of Dot/Icm effector 
proteins has been a challenge in the Legionella field for some time due to the large 
number and high functional redundancy of translocated proteins (Zhu et al., 2011). 
 97
Although most currently characterised effector proteins are not absolutely required for 
intracellular replication, some have been identified with significant roles in infection 
(Laguna et al., 2006, Lomma et al., 2010). Legionella translocated protein B (LtpB), LtpG 
and LtpJ were recently identified in the sequencing of the L. pneumophila 130b genome 
and have been shown to be translocated into host cells in a DotA-dependent manner, 
however have unknown functions (Schroeder et al., 2011). PieE is a conserved, coiled 
coil containing effector protein of unknown function also translocated by the Dot/Icm 
system (Ninio et al., 2009). In order to determine the role of these genes in the L. 
pneumophila model, gene deletion mutants were acquired from Dr Gunnar Schroeder 
and Dr Aurelie Mousnier (Imperial College). Larvae were infected with 107 CFU L. 
pneumophila 130b WT, ΔDotA, the selected mutant and relevant complemented strain 
and mortality and replication monitored over 72 hours. None of the four mutant strains 
tested exhibited phenotypes either in the ability of the strain to cause larval mortality 
(Fig. 3.14A, C, E, G) or replication of the bacteria (Fig. 3.14B, D, F, H). These results fit 
with previously reported data, deletion of PieE and a number of other proteins in this 
family did not affect bacterial replication in macrophages or amoebae (Ninio et al., 2009) 
and the absence of LtpG did not affect the fitness of the strain in a mixed infection in 
susceptible mouse lungs (E. Hartland, personal communication). These data 
demonstrate that several Dot/Icm effector proteins are dispensable for infection in the 
G. mellonella infection model. This is not unexpected; many other Dot/Icm substrates 
have been shown to be redundant in infection in various models of pathogenesis (Luo et 
al., 2004, Bardill et al., 2005, Ninio et al., 2009) and very few effector proteins have been 
shown to have a role in in vivo infection (Price et al., 2009).  
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Figure 3.14 Four selected Dot/Icm effector proteins do not have a role in L. 
pneumophila virulence in G. mellonella.  
Larvae were infected with 107 L. pneumophila 130b WT, ΔDotA, selected mutant or 
complemented strain and assayed for G. mellonella mortality (A, C, E, G) or bacterial 
replication (B, D, F, H). None of the gene deletion strains had an observable phenotype 
in virulence or replication. Results are the mean of three independent experiments ± 
standard deviation.    
 
3.18 The effector SdhA localises to and promotes stability of the LCV in 
infected G. mellonella haemocytes 
After testing the function of several Dot/Icm effectors with unknown function, it was 
decided to analyse the effect of a protein with a well-defined function. Previously, the 
Dot/Icm effector SdhA has been shown to have an important role in maintenance of the 
LCV, deletion of SdhA led to a significant defect in bacterial replication (Laguna et al., 
2006, Creasey et al., 2012). In order to investigate the role of SdhA in infection of G. 
mellonella, a L. pneumophila 130b ΔSdhA strain and a complementation plasmid 
containing SdhA fused to 4 N-terminal HA tags (p4HA-SdhA) were acquired from Prof 
Elizabeth Hartland (University of Melbourne) and Dr Gunnar Schroeder (Imperial 
College). Translocation and localisation of 4HA-SdhA were confirmed by infecting A549 
lung epithelial cells with WT, ΔSdhA and ΔSdhA expressing p4HA-SdhA. Infected cells 
were fixed at 5 h p.i. and stained using anti-HA and anti-Legionella antibodies (Fig. 
3.15A). 4HA-SdhA was seen localised around the bacteria, in a manner reminiscent of 
the LCV, as previously described (Laguna et al., 2006). However, in approximately 20 – 
45 % of cells, staining appeared to be focussed at the poles of the LCV. Localisation to the 
LCV was also observed in haemocytes extracted from infected G. mellonella larva at 5 h 
p.i (Fig. 3.15B), polar localisation was also seen in this cell type (arrows). By 18 h p.i. 
4HA-SdhA was seen completely surrounding bacteria having lost the distinctive polar 
localisation. Polar localisation has been observed for a number of Dot/Icm effector 
proteins (Conover et al., 2003, VanRheenen et al., 2006), however this has not previously 
been reported for SdhA.  
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Figure 3.15 4HA-SdhA localises to the LCV in both A549 cells and haemocytes  
(A) A549 epithelial cells were infected for 5 h with WT, ΔSdhA or ΔSdhA expressing 
4HA-SdhA on a plasmid, fixed and stained using anti-HA and anti-Legionella antibodies. 
4HA-SdhA could be clearly seen surrounding the bacteria and was concentrated at the 
poles in a subset of cells. No HA staining could be seen in cells infected with the WT or 
ΔSdhA strains. Scale bar is 10 μm. (B) Haemolymph was extracted from G. mellonella 
infected with ΔSdhA or ΔSdhA expressing 4HA-SdhA at 5 and 18 h p.i., fixed and stained 
as above. 4HA-SdhA was seen on the LCV and at the poles (arrows) at 5 h p.i. however by 
18 h p.i. was seen completely surrounding the bacteria. Scale bar is 5 μm.     
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SdhA has previously been shown to have a role in the maintenance of vacuolar stability 
in primary mouse macrophages. To determine if SdhA is important to maintain the 
integrity of the LCV in G. mellonella haemocytes, larvae were infected with L. 
pneumophila WT, ΔSdhA or ΔSdhA expressing 4HA-SdhA, haemocytes isolated at 5 h p.i. 
and their ultrastructure analysed by TEM by Dr Charlotte Stoneham (Imperial College) 
(Fig. 3.16). As previously observed, the LCV formed by WT bacteria showed recruitment 
of the ER (arrows) to large vacuoles. However, the LCV of ΔSdhA often showed signs of 
instability, with electron-dense material apparent within the vacuole (Fig. 3.16). This 
may be due to infiltration of the cytoplasm or release of bacterial contents into the LCV. 
The LCVs of haemocytes infected with the complemented mutant were of a similar 
morphology to those infected with WT bacteria. These observations indicate that SdhA is 
important for the maintenance of LCV stability within G. mellonella haemocytes in 
agreement with previously published results (Creasey et al., 2012), further 
strengthening the G. mellonella model.   
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Figure 3.16 LCVs of L. pneumophila ΔSdhA in haemocytes show signs of instability.  
G. mellonella larvae were infected with WT, ΔSdhA or ΔSdhA expressing p4HA-SdhA L. 
pneumophila 130b for 5 hours. Haemocytes were extracted and processed for transmission 
electron microscopy. Haemocytes infected with WT bacteria contain LCVs of similar 
morphology to those previously described. Recruitment of ER to the LCV is indicated 
(arrows). The LCVs of the ΔSdhA mutant contained electron-dense material, indicating loss 
of stability of the vacuole. The LCVs of the complemented strain were of comparable 
morphology to those of WT bacteria. Images are representative of two independent 
experiments. Scale bar represents 1 µm. 
 103
3.19 Lack of SdhA during infection results in rapid, but transient, haemocyte 
depletion in G. mellonella 
Deletion of SdhA in infection has previously been correlated with death of infected 
macrophages. This can be very rapid with early signs appearing within 30 min p.i. 
(Laguna et al., 2006, Creasey et al., 2012). In order to determine the effects of deletion of 
SdhA in insect haemocytes, larvae were infected with WT, ΔDotA, ΔSdhA or ΔSdhA with 
p4HA-SdhA, the haemolymph extracted at 5 h p.i. and haemocyte concentration 
determined by cell counting. Infection with the ΔSdhA strain resulted in a significantly (P 
< 0.0005) greater loss of haemocytes by 5 h p.i. compared to larvae infected with the 
WT, ΔDotA or the complemented strain (Fig. 3.17). However, at 18 h p.i. haemocyte 
levels in L. pneumophila ΔSdhA infected G. mellonella recovered to levels comparable to 
larvae infected with the avirulent ΔDotA strain. In contrast, the WT and the 
complemented ΔSdhA strains caused significant haemocyte depletion at this time point 
as compared to the ΔDotA-infected sample (P < 0.0003).  
Figure 3.17 Infection with ΔSdhA leads to rapid, transient haemocyte depletion  
Haemocytes from larvae infected with WT, ΔDotA, ΔSdhA or ΔSdhA + pSdhA L. 
pneumophila were extracted at 5 and 18 h p.i. and viable cells counted. Infection with 
ΔSdhA caused significant (P = 0.0004, unpaired T-test) haemocyte depletion at 5 h p.i. 
unlike the WT or complemented strains. At 18 h p.i. haemocyte levels from the ΔSdhA 
strain had recovered to normal levels while over 90% of haemocytes were lost from the 
WT and ΔSdhA with p4HA-SdhA infected larvae. Results mean of 4 experiments ± 
standard deviation  
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3.20 The L. pneumophila ΔSdhA mutant strain is attenuated in growth and 
killing of G. mellonella 
Rapid death of infected cells has previously been correlated with a lack of bacterial 
replication in the ΔSdhA strain (Creasey et al., 2012, Ge et al., 2012, Laguna et al., 2006). 
To determine the importance of SdhA for replication in vivo, the competitive fitness of 
this strain during mixed infection of G. mellonella was examined. Larvae were infected 
with a 1:1 ratio of WT:ΔSdhA or WT:ΔSdhA expressing p4HA-SdhA L. pneumophila, 
haemolymph extracted at 0, 5, 18 and 24 h p.i. and the ratio between WT and mutant 
determined (Fig 3.18A). Although both strain were present in the same proportion in the 
input and at 0 h post infection, the WT strain significantly outcompeted the ΔSdhA strain 
from 5 h p.i. (P = 0.03) to 24 h p.i. (P = 0.008) and this could be complemented by 
expression of SdhA from a plasmid.  
In order to analyse this growth attenuation in G. mellonella in more detail, larvae were 
infected with WT, ΔDotA, ΔSdhA or ΔSdhA expressing 4HA-SdhA and the viable CFU per 
100 μl of haemolymph determined. While the WT bacterial load increased steadily over 
the course of the experiment, the ΔSdhA strain did not replicate and its counts decreased 
more than 10-fold in the first 18 h p.i., but then remained stable at this level (Fig. 3.18B). 
In contrast, the ΔDotA strain was completely cleared by 18 h p.i.. Full growth of the 
ΔSdhA mutant could be restored by complementation with a 4HA-SdhA expression 
plasmid.   
In order to characterise how the fluctuations of haemocyte density and inefficient 
bacterial replication affected larval mortality, ten G. mellonella larvae were infected with 
WT, ΔDotA, ΔSdhA or ΔSdhA expressing 4HA-SdhA L. pneumophila 130b. The ΔSdhA 
strain was significantly attenuated in causing larval mortality compared to the WT 
strain; by 72 h p.i. only 40% of infected larvae had succumbed to infection compared to 
100% for the WT (Fig. 3.18C). This phenotype could be complemented by the addition of 
4HA-SdhA on a plasmid. The ΔSdhA strain did cause increased mortality compared to 
ΔDotA which was avirulent. This indicates that although SdhA has a key role in bacterial 
virulence, other Dot/Icm effectors are also required.  
Together, this data shows that substantial haemocyte depletion alone does not trigger 
death of G. mellonella larvae. In fact, induction of larval death seems to rather be 
determined by the bacterial load at the time of haemocyte depletion, with increased 
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numbers of wild-type L. pneumophila after efficient intracellular replication 
overwhelming the larvae. 
 
Figure 3.18 SdhA is required for virulence and bacterial replication in G. 
mellonella  
(A) Larvae were infected with a 1:1 ratio of WT:ΔSdhA or WT:ΔSdhA+p4HA-SdhA and 
the CFU of each strain determined at 0, 5, 18 and 24 h p.i. The WT strain started to 
outcompete the ΔSdhA strain by 5 h p.i. and very few ΔSdhA bacteria were found by 24 h 
p.i. (B) Larvae were infected with WT, ΔDotA, ΔSdhA or ΔSdhA expressing 4HA-SdhA 
and the CFU in single infections determined. The ΔSdhA strain did not replicate however 
persisted at a higher level than the ΔDotA strain, which was cleared by 18 h p.i. (C) 10 
larvae were infected as in (B) and mortality monitored. Larvae infected with the ΔSdhA 
strain demonstrated significantly lower mortality over the course of the experiment and 
this could be complemented with 4HA-SdhA expression. Results are the mean of at least 
three independent experiments ± standard deviation.    
 
3.21 SdhA is required for bacterial replication in the lungs of A/J mice  
Although the ΔSdhA strain has previously been demonstrated to replicate inefficiently in 
primary mouse macrophages (Laguna et al., 2006), its role during in vivo mouse 
infection has not been investigated. In order, to characterise the virulence of the ΔSdhA 
strain in vivo mixed infections of A/J mice were performed (Animal work by Ms Clare 
Oats, University of Melbourne). In mixed infection the ΔSdhA mutant was strongly 
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outcompeted by the WT strain (mean CI of 0.03 for ΔSdhA versus WT, Fig. 3.19A), 
demonstrating that SdhA is required for fitness of L. pneumophila in murine infection. As 
the ΔSdhA strain had a dramatic phenotype in replication in mixed infections, it was 
decided to investigate the ability of the ΔSdhA strain to replicate in single infections. The 
determination of bacterial CFU after 72 h of single infection with the WT or ΔSdhA strain 
confirmed that the replication of the ΔSdhA strain in mouse lungs was significantly 
reduced (P = 0.0001) in comparison to the WT strain (Fig. 3.19B). These results show 
that the effector SdhA has an important role in replication of L. pneumophila in the A/J 
mouse infection model. Furthermore, the similarities in phenotypes between mice and G. 
mellonella serve to further validate this model for the investigation of L. pneumophila 
infection. 
Figure 3.19 The absence of SdhA results in attenuated growth in mouse lungs.  
(A) The WT strain significantly outcompetes the ΔsdhA strain by 72 h p.i. (CI = 0.03, 
unpaired T-test) (B) In single infections, the ΔsdhA strain is significantly (P = 0.0001, 
unpaired T-test) attenuated in growth at 72 h p.i. compared to the WT.  
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3.22 Discussion 
 
In order to analyse the molecular basis of infection of human pathogens, infection 
models that approximate the human disease are required. Traditionally, small mammals 
such as mice and guinea pigs have been used. These models have the advantage of 
emulating the complexity of immune responses and aspects of human anatomy. 
However, within the past decade significant advances in understanding of the genetics 
and immune responses of insects have led to their more frequent adoption as models of 
infection. In particular, the larva of the greater wax moth Galleria mellonella been 
reported as an easy-to-use model organism for several pathogenic Gram-positive and 
Gram-negative bacteria (Jander et al., 2000, Champion et al., 2009, Joyce et al., 2010, 
Olsen et al., 2011) and fungi (Bergin et al., 2003, Fuchs et al., 2010). Of the pathogens 
that have been tested in the G. mellonella model, several typically infect macrophages in 
the human host (Aperis et al., 2007, Seed et al., 2008, Joyce et al., 2010). In the case of 
several pathogens, phenotypes found in G. mellonella have been recapitulated in other 
models, confirming the utility of G. mellonella as a model organism. Due to the flexibility 
of this model it was decided to test its utility in L. pneumophila infection. 
 
Three prototypic L. pneumophila strains were tested in infection and it was found that G. 
mellonella could withstand infection with a low infectious dose (<106 CFU/larvae), but 
that the larvae succumbed to infection at higher doses. At the highest dose tested all 
three strains caused significant mortality; however, the kinetics of lethality differed 
significantly, L. pneumophila strain 130b was more virulent than the JR32 and Paris 
strains. A systematic comparison of the virulence of these strains in amoeba or 
mammalian models has not been reported. However, the 130b strain was previously 
shown to replicate more efficiently than JR32 in the lungs of intratrachealy infected A/J 
mice and was shown to be more cytopathogenic than a number of other L. pneumophila 
serogroup 1 strains (Samrakandi et al., 2002, Alli et al., 2003). Collectively, these data 
indicate that the G. mellonella model can reproduce the strain-to-strain variations in 
virulence observed in other models, which makes it a quick and inexpensive tool to 
compare the virulence of different L. pneumophila isolates or Legionella species. 
 
The Dot/Icm secretion system of L. pneumophila is essential for infection in all tested 
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infection models including amoebae, human macrophages, mice, and D. melanogaster 
(Berger et al., 1993, Segal et al., 1998b, Santic et al., 2007, Kubori et al., 2008). It was 
found that L. pneumophila-induced mortality of G. mellonella also depended on a 
functional Dot/Icm system with the ΔDotA, ΔDotB and ΔIcmT strains being completely 
avirulent in this model. Interestingly, injection of nonpathogenic Listeria at the doses 
used here (107CFU/larvae) was shown to induce mortality that was attributed to sepsis 
due to the large concentration of bacteria injected (Joyce et al., 2010, Mukherjee et al., 
2010). In combination with the data presented here, this strongly suggests that the 
threshold for sepsis may vary between bacterial strains or that the non-pathogenic 
Listeria strains may have some residual pathogenicity in G. mellonella.   
 
Examining haemocytes from infected G. mellonella revealed L. pneumophila resided in a 
vacuole that ultrastructurally resembled the LCV observed in human macrophages and 
amoebae. This includes the resemblance to the rough ER (Horwitz, 1983, Abu Kwaik, 
1996) seen by TEM and the recruitment of the Dot/Icm effectors SidC, which was 
previously shown to be anchored to the LCV via a phosphatidylinositol-4 phosphate 
anchor (Weber et al., 2006), and SdhA which was also localised to the LCV (Laguna et al., 
2006). These structural similarities strongly suggest that L. pneumophila is utilising 
evolutionary conserved mechanisms to establish an LCV in G. mellonella.   
 
Bacterial replication was measured by direct bacteria enumeration from infected 
insects. Bacterial persistence appeared to be important for L. pneumophila virulence in 
the G. mellonella model. This was demonstrated by the fact that L. pneumophila strain 
Lp02, which did not persist after 18 h p.i., was unable to induce G. mellonella mortality 
despite having a functional T4SS and forming an LCV in haemocytes. Moreover, the 130b 
strain, which replicated better in the larvae than the JR32 strain, induced death more 
rapidly than the JR32 strain, suggesting that in addition to persistence, bacterial 
replication also contributes to L. pneumophila virulence in the G. mellonella model. 
Interestingly, blocking uptake of bacteria by haemocytes through pretreatment of larvae 
by cytochalasin D significantly delayed larval death. This, in combination with the above 
data, suggests that bacterial replication within haemocytes is required for L. 
pneumophila induced mortality in G. mellonella.  
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Analysis of the immune response of G. mellonella to infection with L. pneumophila has 
shed more light on the host-pathogen interactions in the insect. By 2 h p.i. production of 
several antimicrobial peptides (AMPs) such as Gloverin have been induced. Human 
defensins have been shown to have anti-microbial effects on L. pneumophila (Scharf et 
al., 2010) and a G. mellonella defensin was shown to have significant antimicrobial 
effects on L. dumoffii (Palusinska-Szysz et al., 2012). AMPs may contribute to the killing 
of a fraction of extracellular bacteria at the beginning of the infection, at least partially 
providing an explanation for the lack of significant bacterial replication before 18 h p.i. 
Coordinated immune responses such as phonoloxidase activity leading to melanisation 
and nodule formation are also likely to be damaging to extracellular bacteria, further 
contributing to the lag phase seen in bacterial replication.  
 
By between 16 and 18 h p.i. paraffin section demonstrate that the infection has spread 
systemically through the larval tissues. At this point in infection, around 90% of 
haemocytes have been lost. Previously, it has been shown that L. pneumophila escapes 
from human macrophages by promoting cell lysis at late stages of infection (Molmeret et 
al., 2002a) and it is hypothesised that this is occurring in G. mellonella haemocytes. As 
haemocytes are the major source of pro-PO (Cerenius et al., 2004) , this haemocyte 
depletion is likely the cause of the significant drop in PO activity also seen at this time 
point. Alternatively, the insect pathogen Photorhabdus luminescens can specifically 
inhibit PO activity (Eleftherianos et al., 2006) and, although it appears unlikely that L. 
pneumophila would have this ability, this possibility cannot be excluded. By 24 h p.i. the 
immune responses appear to be overwhelmed, consistent with the lack of haemocytes, 
extensive septicaemia is seen, there is significant organ damage and most larvae are 
dead. Depletion of circulating haemocytes upon infection has previously been reported 
and correlated with G. mellonella mortality caused by pathogenic fungi and Gram-
negative bacteria (Chain, 1982), however a causal link was not established. Interestingly, 
infection with the ΔSdhA strain resulted in haemocyte depletion by 5 h p.i. however this 
did not appear to lead to larval mortality, instead haemocyte numbers recovered to 
normal levels at 18 h p.i. This additional data suggests that larval mortality and 
haemocyte depletion are not linked in G. mellonella. 
 
Several families of phospholipase C (PLC) enzymes have been identified and associated 
 110
with bacterial virulence in a number of models (Titball, 1993). As part of a collaboration, 
L. pneumophila mutants defective in PLC activity were generated and tested in the G. 
mellonella model (Aurass et al., 2013). Although individual gene deletion mutants of 
three related phospholipases did not appear to affect larval mortality, a triple deletion 
mutant displayed a significant reduction in virulence. Previously, In vitro experiments 
have shown that deletion of all three genes is required to abolish the PLC activity of the 
bacteria (Aurass et al., 2013), demonstrating that PLC activity itself, rather the action of 
a single secreted or translocated protein has a role in virulence.  
 
Deletion of flagellin did not alter the virulence or ability of the bacteria to replicate G. 
mellonella, which is an important result. Flagella expression has previously been shown 
to have a role in attachment and entry of cell culture cells (Dietrich et al., 2001) and a 
number of studies have described the crucial role L. pneumophila flagellin has in the 
immune response and growth restriction of L. pneumophila in mice (Molofsky et al., 
2006, Ren et al., 2006, Pereira et al., 2011). Flagellin is recognised by the danger signal 
sensor Naip5 in murine macrophages, this triggers inflammasome activation, immune 
signalling and clearance of the bacteria (Molofsky et al., 2006, Lightfield et al., 2008). 
Due to this, L. pneumophila lacking flagellin showed enhanced virulence in mice (Pereira 
et al., 2011). Conversely, in G. mellonella infection lack of flagellin did not increase the 
virulence of L. pneumophila, demonstrating that recognition of flagellin is not required 
for clearance of the bacteria by the innate immune system. This represents an important 
difference between the L. pneumophila mouse and G. mellonella models. Future 
characterisation of the G. mellonella signalling pathways involved in PAMP recognition 
and immune activation will allow the contribution of flagella to L. pneumophila virulence 
to be better understood.     
 
After characterisation of the G. mellonella infection model, it was used to test the role of   
potential L. pneumophila virulence factors. Deletion of four Dot/Icm effector proteins 
had no impact on L. pneumophila virulence or bacterial replication in G. mellonella. Due 
to the well-described prevalence of redundancy between Dot/Icm effectors in L. 
pneumophila (Luo et al., 2004, Bardill et al., 2005, Ragaz et al., 2008), this result is not 
unexpected. More interestingly, it was also demonstrated that a single mutant lacking 
SdhA, a strain with reported replication defect in macrophages, is significantly 
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attenuated in virulence in G. mellonella. Deletion of SdhA resulted in the inability of the 
bacteria to replicate and a significant reduction in larval mortality. SdhA is the first L. 
pneumophila effector protein to be associated with the maintenance of the stability of 
the LCV (Creasey et al., 2012), although the maintenance of vacuolar integrity has been 
studied more extensively in a number of other pathogens (for a review see (Kumar et al., 
2009). The lack of LCV stability in G. mellonella infection was confirmed by transmission 
EM which showed the infiltration of the LCV with an electron dense material believed to 
be the host cell cytoplasm.  
 
In mouse macrophages, deletion of SdhA results in rapid cell death as the bacteria are 
expelled into the cytoplasm and recognised by cytoplasmic PAMP receptors (Creasey et 
al., 2012, Ge et al., 2012). However, the role of SdhA in vivo had not previously been 
analysed. Here it is shown that deletion of SdhA causes a significant, but transient, 
haemocyte depletion in G. mellonella. This suggests that expulsion of the ΔSdhA bacteria 
to the cytoplasm of infected cells resulted in rapid cell death, preventing bacterial 
replication. Haemocytes then proliferated to restore the normal haemocyte density. The 
inability of the ΔSdhA strain to replicate seen in G. mellonella was then confirmed in the 
susceptible A/J mouse model. This demonstrates that vacuolar stability is a requirement 
for L. pneumophila replication in two in vivo models and that there is a good correlation 
between virulence in mice and G. mellonella. 
 
In conclusion, the results presented here demonstrate that G. mellonella is susceptible to 
L. pneumophila infection and that this model reproduces virulence phenotypes observed 
in amoeba and mammalian infection models. Virulence depends on the Dot/Icm T4SS 
and bacteria reside and replicate within a LCV. Although larval immune defences are 
activated, they are not sufficient to clear the infection at high doses. The findings that 
PLC activity and SdhA expression have a role in bacterial virulence demonstrate that G. 
mellonella can be used to characterise the role of secreted and Dot/Icm translocated 
effector proteins. Technically, G. mellonella is a quick, inexpensive model that will allow 
for large scale screening of L. pneumophila strains and mutant libraries. Future advances 
in our knowledge about the G. mellonella immune gene repertoire (Vogel et al., 2011), 
cell death pathways (Khoa et al., 2012b) and haemocyte biology (Lavine et al., 2002, 
Marmaras et al., 2009), together with initiatives to advance RNA interference systems in 
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Lepidoptera spp. (Terenius et al., 2011) will all serve to make G. mellonella a more 
appealing model organism. 
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Chapter 4 – Characterisation of the L. pneumophila protein 
LtpD 
 
The Dot/Icm secretion system is the key virulence factor of L. pneumophila, yet only 
around 15 % of its translocated effectors have been characterised in any detail. By 
defining the function of translocated proteins, it will be possible to understand the wide-
ranging effects L. pneumophila has on the host cell. In order to further this aim, a 
selected L. pneumophila effector protein was characterised in greater detail.  
 
4.1. Prevalence screening of new putative effector proteins from L. 
pneumophila 130b  
Recently, the sequencing of the genome of Legionella pneumophila strain 130b led to the 
identification of ten novel putative Dot/Icm effector proteins based on bioinformatic 
predictions including the presence of eukaryotic domains or homology to other Dot/Icm 
effectors (described in (Schroeder et al., 2011)). None of the selected effectors were 
found in the archetypal Philadelphia strain so their prevalence in L. pneumophila strains 
was analysed in 27 clinical and 27 environmental UK L. pneumophila isolates by PCR 
using gene specific primers. dotA was included as a control and was found in all isolates, 
as has previously been documented (Ko et al., 2003, Costa et al., 2010). The selected 
genes were found with varying frequency, some such as lpw_03701 (ltpD) and 
lpw_20091 (ltpG) were found in over 40 % of isolates while others such as lpw_02301 
(ltpB) were found in less than 10 % of tested isolates (Fig. 4.1A). To complement this 
data, 30 further L. pneumophila isolates from Australia and Malaysia were also tested in 
the laboratory of Dr. Elizabeth Hartland (Fig. 4.1B). This largely followed the UK data 
with lpw_03701 (LtpD) being isolated most frequently and lpw_16311 (ltpF) and 
lpw_26201 (ltpJ) both found in only 7 % of tested strains. These results are in line with 
previous reports showing that L. pneumophila encodes a dynamic repertoire of effector 
genes (Cazalet et al., 2004, Gomez-Valero et al., 2011a). Genomic analysis has 
demonstrated that approximately half of the Dot/Icm substrates are conserved between 
L. pneumophila strains (Schroeder et al., 2011) with the remainder of the repertoire 
varying considerably.     
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Figure 4.1. Prevalence and initial testing of three L. pneumophila proteins  
(A) 54 UK clinical and environmental L. pneumophila isolates were screened for the 
presence of 10 novel genes identified from the L. pneumophila 130b genome. DotA was 
included as a positive control and was found in all isolates tested. (B) Prevalence of 
selected genes in the 54 UK isolates plus 30 isolates from Australia and Malaysia. Results 
confirmed at least three times.  
 
4.2 Validation of the Dot/Icm T4SS-dependent translocation and expression 
of three new effectors  
Three genes encoding putative effectors found with the highest prevalence, lpw_03701, 
lpw_20341 and lpw_25791, were selected for further experimental characterisation. 
Confirmation that the selected genes encoded substrates of the Dot/Icm T4SS was 
performed using a previously described fluorescence-based β-lactamase (TEM1) 
translocation assay as detailed in section 2.5 (de Felipe et al., 2008, Charpentier et al., 
2009, Zhu et al., 2011). Raw246.7 macrophages were infected with L. pneumophila 130b 
wild type (WT) or the T4SS-deficient ΔDotA strain expressing the selected proteins as N-
terminal fusion to TEM1. LegC2 is a previously validated T4BSS-effector protein (de 
Felipe et al., 2008) used as a positive control, while Fab1 is a housekeeping gene not 
expected to be translocated (de Felipe et al., 2008) and included as a negative control. 
Infection of macrophages with WT, but not ΔDotA L. pneumophila, expressing the three 
selected putative effector proteins resulted in a strong increase in the signal for the 
cleaved CCF2, indicating that all three proteins were translocated into host  cells in a 
DotA-dependent manner (Fig. 4.2A). The proteins were named Legionella translocated 
protein D (LtpD) for lpw_03701, LtpH for lpw_20341 and LtpI for lpw_25791.  
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Figure 4.2 Three selected L. pneumophila genes are translocated into host cells 
and expressed in post exponential phase.  
(A) L. pneumophila 130b WT (black bars) or ΔDotA mutant (grey bars) harboring 
pXDC61 TEM1-effectors were used to infect macrophages. The translocation of the 
TEM1-fusions of the LegC2 (positive control), the putative effectors and the negative 
control Fab1 rate is expressed as fold increase of the emission ratio 450/520 nm of each 
sample in relation to the emission ratio of uninfected cells. The fusion proteins of LegC2 
and the Legionella translocated proteins LtpD, LtpH and LtpI, but not the negative 
control Fab1, were translocated into host cells. Bars represent mean of three separate 
experiments ± standard deviation. (B) Using RT-PCR, LtpD, LtpH and LtpI were all 
expressed in post-exponential phase culture. The no-RT (–RT) control demonstrated no 
genomic DNA contamination of the samples. Results representative of at least three 
separate experiments.  
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Many L. pneumophila Dot/Icm effector proteins have been shown to be expressed in the 
post-exponential phase of bacterial replication (Nagai et al., 2002, Conover et al., 2003, 
Luo et al., 2004). RT-PCR on RNA extracted from post-exponential phase L. pneumophila 
130b demonstrated that ltpD, ltpH and ltpI were all expressed at this time point (Fig. 
4.2B). dotA was included as a positive control as it has previously been shown to be 
expressed throughout the bacteria’s growth cycle (Nagai et al., 2001) and the no RT 
control demonstrated that samples were not contaminated with genomic DNA. The 
expression of these genes in post-exponential phase suggests that the selected effector 
proteins are present from the beginning of infection.  
 
4.3 Analysis of the subcellular localisation of three new effectors  
Analysis of the subcellular localisation and phenotypes upon ectopic expression of 
bacterial proteins in mammalian cells has been shown to be helpful in understanding 
protein function (Sisko et al., 2006). Towards this end, all three effector proteins were 
expressed as N-terminal Myc-tag fusion proteins in HeLa cells and their localisation 
visualised by staining using anti-Myc antibodies. The three proteins demonstrated 
distinct localisations in HeLa cells (Fig. 4.3). Myc-LtpD formed large, perinuclear 
vacuolar structures with some smaller vesicles and limited plasma membrane staining, 
Myc-LtpH had a reticular localisation with concentrated staining reminiscent of the Golgi 
apparatus. Myc-LtpI had a reticular localisation with some small vesicles visible and 
extensive staining in the nucleus of transfected cells, possibly as its small size (16 kDa) 
allows passive diffusion into the nucleus. Due to its unusual subcellular localisation and 
high prevalence in the screened L. pneumophila strains, LtpD was selected for further 
characterisation.  
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Figure 4.3 LtpD, LtpH and LtpI have distinct localisations in ectopic expression  
Hela cells were transfected with Myc-LtpD, Myc-LtpH and Myc-LtpI and the localisation 
of the proteins observed by staining with anti-Myc antibodies. Myc-LtpD localised to 
large, perinuclear vesicles while Myc-LtpH displayed a reticular staining concentrated in 
one area near the nucleus. Myc-LtpI localised mostly to the nucleus of transfected cells 
with some small vesicles visible. Results representative of at least three separate 
experiments, scale bar 10 μm.  
 
4.4 LtpD has homologues in other L. pneumophila genomes 
LtpD is not present in the L. pneumophila Philadelphia strain however, homologues exist 
in the recently sequenced Lorraine and HL06041035 strains (Table 4.1). Bioinformatic 
sequence analysis of LtpD revealed that the protein may have evolved by fusion of two L. 
pneumophila predicted Dot/Icm effector proteins. The N-terminus of LtpD, LtpD1-469, 
shares 33% sequence identity with Lpw27671, a highly conserved gene found in all 
available L. pneumophila genomes including 130b (Table 4.1). The C-terminus of LtpD, 
LtpD472-679, shares 64% sequence identity with the C-terminus of Lpp0356, an 
uncharacterized ankyrin repeat-containing protein only found in the L. pneumophila 
Paris (Fig 4.4A). Interestingly, the conserved N-terminal LtpD domain is also found  
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Figure 4.4 LtpD has homologues in other strains and a conserved phosphorylation 
site  
(A) A scheme showing the proteins that share homologous domains with LtpD. Colours 
represent regions homologues between proteins. Yellow indicates a linker region of 
repeated residues. Ankyrin repeats are only present in Lpp0356.  (B) Alignment of LtpD 
and homologous proteins showing conserved MAPK docking site (red) and 
phosphorylation sites (yellow).  
 
Table 4.1. Homologues of LtpD, LtpK and Lpp0356 in the currently available L. 
pneumophila genomes 
Strain 
130b Philadelphia Paris Corby Alcoy Lens Lorraine HL06041035 
(LPW_03701) 
LtpD 
     LPO_0332 LPV_0373 
(LPW_27671) 
LtpK 
lpg2538 lpp2604 LPC_1930 lpa03706 lpl2459 LPO_2746 LPV_2874 
  
 
lpp0356 
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proteins of unknown function in L. pneumophila Paris (Lpp0303) and L. dumoffii 
(FdumT_02243) however, in both of these proteins there is an alternative C-terminus.  
 Further analysis revealed LtpD contained a predicted mitogen-activated protein kinase 
(MAPK) docking site (conserved motif F-F-X-P) with an adjacent serine phosphorylation 
site. This site was also present in Lpw27671 and was highly conserved between the 
Lpw27671 homologues in different L. pneumophila genomes (Fig. 4.4B 
 
4.5 Homologues of LtpD are Dot/Icm effector proteins, localised to the LCV 
In order to determine if Lpw27671 and Lpp0356 are Dot/Icm effector proteins, a 
translocation assay was performed as described above. Using this assay, Lpw27671 and 
Lpp0356 were shown to be translocated into Raw246.7 macrophages in a DotA-
dependent manner (Fig. 4.5A). As Lpw27671 was confirmed as an effector protein, it 
was given the name LtpK. The LtpK homologue from L. pneumophila Philadelphia 
(lpg2538) has recently also been validated as a Dot/Icm translocated protein in an 
exhaustive screen (Zhu et al., 2011).  
The localisation of LtpD, LtpK and Lpp0356 fusion proteins was then examined in 
infection of A549 epithelial cells (Fig. 4.5B). A549 lung epithelial cells were infected with 
wild type (WT) L. pneumophila 130b expressing the protein of interest fused to four N-
terminal HA tags. At 5 h post infection (p.i.) cells were fixed and stained using anti-HA 
(red) antibodies, DNA was visualised by DAPI (blue). Both 4HA-LtpD and 4HA-LtpK 
were seen localised around the bacteria although 4HA-LtpD appeared to stain more 
intensely despite similar amounts of tagged protein produced (results not shown). 4HA-
Lpp0356 was seen exclusively localised on the LCV in approximately 30% of infected 
cells (results not shown). However, 4HA-Lpp0356 was more commonly seen both on the 
LCV and in numerous small vesicles throughout the cytoplasm (Fig. 4.5B). 
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Figure 4.5 Homologues of LtpD are translocated and localise to the LCV  
(A) L. pneumophila 130b WT (black bars) or ΔDotA (grey bars) harboring TEM1-
effectors were used in a translocation assay as described above. The fusion proteins of 
LegC2, LtpD and the putative effectors LtpK and Lpp0356 (but not the negative control 
Fab1) were translocated into host cells. Error bars represent mean ± standard deviation. 
Similar results were obtained in three independent experiments. (B) L. pneumophila WT 
overexpressing effector proteins fused to 4HA tags were used to infect A549 cells for 5 
hours then fixed and stained using an anti-HA antibody (red). Both 4HA-LtpD and 4HA-
LtpK localised around the bacteria in a manner reminiscent of the LCV. 4HA-Lpp0356 
localised to the LCV however was also seen in small vesicles distributed throughout the 
cytoplasm. Results representative of at least three separate experiments. Scale bar 10 
μm.  
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The subcellular localisation of LtpD in ectopic expression had already been investigated 
(Fig. 4.3) so the localisation of Myc-LtpK and Myc-Lpp0356 was examined in transfected 
HeLa cells. Myc tagged LtpK displayed a diffuse localisation with a strong signal in the 
nuclei while Myc-Lpp0356 localised to small vesicles distributed throughout the 
cytoplasm, more reminiscent of the localisation of LtpD (Fig. 4.6).  
These data demonstrate that LtpK and Lpp0356 are Dot/Icm effector proteins with 
distinct localisations in infection and transfection.     
 
 
 
Figure 4.6 LtpK and Lpp0356 have distinct localisations in transfection  
HeLa cells were transfected with Myc-LtpK or Myc-Lpp0356 and stained using anti-Myc 
antibodies (green). Myc-LtpK had a diffuse, cytosolic localisation while Lpp0356 was 
seen in numerous, small vesicular structures. Results representative of at least three 
separate experiments. Scale bar 10 μm.  
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4.6. LtpD localises to the outside of the LCV membrane during infection 
Although A549 epithelial cells have been used as a model for L. pneumophila infection 
(Chang et al., 2005, Newton et al., 2007), it is thought that macrophages are the most 
important cell type in human infection (Winn et al., 1981). For this reason, the 
localisation of LtpD in infection was confirmed by infecting the murine macrophage cell 
line Raw246.1 and the differentiated human macrophage cell line THP-1 (Fig. 4.7A) with 
WT L. pneumophila 4HA-LtpD for 5 h and the localisation observed. 4HA-LtpD was seen 
surrounding bacteria in both cells lines confirming this localisation in physiologically 
relevant cell lines.  
The staining observed for LtpD is reminiscent of proteins localised on the membrane of 
the LCV. In order to confirm this, and to determine if LtpD (which is not predicted to be 
an integral membrane protein) was localised to the inner or outer leaflet of the LCV, 
infected cells were fixed and permeabilised with either digitonin or triton X-100. While 
triton X-100 permeabilises both the plasma and ER-membranes, digitonin is unable to 
permeabilise the ER, and presumably the ER-like LCV, and so leaves these membranes 
intact (Plutner et al., 1992). Antibodies against Legionella LPS did not stain bacteria 
(visualised using DAPI) in LCVs when the cells were permeabilised with digitonin. In 
contrast, LtpD staining surrounding the bacteria was visible in cells permeabilised by 
both methods, confirming the effectiveness of the selective permeabilisation protocol 
(Fig. 4.7B) and suggesting that the 4HA-LtpD is localised on the outer leaflet of the LCV. 
This localisation means that LtpD is in contact with the host cells cytoplasm and so is 
available for modification by host cell proteins.  
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Figure 4.7 LtpD is localised on the cytoplasmic face of the LCV  
(A) RAW246.1 or THP1 macrophage cells were infected with WT expressing 4HA-LtpD for 
5 h, fixed and stained using anti-HA antibodies (red) and DAPI and the same localisation was 
seen as in the A549 cells. (B) After selective permeabilisation of membranes with digitonin 
4HA-LtpD staining was detected using anti-HA antibodies (red) surrounding intracellular 
bacteria, while these bacteria were not accessible for anti-L. pneumophila immunostaining 
(green). This indicates that 4HA-LtpD is localised on the cytoplasmic surface of the LCV. 
Images are representative of at least three independent experiments, scale bar 10 µm.  
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4.7 LtpD is phosphorylated in infection  
Both LtpD and LtpK contain highly conserved MAPK docking and phosphorylation sites. 
Previously, other L. pneumophila effector proteins have been shown to modulate the 
MAPK-pathway (Fontana et al., 2012) as well as other phosphorylation cascades (Ge et 
al., 2009). Therefore it was decided to investigate if LtpD was phosphorylated during 
infection. A549 cells were infected for 18 h with WT L. pneumophila expressing 4HA-
LtpD or 4HA-LtpD1-469 as a negative control. 4HA-LtpD1-469 contains the putative 
phosphorylation site however is not believed to be translocated into host cells. The HA 
tagged LtpD was immunoprecipitated from infected cells using anti-HA agarose beads 
and the bound fraction probed using anti-phospho-serine, anti-phospho-threonine and 
anti-phospho-tyrosine antibodies. Full-length LtpD, but not the non-translocated N-
terminal fragment (LtpD1-469), was recognised by anti-phospho-serine and anti-
phospho-tyrosine but not anti-phospho-threonine antibodies (Fig. 4.8A), suggesting that 
LtpD is phosphorylated during infection. It was not possible to immunoprecipitate 4HA-
LtpD1-469 from infected cells, possibly as this protein was not translocated and so was 
not present in the cells in high enough quantities.  
The MAPK docking site is adjacent to a serine residue (Fig 4.8B), which is assumed to be 
one of the phosphorylation sites. In order to determine if this serine, or the MAPK-
docking site, were important in the localisation of LtpD, site directed mutagenesis was 
used. The serine at position 338 was mutated to alanine (LtpDS338A) or the MAPK-
docking site was abolished by mutation of two phenylalanines to alanines (LtpDFF335AA). 
Mutating these residues has previously been shown sufficient to abolish MAPK docking 
(Jacobs et al., 1999). However, neither of these mutations appeared to affect the 
localisation of LtpD either in infection (Fig. 4.8B) or in transfection (Fig. 4.8C). This 
suggests that although this MAKP-docking site is conserved, it is not important in the 
localisation of LtpD.  As the MAPK-docking site was not required for localisation in 
infection or transfection, it was decided to further analyse the domain or domains 
required for the localisation of LtpD to membranous structures.  
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Figure 4.8 4HA-LtpD is phosphorylated in infection, however the MAPK docking 
and phosphorylation sites are not required for LtpD localisation  
(A) A549 cells were infected for 18 h, lysed and 4HA-LtpD immunoprecipitated using 
anti-HA agarose. After running on an SDS-PAGE gel, 4HA-LtpD can be recognised by anti-
p-tyrosine and anti-p-serine, but not anti-p-threonine, antibodies. Results representative 
of at least three separate experiments. Abolishing the MAPK docking domain LtpDFF335AA 
or phosphorylation site, LtpDS338A, by site directed mutagenesis, does not alter the 
localisation of LtpD in infection (B) or in transfection (C). Results representative of at 
least two experiments, scale bar 10 μm.  
 
4.8 The C-terminal domain of LtpD is sufficient for localisation to the LCV 
Examination of the localisation of LtpD during infection suggested that it is a peripheral 
membrane protein, which associates with the outer leaflet of the LCV. In order to 
determine the domain of LtpD required for localisation on the LCV, N and C-terminal 
fragments were made with reference to the secondary structure and fused to four N-
terminal HA tags. WT L. pneumophila expressing these constructs were used to infect 
A549 cells for 5 h. As expected, 4HA-LtpD1-469 was not translocated and no HA straining 
was seen, additionally demonstrating that no unspecific release of effectors due to lysis 
of bacteria or unspecific antibodies staining occurred. However, 4HA-LtpD472-679 was 
translocated and displayed the same localisation as the full-length protein (Fig. 4.9), 
implying that the C-terminal fragment is sufficient for both translocation and association 
with the LCV in infection.  
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Figure 4.9 LtpD472-679 is sufficient for localisation to the LCV 
A549 cells infected for 5 h with WT L. pneumophila expressing 4HA-LtpD1-469 or 4HA-
LtpD472-679, fixed and stained with anti-Legionella (green) and anti-HA (red) antibodies. 
No HA staining is seen in cells infected with 4HA-LtpD1-469 however 4HA-LtpD472-679 is 
sufficient for localisation to the LCV. Results representative of at least two experiments, 
scale bar 10 μm.  
 
 
4.9. LtpD associates with vesicles via a 17 kDa region, LtpD472-626 
As LtpD1-469 was not translocated, it was not possible to directly observe its localisation 
in infection, instead HeLa cells were transfected with the two domains of LtpD (Fig. 
4.10A). While Myc-LtpD1-469 displayed a diffuse, cytosolic localisation, Myc-LtpD472-679 
showed vesicular localisation, implying that the C-terminus is indeed sufficient to 
mediate the association of LtpD to membranes, as seen in infection and that no other L. 
pneumophila proteins are required. Notably, the vesicular structures of Myc-LtpD472-679 
seemed distinct from the full-length protein with smaller, more widely distributed 
vesicles, suggesting that the N-terminal region might contribute to the formation of the 
large vesicular structures. 
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Figure 4.10 LtpD consists of two domains and associates via a 17 kDa internal 
region, LtpD472-626, with vesicles.  
(A) LtpD or selected fragments of LtpD where ectopically expressed in HeLa cells. Cells 
were then stained with anti-Myc antibody (green) and DAPI (blue). Immunofluorescence 
images of cells transfected with the constructs corresponding to the two domains of LtpD. The 
C-terminal domain of LtpD, LtpD472-679, is sufficient to mediate association with vesicles. (B) 
Schematic overview of the LtpD fragments investigated in this study. (C) Systematic analysis 
of fragments of the C-terminal domain of LtpD revealed that an internal domain, LtpD472-626, 
is required and sufficient for localisation of LtpD to vesicles. Results representative of at least 
two separate experiments, scale bar 10 µm.  
 
In order to further isolate the vesicular-binding domain, additional truncations of LtpD 
(scheme, Fig. 4.10B) were made with reference to the predicted secondary structure. 
Visualisation of these LtpD fragments (Fig. 4.10C) resulted in the identification of an 
internal 17 kDa fragment, Myc-LtpD472-626, which showed vesicular localisation during 
transfection. The smaller fragments Myc-LtpD472-556 or Myc-LtpD556-679, containing only 
parts of the 17 kDa region, showed diffuse distribution throughout the cell. This defines 
Myc-LtpD472-626 as the minimal fragment of LtpD able to associate with vesicles. For 
validation of this region’s importance in association of LtpD to vesicular membranes, 
two internal deletions were made in LtpD, Myc-LtpDΔ472-626, missing the entire 17 kDa 
region, and Myc-LtpDΔ472-556, missing only half of the predicted region of importance. 
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Neither protein was capable of localising to membranes during transfection (Fig. 4.10C), 
demonstrating that LtpD472-626 is both necessary and sufficient for membrane 
localisation during ectopic expression.  
 
4.10. LtpD472-626 is required and sufficient for LtpD recruitment to the LCV 
during infection 
In order to determine if the 17 kDa LtpD472-626 region identified in transfection was also 
important in localisation of LtpD to the LCV in infection, A549 cells were infected for 5 
or 24 h with WT L. pneumophila expressing 4HA-LtpD, 4HA-LtpD472-679, 4HA-LtpDΔ472-626 
or 4HA-LtpD556-679. LtpD and LtpD472-679 localised to the membranes of LCVs at 5 h (data 
not shown) and 24 h p.i. (Fig. 4.11) however, LtpDΔ472-626 and 4HA-LtpD556-679 could not 
be detected after 5 h of infection (data not shown). This could be due to less efficient 
translocation or diffusion of the protein into the cytoplasm resulting in an insufficient 
local concentration for detection. At 24 h p.i. cells contained large numbers of bacteria 
arranged in distinct vacuoles and the membranes of the LCVs were clearly delineated in 
cells infected with the full length and LtpD472-679 constructs. However, when infected 
with bacteria expressing 4HA-LtpDΔ472-626 or 4HA-LtpD556-679 a diffuse cytosolic staining 
and an enrichment of signal in the nucleus was observed (Fig. 4.11). This demonstrates 
that the 17 kDa internal region of LtpD is essential for the association of the protein with 
the LCV and this domain restricts LtpD’s subcellular diffusion during infection.  
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Figure 4.11 The internal region of LtpD, LtpD472-626, is required for localisation of 
LtpD to the LCV.  
A549 cells were infected for 24 hours with WT L. pneumophila 130b expressing 4HA-LtpD, 
4HA-LtpD472-679, 4HA-LtpD556-679 or 4HA-LtpD∆472-626 and stained using anti-HA antibody 
(red) and DAPI DNA stain (blue). 4HA-LtpD and 4HA-LtpD472-679 localized to the LCV, 
while 4HA-LtpD∆472-626 and 4HA-LtpD556-679 displayed diffuse, cytosolic and strong nuclear 
localisation. Results are representative of two separate experiments. Scale bar 10 µm.  
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In order to determine if LtpD472-626 was sufficient for recruitment of LtpD to the LCV, 
A549 cells were transfected with selected Myc-LtpD truncation/deletion constructs, 
allowed to express the construct for 24 h and then infected with WT or ΔDotA bacteria 
for 5 h. Cells transfected with full-length Myc-LtpD and infected with WT, but not ΔDotA, 
bacteria showed recruitment of Myc-LtpD to the LCV around the bacteria (Fig. 4.12A). 
Recruitment was also observed when cells were transfected with LtpD472-679 and 
LtpD472-626 but not in cells expressing LtpDΔ472-626 (Fig. 4.12B). These data show that the 
membrane-association region is sufficient for LCV recruitment. However, as both this 
fragment and the full length LtpD are not recruited to phagosomes containing ΔDotA 
bacteria, the Dot/Icm effector-dependent modification of the LCV, appears to be 
required for LtpD recruitment.  
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Figure 4.12 LtpD472-626 is necessary and sufficient for the recruitment of 
ectopically-expressed Myc-LtpD to the LCV.  
Immunofluorescence images of A549 cells transfected with Myc-LtpD, Myc-LtpD∆472-626 or 
Myc-LtpD472-626 and then infected with WT or ∆DotA L. pneumophila. (A) Myc-LtpD is 
recruited to the LCV of WT but not ∆DotA bacteria during infection. (B) Transfection of 
Myc-LtpD472-679, Myc-LtpD472-626 or Myc-LtpD∆472-626 demonstrates that LtpD472-626 is 
sufficient for the recruitment of Myc-LtpD to the LCV during infection. Results are 
representative of at least three experiments. Scale bar 10 µm.  
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4.11. GST-LtpD472-626 binds phosphatidylinositol-3-phosphate  
A number of L. pneumophila T4SS substrates use phosphoinositides as an anchor to the 
LCV (Weber et al., 2006, Brombacher et al., 2009). To determine if LtpD472-626 also 
mediated association with the LCV by binding to a membrane lipid anchor, GST-LtpD472-
626 was purified and a commercial protein-lipid overlay assay performed against a 
selection of frequent membrane lipids. It was observed that GST-LtpD472-626 bound to 
PtdIns(4)P and, less strongly, to phosphatidylinositol (PtdIns) (Fig. 4.13A) but not to any 
of the other membrane lipids tested. The positive control of the PH domain of PLC-δ1 
fused to GST bound strongly to PtdIns(4,5)P2 as previously described, while GST alone 
did not bind to any lipid tested. As we observed binding to PtdIns(4)P and PtdIns, the 
phosphoinositide binding specificity of LtpD was analysed using a PIP array, which 
included serial dilutions of all seven phosphoinositides spotted on a membrane. 
Interestingly, it was found that, under these conditions, GST-LtpD472-626 bound to 
PtdIns(3)P and, with much lower affinity, PtdIns(4)P. This demonstrates that, in vitro, 
GST-LtpD472-626 preferentially interacts with PtdIns(3)P (Fig. 4.13B).  
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Figure 4.13 GST-LtpD472-626 binds to membrane phospholipids in vitro  
(A) Purified GST-LtpD472-626, GST, or a GST-fusion of the PH domain of PLC-δ1 were 
incubated with nitrocellulose membranes spotted with 100 pmol/spot of various common 
membrane lipids. Protein binding to lipids was detected using an anti-GST antibody. Purified 
GST-LtpD472-626 displayed binding to PtdIns(4)P and, to a lesser extent, to PtdIns. The PH 
domain of PLC-δ1 was used as a positive control and bound strongly to PtdIns(4,5)P2. (B) 
GST-tagged purified proteins were incubated with membranes on which serial dilutions of 
various PtdIns species were spotted as indicated. LtpD472-626-GST bound preferentially to 
PtdIns(3)P and, to a smaller extent, to PtdIns(4)P. Results are representative of three separate 
experiments.  
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4.12 LtpD co-localises with a PtdIns(3)P, but not a PtdIns(4)P marker in 
ectopic expression 
To analyze if LtpD472-626 and LtpD bind to PtdIns(3)P on cellular membranes, full length 
LtpD and LtpD472-679 were ectopically expressed together with the PtdIns(4)P-binding 
domain of SidC (HA-SidC609-918) or 2xFYVE-GFP. FYVE is a conserved PtdIns(3)P binding 
domain present in several eukaryotic proteins and is a well-established marker of 
PtdIns(3)P in cellular membranes (Gillooly et al., 2000, Sbrissa et al., 2002). Co-
transfection revealed no co-localisation between HA-SidC609-918 and Myc-LtpD or Myc-
LtpD472-626 (Fig. 4.14A). However, co-expression of 2xFYVE-GFP and Myc-LtpD or Myc-
LtpD472-626 demonstrated co-localisation in vesicular structures (Fig. 4.14B).  
The C-terminus of LtpD shares 66% identity with the L. pneumophila Paris effector 
Lpp0356 which also has similar localisations in infection and transfection (Fig. 4.5B and 
Fig 4.6) therefore Lpp0356 may also interact with PtdIns(3)P. Upon co-expression of the 
fusion proteins in HeLa cells, it was observed that Myc-Lpp0356 co-localised with 
2xFYVE-GFP (Fig. 4.14C), suggesting that Lpp0356 also binds to PtdIns(3)P. Future 
studies will confirm if there is a direct interaction between Lpp0356 and PtdIns(3)P. 
Taken together, these data show that the C-terminus of LtpD contains a PtdIns(3)P 
binding domain (LtpD472-626) via which the effector is anchored to the phospholipid on 
membranes. 
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Figure 4.14 Myc-LtpD co-localises with 2xFYVE-GFP but not HA-SidC609-918 in co-
transfection  
(A) HeLa cells were co-transfected with Myc-LtpD or Myc-LtpD472-626 and HA-SidC609-918 
and stained using anti-Myc (green) and anti-HA (red) antibodies.
 
No co-localisation with HA-
SidC609-918, a marker for PtdIns(4)P could be observed. (B) However, both Myc-LtpD and 
Myc-LtpD472-626 co-localised with 2xFYVE-GFP, a marker for PtdIns(3)P. (C) Upon co-
transfection, Myc-Lpp0356 co-localises with 2xFYVE-GFP. Images representative of at least 
two separate experiments, scale bar 10 µm. 
 
4.13 Initial results suggest that PtdIns(3)P is present in the LCV membrane 
Although the contribution of PtdIns(4)P to the LCV membrane is well established,  
(Brombacher et al., 2009, Weber et al., 2009b, Hsu et al., 2012) the role of PtdIns(3)P has 
not been well investigated. Classically, PtdIns(3)P is found exclusively on early 
endosomes, markers of which have been shown to be excluded from the LCV (Clemens et 
al., 2000a, Urwyler et al., 2009b). Despite this, several LCV-localised effectors have been 
shown to bind PtdIns(3)P in vitro (Jank et al., 2012) however, PtdIns(3)P has never been 
shown to be present in the LCV. To being to address this question, A549 cells were 
transfected with 2xFYVE-GFP then infected for 5 h, fixed and stained and the localisation 
of FYVE observed. When infected with the WT strain, 2xFYVE-GFP recruitment to the 
bacteria could occasionally be seen in a small proportion of cells either as recruitment of 
vesicular structures to around the bacteria or co-localisation with the Legionella LPS 
staining (Fig. 4.15). These preliminary results suggests that PtdIns(3)P is found on the 
LCV however, more studies including time courses, would have to be performed to 
confirms this. The fact that 2xFYVE-GFP recruitment is only seen occasionally in 
infection while 4HA-LtpD is always seen on the LCV suggests that PtdIns(3)P in the LCV 
may be masked by other bacterial proteins, preventing 2xFYVE-GFP recruitment. 
Alternatively, the high local concentration of PtdIns(4)P in the LCV membrane (Weber et 
al., 2006, Brombacher et al., 2009) may promote binding of LtpD to PtdIns(4)P in 
infection as it is shown to interact with this lipid in the absence of PtdIns(3)P (Fig. 
4.13A).  
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Figure 4.15 2xFYVE-GFP is occasionally recruited to the LCV during infection  
A549 cells were transfected with 2xFYVE-GFP, a marker of PtdIns(3)P, then infected for 5 h 
with WT or ∆DotA L. pneumophila. In some cells, the WT, but not the ∆DotA, bacteria 
recruited 2xFYVE-GFP to the LCV. Scale bar 10 µm.  
 
4.14. Inhibition of PI-3K does not abolish LtpD localisation in transfection or in 
infection 
As LtpD was shown to bind to PtdIns(3)P in vitro, presumably depleting the pool of 
PtdIns(3)P would alter its subcellular localisation. Wortmannin is a potent inhibitor of 
phosphoinositide 3 kinase (PI-3K), the enzyme required for PtdIns(3)P production 
(Arcaro et al., 1993) and wortmannin treatment has been shown to abolish the 
localisation of the PtdIns(3)P-binding protein early endosomal antigen 1 (EEA1) 
(Simonsen et al., 1998, Sbrissa et al., 2002). In order to determine if wortmannin 
treatment could alter LtpD localisation, Hela cells were co-transfected with LtpD and 
2xFYVE-GFP, allowed to express for 20 h and treated for 1 h with 100 nM wortmannin 
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before fixation and staining. Wortmannin treatment completely abolished the vesicular 
localisation of 2xFYVE-GFP however did not affect the localisation of Myc-LtpD (Fig. 
4.16A). The effect of PI-3K inhibition was also analysed during infection, A549 cells 
expressing 2xFYVE-GFP were infected for 3 h with WT L. pneumophila expressing 4HA-
LtpD then treated for a further 1 h with 100 nM wortmannin in order to avoid pleotropic 
effects of the inhibition of PI-3K on the entry of the bacteria or establishment of the LCV 
(Weber et al., 2006). Although wortmannin treatment was effective in abolishing 
2xFYVE-GFP vesicular localisation, treatment of cells did not affect the recruitment of 
4HA-LtpD to the LCV (Fig. 4.16B). There are a number of possible explanations for this 
seemingly contradictory result. Potentially, the interaction with LtpD, but not 2xFYVE, 
prevents or slows down PtdIns(3)P turnover, allowing LtpD to remain anchored to the 
membrane. As LtpD was also shown to bind to PtdIns(4)P with lower affinity and 
PtdIns(4)P production is unlikely to be unaffected by wortmannin at the concentrations 
used (Etkovitz et al., 2007), it is possible that when the pool of PtdIns(3)P is diminished, 
LtpD uses PtdIns(4)P as an anchor. Alternatively, a wortmannin-insensitive host cell co-
factor may be required for LtpD localisation within cells. Further studies will attempt to 
answer these questions.  
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Figure 4.16 Treatment with wortmannin does not abolish LtpD localisation in 
infection or in transfection  
(A) HeLa cells were co-transfected with 2xFYVE-GFP and Myc-LtpD for 18 h then treated 
for 4 h with 100 nM wortmannin. Wortmannin treatment abolished localisation of 2xFYVE-
GFP but did not affect Myc-LtpD. (B) A549 cells were transfected with 2xFYVE-GFP then 
infected for 1 h with WT L. pneumophila 4HA-LtpD and then treated with 100 nM 
wortmannin for 4 h. As above, wortmannin treatment abolished 2xFYVE-GFP localisation 
but did not prevent 4HA-LtpD recruitment to the LCV. Results representative of at least two 
separate experiments, scale bar 10 µm.  
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4.15. Ectopically expressed LtpD interferes with vesicular trafficking 
In order to investigate the effect of expression of LtpD in eukaryotic cells, differential 
permeabilisation using digitonin or Triton X-100 was performed to determine if LtpD 
was on the inside or outside of the vesicular structures seen in transfection. No staining 
was observed using antibodies against lamina A, a component of the inner nuclear 
membrane (Gruenbaum et al., 2003), when the cells were permeabilised with digitonin 
however, staining was seen upon Triton X-100 permeabilisation (Fig. 4.17A). In contrast, 
Myc-LtpD staining was visible in cells permeabilised by both methods, suggesting that 
the Myc-LtpD is localised on the outer membrane leaflet of the vesicular structures seen 
in ectopic expression. 
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Figure 4.17 Myc-LtpD localises to the outside of large vesicular structures that do 
not co-localise with selected cellular organelles  
(A) After selective permeabilisation of membranes with Triton X-100, Myc-LtpD staining 
(green) was detected on vesicular structures and lamina A (red) was observed on the nuclear 
membrane however, upon permeabilisation with digitonin, lamina A was not accessible to 
antibodies. This indicates that Myc-LtpD is localised on the cytoplasmic surface of the 
vesicular structures. (B) HeLa cells were transfected with Myc-LtpD, fixed and stained using 
anti-Myc (green) and antibodies for selected cellular markers (red), DAPI DNA stain was also 
included. To visualise mitochondria, live cells were loaded with Mitotracker. No significant 
co-localisation between Myc-LtpD and Mitotracker, calnexin, GM130 or catalase was 
observed. Results are representative of at least two independent experiments. Scale bar 10 µm.  
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A number of Dot/Icm effector proteins have been shown to alter vesicular trafficking in 
human cells and in yeast (Shohdy et al., 2005, Franco et al., 2012). To investigate the 
makeup of the LtpD vesicular structures, the co-localisation with markers of various 
cellular compartments by direct antibody straining was analysed. Myc-LtpD did not co-
localise with or redistribute markers of the ER (calnexin), Golgi apparatus (GM130), 
peroxisomes (catalase) or mitochondria (Mitotracker) (Fig. 4.17B).  
 
As it was known that LtpD interacts with PtdIns(3), a key regulator of endocytic 
trafficking, it was decided to observe the effects of LtpD on the endocytic pathway. Myc-
LtpD was either co-transfected with markers of endosomal compartments fused to GFP 
(Fig. 4.18A) or transfected cells were stained with specific antibodies (Fig. 4.18B). Myc-
LtpD redistributed and co-localised with (arrows) markers of the endocytic pathway 
including early endosomes (Rab5-GFP and EEA1), early/recycling endosomes (VAMP3-
GFP and Rab4-GFP), late endosomes (Rab7-GFP) and lysosomes (LAMP2) however, did 
not affect the localisation of Rab1-GFP. Rab1 regulates the Golgi to ER secretory pathway 
and is recruited to the LCV where it is the target for several L. pneumophila effectors 
(Mukherjee et al., 2011, Tan et al., 2011b). The lack of Rab1, GM130 and calnexin (Fig. 
17B) redistribution upon ectopic-expression of LtpD suggests that LtpD causes a 
dramatic subversion of the endocytic pathway, but not the secretory pathway in HeLa 
cells.  
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Figure 4.18 Myc-LtpD co-localises with and redistributes markers of the endocytic 
pathway.  
HeLa cells were transfected with Myc-LtpD and either co-transfected (A) or specifically 
immunostained (B) for markers of the endocytic pathway. (A) Myc-LtpD co-localised with 
(arrows) and redistributed the endocytic markers Rab5-GFP, Rab4-GFP, VAMP3-GFP and 
Rab7-GFP but not the ER/Golgi marker Rab1-GFP or the recycling endosome marker Rab11-
GFP. (B) Myc-LtpD also co-localised with EEA1 and LAMP2. Images are representative of 
at least 3 separate experiments. Scale bar 10 µm.  
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4.16. Expression of 4HA-LtpD does not affect Rab5 localisation in infection 
 The small GTPase Rab5 is an EEA1 effector that also binds to PtdIns(3)P on early 
endosomes (Simonsen et al., 1998) and both Rab5 and EEA1 are crucial in early 
endosome fusion. As LtpD alters the localisation of Rab5 in ectopic expression, the result 
of overexpression of 4HA-LtpD was observed in infection. A549 cells were transduced 
using a non-replicating baculovirus expressing Rab5-GFP and the localisation of Rab5-
GFP observed during infection. BV.Rab5-GFP was not seen to be recruited to the LCV in 
infection with either WT or WT expressing 4HA-LtpD (Fig. 4.19). Previously, Rab5 has 
been shown to be excluded from the LCV during infection (Clemens et al., 2000a, 
Urwyler et al., 2009b) and the Dot/Icm effector VipD was shown to directly block Rab5 
activity (Ku et al., 2012). It is possible that LtpD promotes the recruitment of endosomal 
markers such as Rab5 however this action is inhibited by other translocated effectors. 
Antagonism between the functions of L. pneumophila effectors has previously been 
observed (Muller et al., 2010, Tan et al., 2011b) and may suggest that LtpD is temporally 
regulated. 
 
  
Figure 4.19 Expression of 4HA-LtpD does not affect Rab5-GFP recruitment to the 
LCV  
A549 cells were transduced with BV.GFP-Rab5 then infected with WT L. pneumophila or 
WT expressing 4HA-LtpD however no recruitment of BV.GFP-Rab5 was observed. Images 
representative of at least two separate experiments, scale bar 10 µm. 
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4.17 LtpD interacts with the host protein inositol (myo)-1 (or 4)-
monophosphatase-1 
To gain an insight into the function of LtpD, potential binding partners were sought. A 
yeast-2-hybrid (Y2H) screen was performed using LtpD as bait and a HeLa cDNA library 
of prey proteins, the hits obtained are summarised in Table 4.2. Of these, the enzyme 
inositol (myo)-1 (or 4)-monophosphatase-1 (IMPA1) appeared the most interesting for 
further study as it has previously been found in a proteomic study of the LCV (Urwyler et 
al., 2009b). A direct Y2H assay confirmed the interaction between LtpD and full length 
IMPA1 (Fig. 4.20A).  
Table 4.2 List of hits from Y2H 
screen 
Gene Name 
No. of 
Hits 
Structural maintenance of 
chromosomes 4 (SMC4) 
1 
Myotrophin (MTPN) Leucine repeat 
protein 
1 
(myo)- Inositol -1(or 4)-
monophosphatase 1 (IMPA1) 
1 
E3 ubiquitin-protein ligase (RNF8) 2 
Leucine rich repeat containing 59 
(LRRC59) 
1 
Splicing factor, arginine/serine-rich 
11 (SFRS11) 
1 
COX11 homolog  1 
Activating transcription factor 7 
interacting protein (ATF71P)  
1 
 
In mammals, two inositol monophosphatase genes have been identified, IMPA1 and 
IMPA2 which can be distinguished by spatial expression and activity in vitro (Ohnishi et 
al., 2007) and are both present at similar levels in human macrophages (De Meyer et al., 
2011). IMPA1 and IMPA2 have 53% identity at the amino acid level so it was decided to 
test the ability of LtpD to bind IMPA2. However, using the Y2H system, no evidence of 
interaction with IMPA2 could be seen, suggesting that LtpD does not bind to IMPA2 
under these conditions (Fig. 4.20B).  
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Figure 4.20 LtpD interacts with the host cell enzyme inositol (myo)-1 (or 4)-
monophosphatase 1 (IMPA1).  
(A) AH109 yeast co-transformed with pGBT9_LtpD and pGADT7_IMPA1 grew on both 
DDO and QDO selective media while co-transformation of either pGBT9_LtpD or 
pGADT7_IMPA1 with the empty pGADT7 or pGBT9 vectors, respectively, was unable to 
allow yeast growth on QDO. This demonstrates interaction of LtpD with IMPA1 however 
when the experiment was repeated using pGADT7_IMPA2 no interaction could be observed. 
(B) Co-transformation of AH109 with pGADT7_IMPA1 and pGBT9_LtpD1-472 or 
pGBT9_LtpD472-679 showed that LtpD472-679 is necessary and sufficient for the interaction 
between LtpD and IMPA1.  Results representative of at least two separate experiments.  
 
 
To map the domain of LtpD required for binding to IMPA1, direct Y2H experiments to 
test if LtpD1-469 or LtpD472-679 interact with IMPA1 were set up. Only transformation of 
yeast with the IMPA1 prey plasmid and the LtpD472-679 bait plasmid reconstituted growth 
on selective media, showing that the interaction with IMPA1 occurs through the C-
terminal domain of LtpD (Fig. 4.20C).  
To corroborate the interaction of IMPA1 with LtpD in an alternative assay, it was tested 
if Myc-LtpD and FLAG-IMPA1 could be co-immunoprecipitated from co-transfected HeLa 
cells. IMPA1-FLAG was specifically immunoprecipitated using anti-Myc antibodies only 
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when Myc-LtpD was present (Fig. 4.21A). Furthermore, confirming the results from the 
Y2H, Myc-LtpD472-679 was sufficient to immunoprecipitate FLAG-IMPA1 (Fig. 4.21B). This 
demonstrates that LtpD and IMPA1 interact in mammalian cells and that the C-terminus 
of LtpD, LtpD472-679 is sufficient for this interaction. 
 
Figure 4.21 Co-immunoprecipitation indicates LtpD/IMPA1 interaction via 
LtpD472-679.  
HeLa cells were co-transfected with Myc-LtpD full length (A), Myc-LtpD1-469 or Myc-
LtpD472-679 (B) and IMPA1-FLAG. IMPA1-FLAG could be co-immunoprecipitated with 
Myc-LtpD and Myc-LtpD472-679 but not Myc-LtpD1-469 using anti-Myc antibodies. Results 
representative of at least three separate experiments. 
 
4.18 Inhibition of IMPA1 activity does not affect LtpD localisation in infection  
IMPA1 activity can affect the production of phosphoinositides within the cell, inhibition 
of IMPA1 activity in D. discoideum has been shown to reduce the rate of formation of 
PtdInsP and PtdIns(4,5)P2 (King et al., 2009). In order to determine if IMPA1 inhibition 
of infected cells affected LtpD localisation, A549 cells were infected for 1 h with WT L. 
pneumophila 130b expressing 4HA-LtpD to allow internalisation of the bacteria, then 
washed and treated with 10 mM lithium chloride or 1 mM L-690,330 for 17 h. Lithium is 
a potent, non-competitive inhibitor of IMPA1 that can also inhibit other enzymes in the 
same pathway (Williams et al., 2002, Jope, 2003, Haimovich et al., 2012), while L-
690,330 is a specific, competitive inhibitor (Atack et al., 1993). Cells were fixed and the 
localisation of 4HA-LtpD analysed by immunofluorescence microscopy. Treated cells did 
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not display significantly altered cell death after infection (results not shown). Treatment 
with the IMPA1-inhibitors did not appear to affect 4HA-LtpD localisation and the 
bacteria could clearly replicate within treated cells (Fig. 4.22A). 
 
Figure 4.22 IMPA1 activity is not required for 4HA-LtpD localisation in infection 
and purified LtpD does not affect His-IMPA1 activity  
(A) A549 cells were infected for 1 h with WT expressing 4HA-LtpD then treated for 17 h 
with either 10 mM lithium chloride or 10 mM L-690,330, fixed and stained with anti-HA 
(red). Treatment of cells did not affect 4HA-LtpD localisation. Results representative of two 
separate experiments, scale bar 10 µm. (B) Free phosphate released by His-IMPA1 from the 
substrate inositol monophosphate was quantified using the Malachite green assay. Incubation 
of IMPA1 with the substrate resulted in the release of phosphate however the addition of GST 
alone or GST-LtPD did not affect the quantity of phosphate released. The specific inhibitor L-
690,330 was able to prevent IMPA1 activity. Results mean of two separate experiments 
performed in triplicate ± standard deviation.  
 
4.19 LtpD does not affect IMPA1 activity in vitro 
It has been shown that binding partners of IMPA1, such as calbindin, can alter its 
enzymatic activity in vitro (Berggard et al., 2002, Vig et al., 2009). In order to determine 
if LtpD was capable of directly altering IMPA1 activity, His-IMPA1 was purified and used 
in a Malachite green assay which quantifies phosphate released from the substrate, 
inositol monophosphate. L-690,330 was included to confirm that phosphate release is 
due to IMPA1 activity and not unspecific phosphatases. Incubation of GST-LtpD with the 
substrate in the absence of IMPA1 did not result in the release of phosphate (results not 
shown). Addition of purified GST-LtpD or GST did not alter the quantity of phosphate 
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released (Fig. 4.22B) suggesting that LtpD does not directly modulate IMPA1 activity in 
vitro.  
4.20 Inhibition of IMPA1 activity results in a subtle defect in bacterial 
replication 
In order to determine if IMPA1 activity was required for bacterial replication, THP1 
macrophages were infected with WT or ΔDotA L. pneumophila 130b then either 
untreated or treated with 10 mM L-690,330 and the CFU/ml was determined at 0, 24, 48 
or 72 h p.i. As expected, the ΔDotA strain did not replicate over the course of the 
experiment and inhibition of IMPA1 activity did not affect the bacterial clearance. 
Interestingly, treatment with L-690,330 appeared to result in a small but significant (P = 
0.0004) decrease in bacterial replication at 48 h p.i. however no significant decrease at 
24 or 72 h p.i. (Fig. 4.23). These results suggest that IMPA1 activity contributes to 
bacterial replication but that L. pneumophila replication can occur in its absence. As lack 
of IMPA1 activity can be complemented by increased uptake of inositol from the 
environment (Einat et al., 1998), it is possible that a more dramatic phenotype could be 
observed if the experiment was carried out in the absence of inositol in the media.  
 
Figure 4.23 Inhibition of IMPA1 activity results in a small inhibition of L. 
pneumophila replication.  
Differentiated THP1 cells were infected with WT or ∆DotA L. pneumophila 130b for 1 h then 
treated with 10 mM L-690,330 for the duration of the assay, CFU/ml was determined at 0, 24, 
48 and 72 h p.i. No difference in the kinetics of the ∆DotA strain was observed however at 48 
h p.i. there was a significant (P = 0.004, unpaired T-test) decrease in CFU for the WT. n.s. 
Not significant. Results mean of three separate experiments  ± standard deviation.  
 
 150
4.21 Deletion of LtpD does not affect recruitment of ER markers to the LCV 
In order to characterise the role of LtpD in infection, a gene deletion mutant was 
constructed in L. pneumophila 130b where LtpD was replaced with a kanamycin 
resistance cassette. Several characterised effector proteins affect the recruitment of ER-
derived vesicles to the LCV (Ragaz et al., 2008, Ninio et al., 2009, Hervet et al., 2011) so it 
was decided to test if deletion of LtpD affected ER-recruitment in infection. CREB3 is a 
transcription factor that is localised to the ER (Liang et al., 2006) and was used as a 
marker for the ER. A549 cells ectopically expressing CREB3-FLAG were infected for 5 h 
with either the WT or ΔLtpD L. pneumophila 130b strain and were fixed and stained 
using anti-FLAG and anti-Legionella antibodies. CREB3-FLAG was recruited to the LCV in 
infection in both the WT and ΔLtpD strain (Fig. 4.24A) and no differences in CREB3-
FLAG recruitment were observed.  
Calnexin, another ER-resident protein, is a well-established marker of the LCV (Kagan et 
al., 2002, Derre et al., 2004) and the amoebae Dictyostelium discoideum expressing 
calnexin-GFP has been used to visualise the LCV during infection (Derre et al., 2004, 
Fajardo et al., 2004, Urwyler et al., 2009b). D. discoideum A2X stably expressing calnexin-
GFP were infected at an MOI of 40 and DAPI was used to visualise the nucleus and 
bacteria. At 5 h p.i. both WT and ΔLtpD bacteria had recruited calnexin-GFP to the LCV 
and no difference in the recruitment could be seen (Fig. 4.24B). These results 
demonstrate that the ΔLtpD strain is able to recruit ER-derived vesicles to the LCV.  
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Figure 4.24 Deletion of LtpD does not affect ER-resident protein recruitment 
(A) A549 cells were transfected with CREB3-FLAG then infected with L. pneumophila WT 
or ∆LtpD for 5 h. Cells were stained using anti-Legionella (red), anti-FLAG (green) and 
DAPI DNA stain. CREB-FLAG was seen surrounding both the WT and ∆LtpD bacteria and 
no difference could be seen between the strains. (B) D. discoideum expressing calnexin-GFP 
were infected with WT and ∆LtpD for 5 h, Calnexin-GFP was seen surrounding both strains 
equally. Results representative of at least two separate experiments, scale bar 10 µm.       
 
4.22. LtpD does not affect PtdIns(4)P-recruitment to the LCV 
It is now well established that L. pneumophila increases the concentration of PtdIns(4)P 
on the LCV through the action of multiple effector proteins (Weber et al., 2009b, Hsu et 
al., 2012) and that a number of effectors, including  SidC specifically bind to PtdIns(4)P 
(Weber et al., 2006). The PtdIns(4)P-binding domain of SidC has been identified as 
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SidC609-918 (Weber et al., 2006), this region was used as a marker for the presence of 
PtdIns(4)P in the LCV membrane. SidC609-918 was fused to an N-terminal Myc-tag and 
ectopically expressed in A549 cells as a marker for PtdIns(4)P. Transfected cells were 
then infected with WT, ΔLtpD or WT expressing 4HA-LtpD for 5 h and fixed and stained 
as previously described. All three strains recruited Myc-SidC to the LCV and no 
significant differences in the Myc staining could be observed (Fig. 4.25). This 
demonstrates that the presence or absence of LtpD does not significantly affect the 
recruitment of PtdIns(4)P-binding domain of SidC to the LCV.  
 
Figure 4.25 Deletion of LtpD does not affect PtdIns(4)P-recruitment to the LCV  
A549 cells were transfected with Myc-SidC609-918, the PtdIns(4)P-binding domain of SidC, 
and infected for 5 h with WT, ∆LtpD or ∆LtpD expressing p4HA-LtpD. Cells were stained 
with ant-Myc and anti-Legionella or anti-HA. No difference in recruitment between the WT, 
∆LtpD and 4HA-LtpD strains was seen. Results representative of two separate experiments, 
scale bar 10 µm.       
 
4.23. LtpD has a role in bacterial replication in macrophages 
In order to determine the role of LtpD during infection, the ΔLtpD strain was used in 
infections of A549 epithelial cells and THP-1 macrophages. In order to determine if the 
ΔLtpD strain had a defect in entering cells a gentamicin protection assay was performed, 
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A549 cells were infected with WT, ΔDotA, ΔLtpD L. pneumophila 130b or ΔLtpD 
expressing 4HA-LtpD on a plasmid at an MOI of 40 for 1 h. After 1 h of gentamicin 
treatment (to remove extracellular bacteria), the cells were lysed and the percentage of 
the inoculum that had been internalised quantified. No significant difference in the 
percentage of bacteria that were protected from gentamicin treatment between the WT 
and the ΔLtpD strain could be seen although a lower percentage of the ΔDotA bacteria 
were able to enter the cells (Fig. 26A). The percentage of internalised bacteria was 
broadly in line with what has previously been reported in this cell type (Newton et al., 
2006). In cells infected as above, the intracellular growth over 72 h was determined by 
bacterial plating. The ΔDotA strain did not replicate however persisted over the course 
of the experiment. No difference in the replication between the other strains was seen 
(Fig. 4.26B).  
As macrophages are believed to be the primary cell type infected in lungs (Winn et al., 
1981), the contribution of LtpD to infection was also analysed in differentiated, 
macrophage-like THP-1 cells. No difference was measured between the WT and ΔLtpD 
strains in the percentage of bacteria to be internalised after 1 h of infection (Fig. 4.26C) 
or to replicate during the first 18 h (Fig. 4.20D). However, at 24 h post infection the 
ΔLtpD strain had a subtle but significant (P = 0.0021) growth defect compared to the WT 
(Fig. 4.26D). This growth defect could be complemented by addition of 4HA-LtpD on a 
plasmid, confirming that the growth defect is due to absence of LtpD. 
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Figure 4.26 LtpD has a role in the replication of L. pneumophila 130b in THP-1 
macrophages.  
A549 cells were infected with L. pneumophila WT, ∆DotA ∆LtpD or ∆LtpD expressing 
4HA-LtpD (∆LtpD + p4HA-LtpD) and bacterial CFU quantified by plating. (A) Percentage of 
bacteria invading cells was determined after infecting for 1 h, treating with gentemicin and the 
percentage of bacteria remaining at 1 h compared to the inoculum. No differences in the 
percentage of the inoculum internalised were seen between the WT and ∆LtpD. (B) A549 
cells were infected as above and bacterial CFU determined. The ∆DotA strain did not 
replicate and no difference between the WT and ∆LtpD strains could be seen. (C) THP-1 
macrophages were infected as above and the percentage of internalised cells calculated. No 
significant differences between the strains were observed. (D) Bacterial CFU from infected 
THP-1 cells at indicated time points. No difference in CFUs between the WT and ∆LtpD 
strains was seen in the first 18 h p.i. From 24h p.i., the ∆LtpD strain showed a small but 
significant growth defect compared to the WT strain. This growth defect could be 
complemented by addition of p4HA-LtpD. Results are mean of at least three separate 
experiments ± standard deviation, significance calculated using unpaired T-test. 
 
Replication of L. pneumophila is associated with host cell death at later time points 
(Molmeret et al., 2002a), as the ΔLtpD strain was only attenuated at later time points, it 
was decided to analyse cell death. In order to quantify this, cell detachment (an early 
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step in cell death) was observed by determining the percentage of cells that remained 
after 8 h of infection in comparison to uninfected control cells. When infected at a high 
MOI (40) with the WT strain, only 25.4 ± 3.0% THP-1 cells remained while 80.0 ± 8.9% 
of cells remained after infection with the avirulent ΔDotA strain (Fig. 4.27). After 
infection with the ΔLtpD strain, 38.9 ± 5.0% of cells remained which was significantly (P 
= 0.004) more than the WT and this phenotype could be complemented by providing 
LtpD on a plasmid. These data show that LtpD has a subtle role in the replication of L. 
pneumophila in macrophages but not epithelial cells and that this attenuation is 
accompanied by reduced cell detachment.  
 
Figure 4.27 LtpD has a role in cell death in THP-1 macrophages 
Infection of THP-1 macrophages by ∆LtpD resulted in less cell detachment at 8 h p.i. than 
upon infection with L. pneumophila WT which could be complemented by expression of 
p4HA-LtpD. Results expressed as a percentage of cells remaining compared to the uninfected 
control. Results are mean of at least three separate experiments ± standard deviation, 
significance calculated using unpaired T-test. 
 
4.24. LtpD in infection of the G. mellonella infection model  
In order to determine of LtpD was required for Legionella virulence in in vivo infection 
models the G. mellonella model was used. Ten G. mellonella larvae were infected with 107 
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CFU of bacteria and larval survival monitored over 72 h p.i. There was no significant 
difference in larval mortality between the wild type and ΔLtpD strains over the course of 
the experiment (Fig. 4.28A).  
To confirm that LtpD had the same localisation in haemocytes as in human epithelial 
cells and macrophages, haemocytes infected with 4HA-LtpD were extracted at 5 and 24 
h p.i. and stained using anti-HA antibodies, DAPI was used to localise bacteria. 4HA-LtpD 
localised to the membrane of the LCV at both 5 and 24 h p.i. (Fig. 4.28B), confirming that 
the localisation of LtpD is unchanged in G. mellonella infection.  
 
Figure 4.28 LtpD has a role in fitness, but not mortality, in the G. mellonella 
infection model. 
Ten G. mellonella larvae were infected with 107 L. pneumophila 130b WT, ∆DotA, ∆LtpD or 
∆LtpD expressing 4HA-LtpD. (A) Deletion of LtpD did not affect larval mortality compared 
to the WT. Results mean of three separate experiments ± standard deviation. (B) The 
haemolymph of larvae infected with ∆LtpD expressing 4HA-LtpD was extracted at 5 and 24 h 
p.i, fixed and stained using anti-HA antibodies (red) and DAPI DNA stain (blue). 4HA-LtpD 
localised to the LCV at both 5 and 24 h p.i. Results are representative of at least two separate 
experiments, scale bar 5 µm.  
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Figure 4.29 LtpD has a role in bacterial fitness in the G. mellonella model 
Larvae were injected with WT and either ∆LtpD or ∆LtpD + p4HA-LtpD in a 1:1 ratio and 
the ratio of WT to mutant calculated at 0, 5, 18 and 24 h p.i. The WT significantly (P < 0.01, 
unpaired T-test) outcompeted the ∆LtpD strain at 18 and 24 h p.i. compared to the 
complemented strain. Please note the variation in scale of the graphs. Each point represents a 
separate experiment (from the pooled haemolymph of three larvae) while the bar is the mean 
± standard deviation.  
 
Although LtpD did not have a role in virulence in G. mellonella, it may contribute to the 
fitness of the bacteria. In order to test this hypothesis mixed infections were performed, 
aimed at establishing the competitive index (CI) of the mutant compared to the WT. 
After infecting larvae with a 1:1 ratio of WT to ΔLtpD or ΔLtpD + p4HA-LtpD bacteria, 
haemolymph was extracted at 0, 5, 18 and 24 h p.i. and the CFU of both strains was 
determined by plating onto selective CYE agar. No significant variation in the ratio of WT 
to ΔLtpD could be seen at 0 and 5 h p.i. However, at 18 and 24 h p.i. the WT significantly 
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(P = 0.0086 at 18 and P = 0.01 at 24 h p.i.) outcompeted ΔLtpD compared to mixed 
infections with WT and the complemented ΔLtpD + p4HA-LtpD strain (Fig. 4.26C). This 
demonstrates that LtpD contributes to the fitness of L. pneumophila in the G. mellonella 
infection model. 
 
4.25. LtpD has a role in bacterial replication and haemocyte destruction in the 
G. mellonella model 
In order to further characterise the role of LtpD, bacterial replication over the first 24 h 
during single infections was quantified. Larvae were infected as above and the 
haemolymph extracted at 0, 5, 18 and 24 h p.i. and plated onto CYE plates. The ΔDotA 
strain was cleared as expected and no difference CFUs between the WT and ΔLtpD could 
be detected until 18 h post infection (Fig. 4.30A). Importantly, a small but significant (P < 
0.005) difference between the WT and the ΔLtpD strain at 24 h p.i. was observed, which 
could be complemented by expressing 4HA-LtpD from a plasmid.  
Due to the rapid induction of larval mortality, it was not possible to observe bacterial 
replication past 24 h p.i. under standard conditions. In order to avoid this issue, larvae 
were injected with 106 CFU rather then 107 as this was shown to allow greater larval 
survival, allowing bacterial replication to be observed over 72 h. The WT strain 
continued to replicate over the experiment, reaching over 1 x 106 CFU/100g of 
haemolymph by 72 h p.i. while the ΔDotA strain exhibited no replication however 
appeared to persist at a very low level throughout the experiment. As seen above, there 
was no difference in replication between the WT and ΔLtpD strains over the first 18 h 
p.i. However, at 24 h p.i. there was a dip in CFU in the ΔLtpD strain and although the 
strain continued to replicate it did not catch up to WT levels within the 72 h p.i. (Fig. 
4.30B). Interestingly, the ΔLtpD strain could be complemented by addition of p4HA-LtpD 
up to 24 h p.i. after which the ΔLtpD + p4HA-LtpD strain behaved as the ΔLtpD strain. 
This could be due to loss of the plasmid, which has been reported previously (Higa et al., 
2001, Molofsky et al., 2006). 
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Figure 4.30 The LtpD strain has a defect in replication in G. mellonella  
(A) Larvae were infected with 107 L. pneumophila 130b WT, ∆DotA, ∆LtpD or ∆LtpD 
expressing 4HA-LtpD. Haemolymph was extracted from infected larvae at 0, 5, 18 and 24 h 
p.i and the CFU quantified. No difference between the WT and ∆LtpD strains could be seen 
up to 18 h p.i. However, at 24 h p.i. there was a significant difference in the CFU (P = 0.004, 
unpaired T-test), which could be complemented by expression of 4HA-LtpD. (B) Larvae were 
infected with 106 CFU of WT, ∆DotA, ∆LtpD or ∆LtpD expressing p4HA-LtpD and the 
haemolymph extracted and CFU quantified at 0, 5, 18, 24, 48 and 72 h p.i. The ∆LtpD strain 
reached lower CFUs (P < 0.06, unpaired T-test) than the WT after 24 h p.i. and this difference 
remained steady over the course of the experiment. Results are the mean of three separate 
experiments ± standard deviation. (C) Larvae were infected as above with the addition of the 
∆LtpD + p4HA-LtpD472-679 strain. Haemolymph was extracted from infected larvae and the 
number of haemocytes quantified at 5, 18 and 24 h p.i. No difference in haemocyte number 
between the WT and ∆LtpD strains could be seen at 5 or 24 h p.i. however at 18 h there was a 
significant (P = 0.004, unpaired T-test) difference in haemocyte number between the two 
strains. Results are the mean of four separate experiments ± standard deviation.   
 
The characterisation of G. mellonella as L. pneumophila model showed that infection with 
WT L. pneumophila resulted in significant haemocyte depletion by 18 h p.i. As deletion of 
LtpD resulted in less cell detachment during macrophage infection, the requirement of 
LtpD in haemocyte depletion was tested (Fig. 4.30C). Haemolymph was extracted from 
insects infected as above at 5, 18 and 24 h p.i. and the haemocyte concentration 
determined. At 5 h p.i. no difference in haemocyte concentration could be detected 
between the larvae infected with the different strains. However, at 18 h p.i. larvae 
infected with the ΔLtpD strain contained significantly (P = 0.004) more haemocytes than 
the WT infected larvae and by 24 h p.i. this difference was abolished. Therefore, 
infection with the ΔLtpD strain appeared to result in a delay in haemocyte destruction. 
Interestingly, complementation of the ΔLtpD strain with a plasmid encoding only 4HA-
LtpD472-679 resulted in a partial complementation in the observed phenotype, suggesting 
that the C-terminal of LtpD has an important role in the proteins function, however that 
the entire protein is required for the in vivo effect of LtpD.  
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4.26. LtpD is required for L. pneumophila fitness during replication in A/J 
mouse lungs  
As LtpD was shown to have a role in the G. mellonella in vivo model, the competitive 
fitness of the ΔLtpD mutant in a mixed infection of susceptible A/J mice was determined 
(Fig. 4.31). Mouse work was carried out by Ms. Clare Oats (University of Melbourne). 
Determination of bacterial CFU after 72 h showed a mean CI of 0.372 for ΔLtpD versus 
WT and a mean CI of 1.219 for ΔLtpD + p4HA-LtpD (P = 0.017) versus WT infection, 
mirroring the results found in G. mellonella and indicating that LtpD is required for full 
fitness in the mouse lung.  
 
Figure 4.31 LtpD has a role in the fitness of L. pneumophila in the A/J mouse model  
Pulmonary infections of A/J mice with L. pneumophila 130b WT and either the mutant 
∆LtpD strain or ∆LtpD + p4HA-LtpD in a 1:1 ratio were introduced into the lungs of A/J 
mice by intratracheal inoculation. At 72 h p.i., the ratio of WT to ∆LtpD in infected lungs was 
determined. The ∆LtpD strain was outcompeted (competitive index = 0.372) by the WT in the 
mouse lung and this could be complemented. Data are representative of actual values obtained 
per mouse and a solid bar represents the mean value (P=0.017, unpaired T-test). 
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4.27. Discussion 
 
The Dot/Icm T4SS of L. pneumophila translocates over 275 effector proteins into the 
host cell, however the function of most remains unknown (Zhu et al., 2011). Recent 
advances in the characterisation of some of these proteins have shown that L. 
pneumophila can alter a multitude of cellular processes including lipid metabolism (Hsu 
et al., 2012), protein synthesis (Fontana et al., 2011), vesicular trafficking (Ge et al., 
2009), innate immune signaling (Ge et al., 2009), autophagy (Choy et al., 2012) and 
apoptosis (Banga et al., 2007). In order to further understand the effects of translocated 
proteins on the host cell, the function of the Dot/Icm effector LtpD was studied. In this 
study, LtpD was found to localise to the LCV via a direct interaction with PtdIns(3)P and 
to bind to the host cell enzyme IMPA1. The implications for this are discussed in further 
detail below. A model for the action of LtpD is presented in Fig. 4.32.  
Figure 4.32 Schematic demonstrating a model of LtpD function in infection. 
LtpD is translocated by the Dot/Icm secretion system and localises to the LCV through 
direct interaction with PtdIns(3)P. The C-terminus of LtpD also binds IMPA1 and 
potentially recruits this protein to the LCV. 
 
LtpD joins the ranks of PtdInsP-anchored Legionella effector proteins as a 17 kDa 
internal domain (LtpD472-626), mediated interaction with PtdIns(3)P. Several PtdIns(3)P-
binding L. pneumophila effectors have previously been identified, the effector SetA and 
the non-T4SS effector LpnE both preferentially bind PtdIns(3)P while LidA binds 
PtdIns(3)P and, with slightly lower affinity, PtdIns(4)P (Weber et al., 2009b, Neunuebel 
et al., 2011, Jank et al., 2012). Similarly, SidM which interacts preferentially with 
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PtdIns(4)P, was found to bind PtdIns(3)P with limited efficiency in vitro (Brombacher et 
al., 2009). It is clear that LtpD preferentially binds to PtdIns(3)P, however in vitro results 
suggest that in the absence of PtdIns(3)P, LtpD is capable of binding to other lipid 
species, such as PtdIns(4)P. Interestingly, abolishing PtdIns(3)P production by 
inhibition of PI-3K by wortmannin did not alter the localisation of LtpD in ectopic 
expression or in infection, although 2xFYVE-GFP localisation was eliminated. Typically, 
PtdIns(3)P is turned over very quickly (Stack et al., 1995), resulting in the rapid loss of 
2xFYVE-GFP localisation upon PI-3K inhibition. It is possible that the interaction 
between LtpD and PtdIns(3)P prevents turnover of the phospholipid. This has been 
previously observed in binding by host cell proteins to PtdIns(3)P, preventing its  
degradation and leading to an increase of PtdIns(3)P in the cell (Wurmser et al., 1998).   
 
An alternative hypothesis for this result may be that different mechanisms are used in 
transfection and infection, potentially there may be no PtdIns(3)P in the LCV, and so 
instead LtpD binds to PtdIns(4)P in the LCV. L. pneumophila specifically up-regulates the 
level of PtdIns(4)P on the LCV (Weber et al., 2009b, Hsu et al., 2012). However, the 
localisatin of several PtdIns(3)P-binding effectors on the LCV suggests that this 
phospholipid is also present. Our observation that ectopically-expressed full length LtpD 
and the 17 kDa PtdIns(3)P-binding region of LtpD472-626, but not LtpD lacking the 17 kDa 
region, could be recruited to intracellular WT L. pneumophila, supports this hypothesis. 
However, host or L. pneumophila PtdInsP-metabolising enzymes which influence the 
PtdIns(3)P level on the LCV have not yet been identified. Interestingly, it has been 
shown that inhibition of PI-3K activity promotes intracellular replication (Weber et al., 
2006, Peracino et al., 2010), however the complexity of the signaling pathways involved 
means there is no guarantee PtdIns(3)P is found on the LCV. Detailed kinetics and 
quantification of PtdIns(3)P levels correlated to the presence and quantity of 
endogenous PtdIns(3)P-binding effectors on the LCV are needed to clarify the 
mechanisms underlying the exploitation of PtdIns(3)P by L. pneumophila. In eukaryotic 
cells, PtdIns(3)P is a less abundant phosphoinositide found exclusively on early 
endosomes (Behnia et al., 2005). It has been shown that early endosome-associated 
proteins are excluded from the LCV (Clemens et al., 2000a, Urwyler et al., 2009a) 
 164
suggesting that either any recruitment of PtdIns(3)P occurs transiently or that other 
mechanisms are at work preventing the recruitment of early endosomal proteins.  
 
It was found that LtpD binds to inositol (myo)-1 (or 4)-monophosphatase-1 (IMPA1) 
however not to the homologue, IMPA2, and that this interaction is mediated via LtpD472-
679. The D. discoideum homologue of IMPA1 was previously found in a proteomic analysis 
of the LCV (Urwyler et al., 2009b), however was not found in another similar study 
(Shevchuk et al., 2009). It should be noted that these studies were carried out using 
different methods of purification and different L. pneumophila strains, so variations 
between the results is to be expected. One caveat is that the study carried out by 
Urwyler and colleagues used L. pneumophila strain Philadelphia, which does not express 
an LtpD homologue, indicating that recruitment of the enzyme can occur independently 
of LtpD. Similarly, the inositol polyphosphate 5-phosphatase OCRL1 interacts directly 
with PtdIns(3)P-binding protein LpnE, which is localised on the LCV, however OCRL1 
recruitment occurs independently of LpnE expression (Weber et al., 2009b), suggesting 
that other host or L. pneumophila proteins have a role in its recruitment. Future studies 
will attempt to confirm the localisation of IMPA1 on the LCV.  
 
The enzymatic activity of IMPA1 has been investigated thoroughly due to its proposed 
role in the pathogenesis of bipolar disorder (Williams et al., 2002), yet it has not been 
previously identified as target for bacterial virulence factors. The key role IMPA1 
occupies in the production of PtdIns may suggest that L. pneumophila may targets it to 
regulate the lipid metabolism of the cell. However, the in vitro phosphate assay did not 
show a role for LtpD either in inhibiting or activating IMPA1. It is possible that other 
proteins, of either host or bacterial origin, are also required for modulation of the 
enzyme’s activity. Furthermore, the assay was undertaken using optimal conditions for 
in vitro IMPA1 activity (Barnett et al., 1970, Ohnishi et al., 2007, Vig et al., 2009) 
however, interaction of the IMPA1-binding protein calbindin D28k has the greatest 
effect at suboptimal conditions (Berggard et al, 2002)  so the effect of LtpD may only be 
seen under specific conditions. Recently, the effectors LpdA and LecE have been 
implicated in the subversion of phospholipid biosynthesis by L. pneumophila (Viner et 
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al., 2012). Further studies will reveal how LpdA, LecE and LtpD act to manipulate host 
lipid metabolism and if LtpD is capable of modulating IMPA1 activity.    
 
Upon ectopic expression, it was found that LtpD co-localises with and redistributes a 
number of markers of the endosomal pathway, including EEA1, Rab5, Rab4, VAMP3, 
Rab7 and LAMP2. Vesicular trafficking and maturation is a highly dynamic process, 
which is tightly regulated by a complex network of protein-protein and protein-lipid 
interactions (Nicot et al., 2008, Huotari et al., 2011). EEA1 and Rab5 are usually found on 
early endosomes, which are also enriched in PtdIns(3)P, possibly explaining the co-
localization of LtpD with these markers. However, LtpD also induces redistribution of 
early endosomes to large perinuclear structures, which contain markers typically found 
other vesicular compartments. Previously, studies in yeast have found that ectopic 
expression of a number of L. pneumophila effector proteins affects vesicular trafficking 
(Shohdy et al., 2005, de Felipe et al., 2008). L. pneumophila is commonly assumed to 
avoid the endocytic pathway; however selective interactions may occur as Rab7 and 
components of the vATPase have been shown to be recruited to the LCV (Clemens et al., 
2000b, Urwyler et al., 2009b) while LAMP1 is found at later time points (Sturgill-
Koszycki et al., 2000, Urwyler et al., 2009b). This data may suggest a role for LtpD in the 
evasion and/or selective interaction of the LCV with the endosomal pathway.  
 
Importantly, it was showed that LtpD contributes to the fitness of L. pneumophila 130b 
during replication in both macrophages and in more complex in vivo models of infection. 
The replication defect of the ΔLtpD strain in macrophages and G. mellonella is subtle; 
however as LtpD is not conserved across L. pneumophila isolates, it was unlikely that the 
effector would be indispensable for intracellular replication. No defect in the ability of 
the bacteria to be internalised or the replication was observed before 24 h p.i. in any of 
the models tested. This suggests that the ΔLtpD strain, rather than having a defect in the 
establishment of the LCV (confirmed by the ability of the bacteria to recruit ER to the 
LCV) or in intracellular replication, instead is less able to escape from the host cell. 
Several bacterial proteins have previously been shown to be important in the egress of 
the bacteria from the cells; the Dot/Icm effectors LepA and LepB, are required for 
release of bacteria from amoebae but not macrophages (Chen et al., 2004), while IcmT is 
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required for cytolysis-mediated escape from both mammalian cells and amoebae (Alli et 
al., 2000, Molmeret et al., 2002b). L. pneumophila mutants defective in bacterial egress 
from macrophages underwent significantly less contact-dependent cytotoxicity within 
the first 24 - 48 hours p.i. compared to the WT and were significantly attenuated in the 
A/J mouse mode (Alli et al., 2000). These data are reminiscent of the results acquired for 
the ΔLtpD strain and bacterial egress in the mutant strain will be further investigated in 
future studies. The mechanism by which LtpD could affect bacterial egress is elusive; 
IcmT is predicted to be a pore-forming toxin (Molmeret et al., 2002b, Chen et al., 2004, 
Chen et al., 2007) however, results from transfection and bioinformatic predications 
gave no indication that LtpD has any toxin activity. As the depletion of G. mellonella 
haemocytes could only be partially restored by expression of the C-terminus of LtpD, the 
N-terminal domain may have a role in intracellular replication. Further characterisation 
of this domain may help shed light on this interesting question.  
 
Taken together, I have demonstrated that the novel Dot/Icm T4SS effector LtpD binds to 
the lipid PtdIns(3)P and the host cell protein IMPA1. The presence of LtpD contributes to 
the fitness of L. pneumophila 130b in infection of macrophages and the lungs of 
susceptible mice. Future studies will focus on elucidating the function of the members of 
the LtpD-family of hybrid effectors and the role of IMPA1 in L. pneumophila infection. 
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Chapter 5 – General Discussion  
 
5.1 How can the G. mellonella model be used to further investigate L. 
pneumophila pathogenesis? 
 
The evolutionary adaptations that have allowed Legionella to parasitise amoebae are 
believed to enable it to survive and replicate within mammalian macrophages. It is likely 
that it is this ability to subvert conserved evolutionary pathways in phagocytes that also 
allows L. pneumophila to infect haemocytes from insects such as D. melanogaster and G. 
mellonella. Use of G. mellonella as a model host has several technical advantages over 
other infection models: the larvae are large enough to be infected by injection by hand 
and do not require anaesthesia; furthermore, results can be obtained rapidly and there a 
number of quick assays, including analysis of larval mortality, bacterial replication and 
haemocyte enumeration, for analysis of L. pneumophila virulence. Additionally, unlike D. 
discoideum, G. mellonella expresses the transcription factor NF-κB and several caspases 
(Golstein et al., 2003, Roisin-Bouffay et al., 2004, Vogel et al., 2011, Khoa et al., 2012b), 
allowing for a greater understanding of the manipulation of immune signalling or cell 
death by L. pneumophila. Use of G. mellonella also has ethical advantages, as an 
invertebrate, it is not subject to ethical guidelines in working with animals and can 
contribute to the reduction and replacement of animals in biomedical research. 
 
This work has focused on establishing the G. mellonella model for L. pneumophila 
infection, however the ease of use and flexibility of this model make it ideal for further 
studies. Of the over 50 identified Legionella spp., half have been associated with human 
disease (Newton et al., 2010). The most clinically relevant species, aside from L. 
pneumophila, are L. longbeachae and L. bozemanii (Muder et al., 2002, Phares et al., 
2007) and would be ideal candidates to test in the G. mellonella model. These could be 
compared to environmental species that are rarely associated with disease, such as L. 
anisa (Muder et al., 2002), and species where the virulence is unknown in humans. A 
study comparing virulence between several Legionella spp. has been performed in 
human macrophages (Alli et al., 2003) however, has not yet been attempted in vivo. It 
would be interesting to determine whether the virulence in G. mellonella matches the 
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prevalence and exacerbation of clinical cases. Although 90% of human disease is 
associated with L. pneumophila serogroup 1, infection with L. pneumophila serogroup 6 
has been suggested to result in worse clinical outcomes (Marston et al., 1994, St-Martin, 
2013), however there is currently no hypothesis for the mechanism of this increased 
virulence. Using G. mellonella to investigate the virulence of Legionella spp. and L. 
pneumophila non-serogroup 1 strains could provide a quick, cost-effective model for 
direct comparison of species and strains.  
 
There are number of L. pneumophila strains typically used in research, however 
relatively few studies have been performed directly comparing them (Samrakandi et al., 
2002, Alli et al., 2003, Buse et al., 2011). The significant variation in virulence between 
four commonly used L. pneumophila strains in G. mellonella seen here, suggests that a 
more comprehensive screen could determine a representative set of strains for further 
characterisation in mice or cell culture assays. This strategy been successfully completed 
using Burkholderia cepacia complex in a G. mellonella infection model (Seed et al., 2008) 
and the data obtained demonstrated a good correlation between virulence in G. 
mellonella and in other models. In addition, combining the comparative virulence of 
strains with genomic data could potentially lead to the identification of novel bacterial 
virulence factors, which could then be further tested. 
 
Various cells types have been used to screen libraries of mutants and these studies have 
been important in identifying a number of virulence factors, including the initial 
discovery of the Dot/Icm secretion system (Brand et al., 1994, Segal et al., 1998a, Aurass 
et al., 2009). By using a more complex, multicellular model such as G. mellonella, it is 
possible that mutants with more subtle phenotypes could be distinguished. For example, 
abolishing phospholipase A activity (via deletion of PlaB) has no effect in bacterial 
replication in cell culture but bacteria display significantly reduced virulence in the 
mouse model (Flieger et al., 2004, Schunder et al., 2011). The ease of infection and of 
monitoring larvae for bacterial-induced mortality makes G. mellonella an attractive 
model for large-scale experiments. One previous study has used successfully guinea pigs 
for phenotypic analysis in this manner and discovered both previously identified and 
novel virulence factors (Edelstein et al., 1999). However, using mammalian models for 
this type of experiment can be prohibitively expensive and time-consuming so use of G. 
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mellonella would present a major advantage. As well as the search for novel virulence 
factors, it would be interesting to analyse the contribution of some established factors 
related to pathogenesis. It has been found that deletion of around 15 % of the genome 
prevented replication of L. pneumophila in amoebae but did not affect growth in 
macrophages (O'Connor et al., 2011), it would be interesting to analyse this strain in G. 
mellonella and compare with cell culture models. The T2SS of L. pneumophila has also 
been shown to be required for bacterial replication in the mouse model (Rossier et al., 
2004, McCoy-Simandle et al., 2011). However, as with the Dot/Icm T4SS, a number of 
effectors appear to be redundant in cell culture. Potentially, use of the more complex G. 
mellonella model could determine roles for these secreted proteins. 
 
Much of the interest in the L. pneumophila field is in establishing the function of the 
numerous Dot/Icm substrates, however redundancy between the effectors has been a 
stumbling block. In this study, the function of several proteins were analysed, most of 
which did not have an appreciable phenotype in virulence or bacterial replication. 
However, SdhA or combined deletion of three phospholipases did have a significant 
effect on virulence. Future studies could examine the role of AnkB or LubX, both of 
which have been shown to have a role in vivo (Kubori et al., 2010, Lomma et al., 2010) or 
of effectors which are important in cell culture but not yet tested in in vivo models such 
as SidJ or LegK2 (Liu et al., 2007, Hervet et al., 2011).  
 
Several approaches could be taken to even further develop G. mellonella as a model 
organism. Currently, researchers either maintain their own stocks of G. mellonella which 
can be done relatively cheaply and easily (Ramarao et al., 2012) or have bought larvae 
commercially available as fishing bait or reptile food. Although purchasing larvae is 
convenient it can be more difficult to standardise experimental conditions and the 
genetic variation between individual larvae is unknown. Using larger group numbers 
can reduce this variation however; the existence of a genetically identical prototype G. 
mellonella strain would be of benefit. An important approach will be the sequencing of 
the genome, this will be essential if G. mellonella is to become a widely adopted model 
and is currently a major weakness of this model over others such as D. melanogaster or 
C. elegans. Understanding of immune-related signaling pathways in Lepidopteran insects 
has increased significantly over recent years with the publication of the immune-related 
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transcriptome (Vogel et al., 2011, Khoa et al., 2012a). The transcriptome, potentially in 
combination with a future genome sequence, will provide researchers with important 
information, including identification of novel immune-related proteins and contributing 
to understanding how bacterial pathogens can evade clearance by the immune system. 
Likewise, the creation of genetic tools would be a major boon to the G. mellonella model. 
Techniques to knock out selected genes exist for D. melanogaster (Rong et al., 2001) and 
transposon-based techniques have existed for a number of insect species for many years 
(reviewed in (Fraser, 2012)). In combination with the genome, the ability to alter the 
host genetic environment would be a major technical advantage.  
The recent uptick of interest in invertebrate models as models for human infections is 
likely to drive many of these changes. Already, standardised protocols are becoming 
available (Fuchs et al., 2010, Ramarao et al., 2012) and efforts are being made to 
increase consistency between researchers working with invertebrates (Junqueira, 
2012).  
 
5.2 The role of LtpD in L. pneumophila infection   
 
In the past ten years, over 275 substrates of the Dot/Icm secretion system have been 
discovered, of which at least 35 have been characterised in some detail. Although the 
sheer quantity of proteins can be daunting, investigation into L. pneumophila effector 
proteins has proved fruitful and demonstrated a number of virulence strategies not 
previously observed in other pathogens. This includes the first documentation of a  
‘metaeffector’, an effector that alters the expression of another effector (Kubori et al., 
2010). Additionally, the exquisite control L. pneumophila exerts over Rab1 through post-
translational modifications (Mukherjee et al., 2011, Tan et al., 2011b, Mihai Gazdag et al., 
2013) has revealed a number of novel biochemical mechanism, which may have further 
implications in cell biology. Regardless, the complexity of potential interactions, along 
with the high level of redundancy exhibited, makes the characterisation of individual 
proteins challenging. This may be about to change with the recent publication of a novel 
method to abrogate redundancy using a combination of bacterial deletion mutants and 
siRNA (O'Connor et al., 2012). By using this method, researchers can gain an 
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understanding of a proteins function in infection, something that previously has been 
very difficult.    
 
In this study I chose to focus on the Dot/Icm effector LtpD. LtpD is an unusual effector 
protein; alignment studies revealed that it appears to be a chimera of two separate 
proteins, both of which are found as domains of other translocated proteins. 
Interestingly, in this study no function was found for the N-terminal domain of LtpD. The 
homologue of this region, LtpK was identified here as a Dot/Icm effector protein and the 
LtpK homologue in the Philadelphia strain, Lpg2538, was previously identified in a 
transposon mutagenesis screen to have a role in bacterial replication in A. castellanii 
(Aurass et al., 2009). Moreover, Lpg2538 was shown to be required for bacterial 
replication in the absence of Bet5 from D. melanogaster, a protein involved in the 
tethering of ER-derived vesicles to target membranes (O'Connor et al., 2012). These 
results help confirm the importance of the LtpD-family of proteins to bacterial 
replication. Future studies will focus on the role of Lpg2538/LtpK in infection and 
determine if LtpK is able to partially complement for the lack of LtpD. The C-terminus of 
LtpD is homologous to the ankyrin repeat containing protein, Lpp0356, a Dot/Icm 
effector found only in the Paris strain. The presence of this C-terminal domain in two, 
otherwise unrelated effectors, suggests that this domain may act as a module to be 
swapped between effectors. Here, it is shown that this module mediates localisation of 
the protein by binding directly to PtdIns(3)P and early results suggest that Lpp0356 also 
binds this lipid.   
 
The manipulation of phosphoinositides by intracellular bacterial pathogens is well 
established (reviewed in (Pizarro-Cerda et al., 2004, Weber et al., 2009a, Payrastre et al., 
2012)). Using PtdIns as anchors for translocated effectors appears to be a fairly common 
mechanism for localisation of L. pneumophila effectors, however appears rarer for other 
bacterial pathogens. Anchoring of pathogen proteins via PtdIns has been seen in 
eukaryotic pathogens of plants where effectors were shown to bind to PtdIns(3)P on the 
outer membrane of the cell and to gain entry to the host cell by endocytosis (Kale et al., 
2010). Additionally, a RalF homologue from Rickettsia prowazekii has been shown to 
bind PtdIns(4,5)P2 and PtdIns(3,4,5)P3 although interestingly, L. pneumophila RalF does 
not appear to bind to these lipids (Brombacher et al., 2009, Alix et al., 2012). The lack of 
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sequence or structural homology to known PtdIns-binding domains in L. pneumophila 
effectors implies that translocated proteins from other bacterial pathogens may use 
anchoring to PtdInsP for localisation. Protocols to pull-down and identify PtdInsP-
binding proteins in infection using commercially available PtdInsP lipid vesicles have 
recently been published (Weber et al., 2013) and would be relatively easy to translate 
for other intracellular bacterial proteins such as Salmonella or Chlamydia.    
 
Although L. pneumophila has a number of mechanisms to utilize or modify lipids of the 
vacuole, the lipid composition of the LCV is still largely unknown. It has been established 
that PtdIns(4)P is present and that L. pneumophila actively acts to increase its 
concentration, however the presence or quantity of other PtdIns species is unknown. 
Mass spectrometry can be used to quantify PtdIns species from complex lipid 
membranes (Wenk et al., 2003) however, distinguishing lipids from a small vacuole from 
the total cellular lipids is technically challenging. The recent success of isolating vacuoles 
from infected D. discoideum (Urwyler et al., 2009b) provides a possible solution. 
Determination of the total lipid concentration of the LCV would allow the contribution of 
selected L. pneumophila proteins known to alter PtdIns metabolism, e.g. SidF (Hsu et al., 
2012), to be analysed and quantified. This technique would also allow the presence of 
PtdIns(3)P in the LCV membrane to be analysed, confirming that LtpD, and other 
selected effectors such as SetA (Jank et al., 2012), bind to the LCV via PtdIns(3)P. This 
discovery would trigger further investigation as to why other PtdIns(3)P-binding host 
cell proteins are only rarely seen on the LCV. The pivotal role that this phosphoinositide 
plays in endosomal trafficking suggests that if PtdIns(3)P is present, other effectors such 
as VipD which was recently shown to inhibit Rab5 activity, (Ku et al., 2012), are actively 
preventing the recruitment of endosomal markers.  
 
In this study I discovered that LtpD interacted directly with IMPA1. Although the in vitro 
biochemical activity of this enzyme has been well established (Atack et al., 1995), 
IMPA1’s effects in vivo are still being investigated. It is known that IMPA1 catalyses the 
rate-limiting step of inositol production, however, cells can still gain inositol from the 
environment, obfuscating results from in vivo experiments (Cryns et al., 2008). Although 
there is a suggestion that over activity of IMPA1 has a role in the pathology of biopolar 
disease, the mechanism remains unspecified and under debate (Williams et al., 2002, 
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Harwood, 2005, Silverstone et al., 2009). In addition, although it is known that 
interaction of IMPA1 with its binding partners can increase the enzyme’s activity 
(Berggard et al., 2002, Vig et al., 2009), the result of increased activity in vivo is 
unknown. It is possible that increasing the activity of IMPA1 could result in depletion of 
its substrate, inositol monophosphate. Inositol phosphates and derivatives are key 
signaling molecules in a huge number of cellular processes (Balla et al., 2009) and so any 
change in local concentration could have pleotropic effects on cellular function (Berridge 
et al., 1989, Harwood, 2005, Koldobskiy et al., 2011). IMPA1 has not previously been 
implicated in infection, however its involvement in a range of processes such as 
apoptosis (De Meyer et al., 2011) and autophagy (Sarkar et al., 2006) may make 
targeting this enzyme potentially attractive for intracellular pathogens. Interestingly, 
inhibition of IMPA1 activity has been shown to modulate phosphoinositide production 
and turnover (King et al., 2009), suggesting a potential mechanism whereby L. 
pneumophila, via LtpD, could modulate the lipid composition of the LCV. Future work 
will provide further insight in the general role of IMPA1 in Legionella infection and the 
consequences of IMPA1 and LtpD interaction for the activity of the enzyme, including 
investigation of the lipid content of the vacuole.  
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5.3 Concluding remarks 
 
This thesis has presented two studies, initially focusing on the development of a novel 
methodology for analysis of Legionella pathogenesis, and then examining the molecular 
function of a bacterial virulence factor. Models of bacterial pathogensis are required in 
order to understand the strategies used by the bacteria to cause disease. The first 
section of this study presents a detailed characterisation of the interaction between L. 
pneumophila and the larva of G. mellonella in an effort to establish a novel infection 
model. This lays the groundwork for future development of the G. mellonella model by 
analyzing the bacterial factors that are required and dispensable for virulence in this 
model. Use of this new tool will allow researchers to find novel factors required for 
virulence in an in vivo model.  
    
Characterisation of L. pneumophila effector proteins has proved to be very fruitful in 
understanding how the bacterium modifies the host cell to create a replicative niche. 
Analysis of the Dot/Icm effector LtpD resulted in the identification of a new family of 
chimeric effector proteins. Most interestingly, the deletion of this gene resulted in a 
defect in bacterial replication and fitness in vivo. The initial description of this family and 
characterisation of LtpD suggests that these proteins are important in bacterial 
replication and future work will determine the function of these proteins in more depth. 
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